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 I. SUMMARY 
At the request of the Walpole Board of Health, the Community Assessment Program (CAP) of 
the Massachusetts Department of Public Health (MDPH), Center for Environmental Health 
(CEH), conducted an evaluation of possible environmental exposures and cancer incidence in 
relation to the Bird, Inc. Landfill, located on Merchant’s Way, southwest of Norfolk Street in 
West Walpole, Massachusetts.  This evaluation was initiated based on community concerns 
about cancer in the MacDonald Circle and Swan Pond Village neighborhoods, and the presence 
of volatile organic compounds (VOCs) detected in groundwater at the landfill.  This project was 
conducted under a cooperative agreement with the Agency for Toxic Substances and Disease 
Registry (ATSDR) for MDPH to conduct public health assessments in Massachusetts.   
The investigation reviews available environmental data for the Bird Landfill site and considers 
potential ways that people may come into contact with contaminants detected in groundwater, 
surface water, and wetland soils and sediment.  The evaluation also looks at the pattern of cancer 
in Walpole, focusing on residential neighborhoods closest to the landfill.  Seven cancer types 
were evaluated in this investigation: cancers of the bladder, kidney, liver, lung and bronchus, and 
leukemia, as well as Hodgkin’s Disease and mesothelioma.  Using data from the Massachusetts 
Cancer Registry, rates for these cancer types were calculated for the town of Walpole as a whole 
and for the three census tracts that comprise the town.  Available information about risk factors, 
including environmental factors, related to the development of cancer was considered.   
Future exposures to VOCs and metals detected in onsite groundwater are possible in the future if 
private wells are installed down-gradient of the landfill, and groundwater is consumed as 
drinking water.  Except under extreme drought conditions, it is unlikely that groundwater 
contaminants detected at the Bird Landfill would reach the Zone II groundwater protection area 
for the Mine Brook municipal wells located 0.8 miles north of the site, and therefore exposures 
through public drinking water would not be expected.  Based on the levels of VOCs detected in 
onsite groundwater, groundwater flow direction, and distance to nearby homes, it is unlikely that 
contaminants would present an exposure concern for indoor air down-gradient of the site.  While 
intermittent exposures to onsite surface water, wetland soil, and sediment may be possible for 
individuals trespassing on site in the past, present, and future, contaminant concentrations 
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 detected in these media are low, and it is unlikely that intermittent exposures would result in 
adverse health effects.   
In general, most of the seven cancer types occurred near the rates expected for Walpole during 
the 19-year time period 1982-2000.  In Walpole as a whole, bladder cancer (1988-1993) and 
kidney cancer (1982-2000 and 1988-1993) were statistically significantly elevated among 
females.  This was due to statistically significant elevations in bladder cancer and kidney cancer 
among females from 1988-1993 in census tract (CT) 4113, where the Bird Landfill site is 
located.  There was also a statistically significant elevation in Hodgkin’s disease among females 
in Walpole as a whole during the middle time period 1988-1993.  An evaluation of available risk 
factor information suggested that tobacco use likely played an important role in diagnoses of 
kidney and bladder cancer for some individuals, and none of the seven cancer types were 
elevated in a consistent pattern over time or in any one area of Walpole.  Review of the 
geographic distribution of each of the cancer types in Walpole revealed no apparent spatial 
patterns at the neighborhood level.  For example, despite the statistically significant elevations 
observed among females during some time periods, the geographic pattern of bladder cancer, 
Hodgkin’s disease, and kidney cancer did not indicate a concentration or an atypical distribution 
of females diagnosed in Walpole as a whole or in CT 4113.  Further, no unusual concentrations 
of individuals diagnosed with the seven cancer types were observed in the vicinity of the Bird 
Landfill site or in any other area of Walpole.   
Based on criteria established by ATDSR, the Bird Landfill site would be classified as posing no 
apparent public health hazard in the past and present.  Since private wells could be installed in 
the path of contaminated groundwater north-northeast of the site making drinking water 
exposures possible, the Bird Landfill poses an indeterminate public health hazard in the future.  
However, based on a review of available environmental data for the Bird Landfill, analysis of 
possible exposure pathways, and an evaluation of the pattern of cancer in the area surrounding 
the site, results do not suggest that a common factor (environmental or nonenvironmental) played 
a primary role in the incidence of cancer in the town of Walpole as a whole or the census tracts 
that divide the town during the 19-year time period 1982-2000.   
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 II. INTRODUCTION 
At the request of the Walpole Board of Health, the Community Assessment Program (CAP) of 
the Massachusetts Department of Public Health (MDPH), Center for Environmental Health 
(CEH), conducted an evaluation of possible environmental exposures and cancer in relation to 
the Bird, Inc. Landfill, located on Merchant’s Way, southwest of Norfolk Street in West 
Walpole, Massachusetts.  This evaluation was initiated based on community concerns about the 
pattern of cancer in two nearby neighborhoods, MacDonald Circle and Swan Pond Village, and 
the presence of volatile organic compounds (VOCs) identified in groundwater samples collected 
at the landfill.  The Bird Landfill, which operated from 1968 to 1997, and these two 
neighborhoods are located approximately 2 miles southwest of Walpole’s town center (see 
Figures 1 and 2).  This project was conducted under a cooperative agreement with the Agency 
for Toxic Substances and Disease Registry (ATSDR) for MDPH to conduct public health 
assessments in Massachusetts.   
This investigation provides a review of potential exposure pathways to chemicals from the Bird 
Landfill, as well as a review of the pattern of cancer in Walpole that focuses on residential 
neighborhoods near the site.  Seven cancer types were selected for this investigation: cancers of 
the bladder, kidney, liver, lung and bronchus, and leukemia, as well as Hodgkin’s Disease and 
mesothelioma.  These cancer types were selected based on their possible relationship to 
contaminants identified at the Bird Landfill, resident concern over suspected elevations in some 
cancer types, and/or statistically significant elevations observed town-wide in published 
Massachusetts Cancer Registry reports (MCR).  To evaluate concerns about potential 
environmental exposures from the Bird Landfill site, MDPH contacted the Massachusetts 
Department of Environmental Protection (MDEP) to obtain and review available environmental 
data.   
Cancer rates were calculated for the town of Walpole during the years 1982–2000, the time 
period for which the most recent and complete cancer incidence data were available from the 
MCR at the time of analysis.  The town of Walpole is divided into three smaller geographic areas 
or census tracts (CTs): CT 4111, CT 4112, and CT 4113.  A census tract is a smaller geographic 
subdivision of a city or town that is designated by the United States Census Bureau.  Because 
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 age-group and gender-specific population information is necessary to calculate incidence rates, 
the census tract is the smallest geographic area for which cancer rates can be accurately 
calculated.  The Bird Landfill, MacDonald Circle, and Swan Pond Village are all located in CT 
4113.  The town of Walpole is located 19 miles southwest of Boston and is bordered by the 
towns of Dover and Westwood to the north, Norwood and Sharon to the east, Foxboro to the 
south, and Norfolk and Medfield to the west.  Walpole is primarily a suburban community and 
comprises an area of 20.5 square miles with 1,100 residents per square mile (U.S. DOC 2000).  
The 2000 United States Census reports a total of 22,824 residents in the town of Walpole (U.S. 
DOC 2000).  Census tract locations and boundaries in Walpole are shown in Figure 1.   
The results of the descriptive cancer analysis can be useful in identifying cancer patterns or 
trends in a geographic context, to determine if a common etiology (i.e., cause associated with the 
development) is possible, and may serve to identify areas where further public health 
investigations or actions may be warranted.  Descriptive analyses may also indicate that an 
excess of known risk factors associated with a disease, such as environmental exposures, exists 
in a certain geographic area.  This descriptive analysis of cancer incidence data cannot be used to 
establish a causal link between a particular risk factor (either environmental or 
nonenvironmental) and the development of cancer.  In addition, this analysis cannot determine 
the cause of any one individual’s cancer diagnosis.  The purpose of this evaluation is to report 
the findings on the patterns of cancer in Walpole, with a particular focus on the neighborhoods in 
the vicinity of the Bird Landfill site, and discuss them in the context of the available 
environmental information to determine whether recommendations for further public health 
action are needed.   
III. OBJECTIVES 
The specific objectives of this investigation were as follows: 
• To evaluate opportunities for environmental exposure(s) to nearby residents to 
contamination identified at the Bird Landfill site; 
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 • To evaluate the incidence rates of seven cancer types in Walpole as a whole and 
in areas near the Bird Landfill site to determine if cancer is occurring more or less 
often than expected; 
• To evaluate the geographic distribution of individuals diagnosed with cancer in 
Walpole to determine if there are any patterns in particular areas of town or in 
relation to areas of potential environmental concern; 
• To review available descriptive information from the Massachusetts Cancer 
Registry (MCR) for individuals diagnosed with cancer in Walpole to see if there 
are any particular characteristics related to known or suspected risk factors, 
including environmental factors, for developing these diseases; and 
• To discuss possible exposure pathways related to the Bird Landfill and the results 
of the cancer incidence evaluation in the context of the available scientific and 
medical literature on cancer and the contaminants of concern to determine 
whether further investigation or public health action is warranted.    
IV. BACKGROUND AND COMMUNITY ENVIRONMENTAL 
CONCERNS 
The Walpole Board of Health and community residents have expressed concerns about elevated 
levels of VOCs historically detected in groundwater at the Bird Landfill site and the incidence of 
cancer in two neighborhood areas, MacDonald Circle and Swan Pond Village, located east and 
northeast of the landfill (Figure 2).  In order to address these community concerns, the MDPH 
contacted the Massachusetts Department of Environmental Protection (MDEP) to obtain and 
review available environmental information pertaining to the Bird Landfill.  In addition, 
information regarding other potential environmental sources located in the area and listed with 
MDEP as a location of a hazardous release or spill was reviewed (MDEP 2005).   
The public health assessment titled “Evaluation of Cancer Incidence, 1982–2000, and 
Environmental Concerns Related to the Bird Landfill in Walpole, Norfolk County, 
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 Massachusetts” was released on September 13, 2006, for a 30-day public comment period.  No 
public comments were received by the MDPH during the public comment period.   
A. Bird Landfill 
The Bird Landfill is located on Merchant’s Way, southwest of Norfolk Street in Walpole, 
Norfolk County, Massachusetts, and the property consists of approximately 85 acres of land 
(GZA 1997).  To the northwest and northeast, the landfill is bordered by low-lying wetlands and 
some commercial developments.  There are residential properties located immediately southwest 
and east of the landfill (Bucket Mill Lane and MacDonald Circle neighborhoods, respectively).  
Refer to Figure 2 for a map of the landfill property.   
As shown in Figure 2, the landfill consists of two areas, Area I to the west and Area II to the east.  
Area I began operation in 1968 and was closed in 1980 (GZA 1997).  Area II began receiving 
process waste from Bird’s Norwood Roofing Plant as early as 1980, operated briefly as a 
recycling facility between 1992 and 1993, and subsequently operated as a landfill again through 
1997.  Neither Area I nor Area II is lined (John Morey, MDEP, personal communication, 2005).  
Area I consists of waste from Bird Manufacturing operations (mainly stone dust), wastes from 
Bird’s Norwood Roofing Plant (rolled roofing, shingles, solid drums of asphalt, stone granules, 
paper, wood, and scrap metal), and Bird’s Walpole Paper Mill (beater waste).  Area II waste 
consists of scrap asphalt roofing shingles, cardboard rolls, fiberglass mat, stone granules, solid 
asphalt, defective wooden pallets, and paper wrapping materials.  While in operation, the landfill 
was covered daily with at least 6 inches of stone dust from Bird, Inc.’s asphalt shingle roofing 
plant or silty sand/silt tailings from S. M. Lorusso’s West Sand Plant, both also located in 
Walpole (GZA 1997).  No asbestos wastes, infectious wastes, sludge, or special hazardous, 
liquid or banned wastes were reportedly accepted at the landfill (GZA 1997).  Area I was loamed 
and seeded in 1980 at the time of closure and Area II was capped in 2000 (GZA 1998, John 
Morey, MDEP, personal communication, 2005).  Post-closure groundwater monitoring continues 
at the landfill and sampling results are reported to the MDEP.   
The Bird Landfill is located outside the Zone II groundwater protection areas for two Walpole 
municipal well fields that draw from the Head of the Neponset Aquifer: the Mine Brook wells to 
the northeast and the Washington Street wells to the east.  A Zone II groundwater protection area 
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 is defined as the area of an aquifer which contributes water to a well under the most severe 
pumping and recharge conditions that can be reasonably anticipated.  Because the landfill is 
located outside the Zone II protection area, it is unlikely that groundwater from Area II of the 
landfill would reach municipal wells.  However, based on regional groundwater flow direction, 
GZA GeoEnvironmental, Inc. (GZA) [1998] identified the Mine Brook No. 2 well as a municipal 
well that would potentially be impacted under a worst case scenario.  Groundwater beneath Area 
I is thought to flow toward wetlands located to the north, south, and west of the landfill (GZA 
1998).  The closest private wells are located approximately 3,000 feet up-gradient or cross-
gradient from the landfill.  Two private wells were identified northeast of the landfill on Spring 
Street; however, GZA has reported that these private wells are located outside the estimated 
extent of potentially impacted groundwater (GZA 1998), and that one of the private wells is not 
in use.   
B. Other Potential Environmental Sources (Massachusetts Department of 
Environmental Protection 21E sites) 
In 1983, the Massachusetts Legislature established a statewide hazardous waste site cleanup 
program (the state Superfund program) under Chapter 21E of Massachusetts General Laws 
(M.G.L c21E, 310 CRM 40.0000).  Under this legislation, MDEP administers investigation and 
clean-up of hazardous material and oil release sites, known as “21E sites”, in the 
Commonwealth. 
The 21E sites are characterized by one or more releases of oil or other hazardous material.  
Releases can result from a variety of sources, including trucks and other vehicles, underground 
storage tanks, and aboveground storage drums.  Releases vary widely with respect to materials 
involved, the relative amount of materials released, and the geographic extent of contamination.  
Information on hazardous material and oil releases is available from 1977 to the present, from 
the MDEP Bureau of Waste Site Cleanup (MDEP 2005).  However, records prior to 1984 are 
known to contain significant data gaps.  
Hazardous material and oil releases are potential sources of exposure to contamination.  It is not 
possible to determine whether individuals residing in the evaluation area were actually exposed 
to contaminants without more detailed information about contaminant movement through the 
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 environment, the population at risk of exposure, a location of actual human contact with the 
contaminant, and evidence that the contaminant actually entered the body of persons at risk of 
exposure through ingestion, dermal absorption, or inhalation.   
In addition to the evaluation of environmental data associated with the Bird Landfill, MDPH 
reviewed the most recent information regarding oil or other hazardous material releases for the 
town of Walpole and mapped the approximate location of release sites with sufficient address 
information using a geographic information system (Figure 3) (ESRI 2004).  A total of 222 
releases were reported in the town of Walpole from 1983 to 2005.  The majority of these releases 
were mapped to an address in town; however, approximately 18% of the releases (n = 40) could 
not be mapped due to insufficient address information (most unmapped releases were located 
along the major roads).  There were no releases reported at the Bird Landfill.  The full list of 
releases recorded as “21E sites” in Walpole is shown in Table 1.   
V. REVIEW OF ENVIRONMENTAL SAMPLING DATA 
To address concerns about possible environmental exposures associated with the Bird Landfill 
site, MDPH reviewed information from several reports on file with MDEP.  Environmental 
sampling data were available for groundwater, surface water, sediment and wetland soils located 
onsite, with groundwater being the main focus of environmental investigations conducted at the 
landfill.  Available environmental sampling data were reviewed, and a screening evaluation was 
conducted to identify those substances that may need to be considered for further analysis to 
determine whether they may be of potential health concern.  The screening analysis identifies 
maximum concentrations of contaminants detected in various types of environmental media (i.e., 
air, soil, water) and compares these concentrations to health-based comparison values established 
by ATSDR (ATSDR 2005b, 2005c).  If an ATSDR comparison value was not available for a 
specific chemical, the maximum detected concentration of that chemical was compared to Risk-
Based Concentrations (RBCs) developed by the United States EPA Region III (U.S. EPA 2004) 
or the applicable groundwater and soil standards developed by MDEP (2004), in that order.  For 
compounds detected in groundwater, maximum concentrations were also compared with state or 
federal drinking water standards.   
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 The ATSDR comparison values are specific concentrations of a chemical for air, soil, or water 
that are used by health assessors to identify environmental contaminants that require further 
evaluation.  These comparison values are developed based on health guidelines and assumed 
exposure situations that represent conservative estimates of human exposure.  Chemical 
concentrations detected in environmental media that are less than a comparison value are not 
likely to pose a health threat.  However, chemical concentrations detected in environmental 
media above a comparison value do not necessarily indicate that a health threat is present.  In 
order for a chemical to impact one’s health, it must not only be present in the environmental 
media, but one must also come in contact with the chemical.  Therefore, if a concentration of a 
chemical is greater than the appropriate comparison value, the potential for exposure to the 
chemical should be further evaluated to determine whether exposure is occurring and whether 
health effects might be possible as a result of that exposure.  The factors related to exposure that 
are unique to the specific situation under investigation need to be considered to determine if an 
adverse health effect from this chemical could occur.   
A. Groundwater 
Environmental investigations associated with the closure of the Bird Landfill identified 
groundwater as the primary environmental media through which site contaminants could migrate 
offsite (GZA 1998).  Evaluation of site hydrology indicated that the majority of groundwater 
flow is through glacial outwash sands (GZA 1997).  Groundwater at the site flows generally in a 
northerly direction.  Local mounding in Area I is thought to cause groundwater in this area to 
flow toward wetlands to the north, east, and west (GZA 1997).  Groundwater flow in the glacial 
outwash aquifer near Area II appears to be in a north-northeast direction away from MacDonald 
Circle homes and in the direction of the Swan Pond Village neighborhood.  Groundwater in the 
deeper bedrock is to the northeast turning northward.   
The locations of groundwater monitoring wells are depicted in Figure 4.  Groundwater from both 
the bedrock and overburden strata was sampled (GZA 1997).  In 1984, seven groundwater 
monitoring wells (designated LF-1 through LF-7) were installed in the overburden of Area II 
during an environmental site assessment conducted for refinancing purposes (GZA 1997).  Four 
of these wells (LF-2, 3, 5 and 6) were replaced in 1988.  Shallow and deep wells were installed at 
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 two locations (LF-3 and LF-6) in 1994 to further investigate down-gradient impacts of Area II.  
In addition, a shallow monitoring well (LF-UP) was installed in 1994 at a location designated to 
be up-gradient of Area II and unaffected by Area I.  In 1996, five additional monitoring wells 
(CSA-1, CSA-2S and CSA-2D, CSA-7S and CSA-7D) were installed down-gradient of Area II, 
as well as five well borings (CSA-3, CSA-4D, CSA-5, CSA-6S and CSA-6D) around the 
perimeter of Area I.   
Most groundwater samples collected from monitoring wells in Area II were analyzed for the 
presence of VOCs, chloride, nitrate, nitrite, and sulfate two times per year (GZA 1997).  
Groundwater from this area was also evaluated every 2 years for metals, pesticides/herbicides, 
and oil and grease.  Metals were analyzed on a yearly basis beginning in 1992.  Monitoring wells 
installed around Area I in 1996 were analyzed for VOCs, nitrate, nitrite, sulfate, chloride, 
cyanide, and metals.  In addition to groundwater sampling at the landfill proper, three monitoring 
wells (B-1S, B-1D, and B-2) were installed at the western edge of the site in 1997 at locations 
designed to be representative of background conditions.  These ‘background’ wells were 
sampled for metals only (GZA 1998).  All groundwater monitoring wells were located on the site 
and no off-site groundwater contamination data were available.   
Table 2 summarizes the maximum concentrations of contaminants detected in Area I and Area II 
groundwater samples that exceeded comparison values.  Because ATSDR comparison values do 
not exist for groundwater, drinking water comparison values were used as screening values.  The 
following compounds were detected in groundwater at the Bird Landfill at levels above 
comparison values for drinking water: arsenic, barium, benzene, cadmium, chloroethane, 
chromium, copper, cis-1,2-dichloroethene, iron, lead, manganese, silver, tetrachloroethene, 
trichloroethene, and vinyl chloride.   
With some exceptions, VOCs were detected above comparison values in shallow and deep 
groundwater samples collected from three monitoring wells down-gradient of Area II.  
Specifically, the maximum concentration of tetrachloroethylene (PCE) (41 parts per billion 
[ppb]) was detected above the EPA Risk-Based Concentration (RBC) (1.2 ppb) and the MDEP 
Massachusetts Maximum Contaminant Level (MMCL) (5 ppb) in LF-6D, a deep monitoring 
well located close to the property boundary and down-gradient of Area II (Figure 4).  PCE was 
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 detected above comparison values each of the 22 times it was detected at this monitoring well 
during the time period 1994 to 2005.  PCE also exceeded comparison values in shallow 
monitoring wells LF-6S and LF-3S and deep monitoring well CSA-7D, all located down-
gradient of Area II.   
Like PCE, the maximum concentration of trichloroethylene (TCE) (34 ppb) was detected above 
the EPA RBC (1.6) and the MDEP MCL (5 ppb) at LF-6D.  TCE exceeded drinking water 
comparison values in shallow monitoring wells LF-3S and LF-6S and in deep monitoring well 
CSA-7D, all located down-gradient of Area II.   
The maximum concentration of vinyl chloride (24 ppb) exceeded the ATSDR Cancer Risk 
Evaluation Guide (CREG) for drinking water (0.03 ppb) and the MDEP MMCL (2 ppb) in 
shallow monitoring well LF-3S, which is close to the down-gradient property limit of Area II 
(Figure 4).  Vinyl chloride was also detected above the CREG and MMCL in shallow and deep 
monitoring wells LF-6S/6D and above the CREG but below the MMCL in shallow and deep 
monitoring wells CSA-7S/7D.   
Cis-1,2-dichloroethene exceeded the EPA RBC (61 ppb) and the MDEP MCL (70 ppb) for 
drinking water two times at separate locations.  The maximum concentration of this contaminant 
(110 ppb) was detected at shallow monitoring well LF-3S.  Cis-1,2-dichloroethene was also 
detected slightly above comparison values in deep monitoring well CSA-7D.   
The maximum concentration of chloroethane (250 ppb) was detected above the EPA RBC (3.6 
ppb) at monitoring well LF-3A, which is close to the down-gradient property limit of Area II 
(Figure 4).  Choroethane also exceeded the EPA RBC at six monitoring wells located both up-
gradient and down-gradient from Area II and at two monitoring wells near Area I.   
While the maximum concentrations of most VOCs were detected in Area II groundwater, the 
maximum concentration of benzene (21 ppb) exceeded the ATSDR CREG for drinking water 
(0.6 ppb) and the MMCL (5 ppb) at monitoring well CSA-3 in the west end of Area I (Figure 4).  
Benzene was also detected above the CREG and MMCL in two monitoring wells near Area I and 
slightly above the CREG (but below the MMCL) at monitoring well LF-3S, which is near the 
down-gradient property limit of Area II.   
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 A variety of metals have been detected in groundwater at the Bird Landfill since site 
investigations began in the mid-1980s.  According to sampling data, metals do not appear to be 
concentrated in any one particular area of the site.  Specifically, the maximum concentration of 
arsenic (189 ppb) exceeded the ATSDR CREG (0.02 ppb) and the U.S. EPA MCL for drinking 
water (10 ppb) at monitoring well LF-UP, a shallow monitoring well located up-gradient of Area 
II, but not down-gradient of Area I (Figure 4).  Arsenic was also detected above the CREG and 
the MCL in some monitoring wells located at or down-gradient from Areas I and II.  With the 
exception of CSA-2D, CSA-6S, and CSA-7D, iron was detected above the EPA RBC for 
drinking water (11,000 ppb) on at least one occasion at all monitoring wells in Areas I and II.  
The maximum concentration of iron (898,000 ppb) was detected at monitoring well LF-3D, a 
deep well located in the down-gradient portion of Area II.  The maximum concentration of lead 
(230 ppb) exceeded the EPA Action Level (15 ppb) at monitoring well LF-UP.  Lead was also 
detected slightly above the Action Level in one monitoring well near Area I and at six 
monitoring wells in both up-gradient and down-gradient locations near Area II.  With a few 
exceptions, manganese was detected above the Reference Dose Media Evaluation Guide 
(RMEG) for adults (2,000 ppb) on at least one occasion at all groundwater sampling locations in 
Areas I and II.  The maximum concentration of manganese (26,000 ppb) was detected in 
monitoring well LF-1, located in the northwest portion of Area II.   
Several other metals were detected slightly above comparison values at various locations 
throughout the site.  Specifically, barium was detected slightly above the RMEG (700 ppb) for 
childhood exposure to drinking water, but less than the adult RMEG of 2,000 ppb at two 
locations: north of Area I at monitoring well CSA-5 (741 ppb) and monitoring well LF-UP (986 
ppb) south of Area II (Figure 4).  Cadmium was detected above the MCL (5 ppb) on five 
occasions at monitoring wells located in Areas I and II.  The maximum concentration of 
cadmium (16.4 ppb) occurred in monitoring well CSA-2D, which is located down-gradient from 
Area II.  Total chromium and hexavalent chromium were detected above the MCL for 
hexavalent chromium at several locations in Areas I and II (comparison values for total 
chromium were not available).  The maximum concentration of total chromium (506 ppb) was 
detected in monitoring well LF-UP, and the maximum concentration of hexavalent chromium 
(580 ppb) was detected in down-gradient shallow well LF-7S.  The maximum concentration of 
copper (818 ppb) was detected above the ATSDR Intermediate Environmental Media Evaluation 
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 Guide (EMEG) for adult exposure (400 ppb) in monitoring well CSA-6S.  Silver was detected 
above the RMEG value for adults (200 ppb) on two occasions in Area II monitoring wells LF-1 
and LF-6D.  The maximum concentration of silver (250 ppb) was detected in LF-1.   
B. Surface Water 
The Bird Landfill is located at the western edge of the Neponset River Drainage Basin (GZA 
1997).  On the western portion of the property, surface water runoff flows south into Cedar 
Swamp, then to Cedar Swamp Brook approximately 8,000 feet south, and finally to the Neponset 
River, approximately 6,000 feet southwest of the site (GZA 1997).  Runoff from the northeastern 
portion of the site is mostly contained by grading at the landfill’s perimeter.  The remainder of 
runoff from Area II flows northeast into a small stream, where it flows northward to another 
segment of the Neponset River approximately 8,000 feet to the northeast.   
Surface water samples were collected from five onsite wetland areas adjacent to the landfill in 
1996 and analyzed for VOCs and metals (GZA 1997).  One sample (SW-1) was collected from 
an iron-stained groundwater seep at the western edge of Area I, another (SW-2) was collected 
from a channel west of Area I, and a third (SW-3) was taken from standing water in wetlands 
south of Area I (Figure 4).  SW-4 was collected from a stream south of Area II, and SW-5 was 
collected from a pond located between the landfill and MacDonald Circle just east of Area II.  
Repeat sampling of surface water locations near Area I occurred through 1998, and sampling of 
surface water locations near Area II were repeated through 2005 (GZA 2005).  In 1997, three 
additional ‘background’ surface water samples were collected from locations that were selected 
for being outside the area where surface water or groundwater from the landfill could migrate.  
Specifically, background surface water samples were collected at locations northwest, west, and 
southeast of the landfill in 1997 and 1998 and analyzed for metals (GZA 1998, 2002).   
Table 3 summarizes the maximum concentrations of contaminants detected in surface water 
samples that exceeded comparison values.  Because ATSDR comparison values do not exist for 
surface water, drinking water comparison values were used as screening values.  This is a 
conservative evaluation because guidelines for chemicals in drinking water assume adults ingest 
2 liters of water per day.  Exposures to chemicals present in surface water not used for drinking 
water purposes would be expected to be less than exposures to chemicals in drinking water.   
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 The maximum concentration of benzene (0.97 ppb) was detected in one surface water sample 
(SW-1) above the ATSDR CREG comparison value for drinking water (0.6 ppb), but was below 
the MDEP MCL for drinking water (5 ppb) (see Table 3).  SW-1 was collected from the iron-
stained groundwater seep at the west end of Area I.  No other VOCs were detected above 
comparison values in surface water.  
The following metals were detected in surface water at concentrations above or slightly above 
comparison values for drinking water: arsenic, barium, cadmium, iron, lead, manganese, and 
silver (Table 3).  Arsenic was detected in SW-5 at 6 ppb, which is above the CREG, but below 
the U.S. EPA MCL of 10 ppb.  Arsenic was not detected at the other four sampling locations.  
Barium was detected at all five sampling locations.  The maximum concentration of barium 
(1,080 ppb), which occurred at SW-1, was above the drinking water RMEG for children (700 
ppb), but below the adult RMEG (2,000 ppb).  Cadmium was detected in SW-1, SW-4, and SW-
5.  The maximum concentration of cadmium (8.6 ppb) was detected in SW-4 at a level slightly 
above the adult EMEG (7 ppb) and the MCL (5 ppb).  The maximum concentration of iron 
(52,000 ppb) was detected above the EPA RBC for drinking water (11,000 ppb) at SW-1.  Iron 
was detected below the EPA RBC at the four other sampling locations.  In 1996, lead was 
detected in surface water (85 ppb) above the EPA Action Level for drinking water (15 ppb) in 
SW-4, collected from the stream south of Area II.  Lead was detected below the EPA Action 
Level for drinking water in all other surface water samples and was detected in just one of 10 
subsequent samples collected at SW-4 since 1996.  The maximum concentration of manganese 
(1,530 ppb) was detected above the child RMEG (500 ppb), but below the adult RMEG (2,000 
ppb) for drinking water at SW-1.  Silver was detected in one of five surface water samples at 85 
ppb.  This concentration was above the RMEG for children (50 ppb), but below the RMEG for 
adult exposure (200 ppb).  All metals were detected within the range of background 
concentrations observed for surface waters (ATSDR 2003).   
C. Sediment/Wetland Soils 
In 1996, sediment and wetland soil samples were collected from approximately the same 
locations as the surface water samples described above and analyzed for metals.  Refer to Figure 
4 for the locations of sediment samples S-1 through S-5.  In 1997 and 1998, wetland soil and 
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 sediment samples were collected from five new locations selected to represent background 
conditions (GZA 1997, 1998).  Based on the available environmental data, no other soil samples 
were collected at the Bird Landfill site.   
All of the metals detected in sediment and wetland soils at the Bird Landfill were within the 
range of background concentrations observed for metals in eastern U.S. soils (Shacklette et al 
1984).   
VI. EXPOSURE PATHWAY ANALYSIS 
An evaluation of potential pathways of exposure was conducted to determine whether 
contamination identified at the Bird Landfill site could be impacting residents of Walpole in the 
past, present, or future.  Exposure to a chemical must first occur before any potential adverse 
health effects can result.  Five conditions must be present for exposure to occur.  First, there must 
be a source of that chemical.  Second, an environmental medium must be contaminated by either 
the source or by chemicals transported away from the source.  Third, there must be a location 
where a person can potentially contact the contaminated medium.  Fourth, there must be a means 
by which the contaminated medium could enter a person’s body, such as ingestion, inhalation, 
and dermal absorption.  Finally, the chemical must actually reach the target organ susceptible to 
the toxic effects caused by that particular substance at a sufficient dose and for a sufficient 
exposure time for an adverse health effect to occur (ATSDR 2005a).   
A completed exposure pathway indicates that exposure to humans occurred in the past, is 
occurring in the present, or will occur in the future.  A completed exposure pathway exists when 
all of the five elements are present.  A potential exposure pathway exists when one or more of 
the five elements is missing or uncertain and indicates that exposure to a contaminant could have 
occurred in the past, could be occurring in the present, or could occur in the future.  An exposure 
pathway can be eliminated if at least one of the five elements is missing and will not likely be 
present in the future.   
To evaluate the potential for health effects, ATSDR Minimal Risk Levels (MRLs) were 
compared to exposure estimates for the contaminants of concern at the Bird Landfill site.  The 
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 MRL is an estimate of daily exposure to a contaminant below which noncancer, adverse health 
outcomes are unlikely to occur.  In addition, exposure estimates for contaminants of concern 
were combined with United States EPA cancer slope factors provided by ATSDR to evaluate 
potential cancer risk.  Refer to Table 4 for a summary of exposure pathways discussed in this 
section.   
A. Exposure to Groundwater  
In general, groundwater at the Bird Landfill site flows in a northerly direction with shallow 
groundwater near Area II flowing to the north-northeast.  Local mounding present in Area I 
causes groundwater to flow toward wetlands located to the north, east, and west (GZA 1997).  
Sampling conducted in monitoring wells located at the down-gradient portion of Area II detected 
VOCs and metals that exceeded health-based comparison values for drinking water.  The 
groundwater wells sampled at the Bird Landfill site were installed for monitoring purposes only, 
and no one ingests water from these wells.   
As noted earlier, the Bird Landfill is located outside the limits of a Zone II groundwater 
protection area for municipal drinking water well fields, which is the area of an aquifer which 
contributes water to a well under the most severe pumping and recharge conditions that can be 
reasonably anticipated.  Groundwater beneath the landfill has never been a source of municipal 
drinking water (GZA 1997, 1998).  If contaminated groundwater from the Bird Landfill were to 
migrate about 0.8 miles north to the Zone II groundwater protection area for the Mine Brook 
wells, it is possible that under extreme drought conditions (i.e., 180 days with no precipitation to 
recharge aquifers) contaminated groundwater could reach and affect water quality at the well 
field.  However, public water supplies are tested and treated on a routine basis in accordance 
with state and federal laws.  Based on this, exposure through municipal drinking water to 
groundwater contamination identified at the Bird Landfill is an unlikely exposure pathway 
(Table 4).   
Although there are two private wells located northeast of the Bird Landfill on Spring Street, one 
is reportedly not in use and the other is used with a residential chemical filter (GZA 1997, 1998).  
It is not known whether groundwater from the private well with a filter has been impacted by 
contaminated groundwater from the Bird Landfill.  However, based on site investigations 
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 conducted for the Bird Landfill by GZA, Inc., GZA determined this well is located outside the 
extent of groundwater potentially impacted by the landfill (GZA 1998).  Therefore, past and 
current exposure to contaminated drinking water from these down-gradient private wells is not 
expected.   
There is no moratorium in place to restrict the installation of new private wells in the town of 
Walpole (R. Chapell, Walpole Board of Health, personal communication, 2006); therefore, 
future exposure to contaminants identified at the Bird Landfill is possible if new private drinking 
water wells are installed in the path of contaminated groundwater.  If nearby residents were to 
ingest contaminated groundwater in the future at concentrations detected in onsite monitoring 
wells, noncancer and cancer health impacts are possible due to exposure to some metals and 
VOCs, in particular, arsenic, manganese, and vinyl chloride.   
B. Exposure to Indoor Air 
While current information indicates there are no private wells in the path of contaminated 
groundwater, exposure to VOCs detected in groundwater at the landfill could occur through 
indoor air in homes with basements if VOCs are present in off-site groundwater at sufficient 
concentrations and if groundwater is shallow.  Based on groundwater elevations in the vicinity of 
MacDonald Circle east of the site, GZA determined that the shallow groundwater flow is away 
from residences and toward an adjacent stream (GZA 1998).  The direction of shallow 
groundwater at the Bird Landfill site is determined to be to the north-northeast (GZA 1998), in 
the general direction of some industrial buildings and Swan Pond Village homes.  There were no 
off-site groundwater sampling data available, so it is unknown whether the concentrations of 
VOCs such as vinyl chloride detected in onsite groundwater monitoring wells exist off-site.  
However, to evaluate a possible vapor intrusion exposure scenario, MDPH received assistance 
from ATSDR to use a model incorporating site-specific information on groundwater, soil, and 
housing for the area (ATSDR, 2005d).   
To evaluate a very conservative scenario, the Johnson-Ettinger mathematical model was first run 
using the maximum concentration of vinyl chloride detected in groundwater at the landfill (24 
ppb) together with the shallowest groundwater depth (7 feet).  Based on these parameters, (i.e., if 
a house with a basement were located on top of the groundwater monitoring well with the 
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 highest vinyl chloride concentration and the shallowest groundwater), the model predicted with 
95% certainty that the indoor air concentration would be at or below 3.75 micrograms per cubic 
meter (μg/m3 -5 1), or a low incremental cancer risk from vapor intrusion to indoor air of 1.4 x 10 .   
To evaluate a slightly less conservative vapor intrusion exposure scenario, the model was also 
run using the average detected vinyl chloride groundwater concentration at the Bird Landfill (3.2 
ppb), with an average depth to groundwater for onsite monitoring wells (20 feet).  Under these 
conditions, the model predicted with 95% certainty that the indoor air concentration would be at 
or below 0.119 μg/m3, and a low cancer risk from vapor intrusion of vinyl chloride to indoor air 
of 4.5 x 10-7 2.    
Some additional considerations suggest model estimates would be even lower.  First, it is 
important to consider that the closest down-gradient building is located approximately 850 feet 
away, and the closest Swan Pond Village homes are located approximately 1500 feet away from 
the landfill.  Since the maximum contaminant concentrations are typically located closest to the 
source, actual down-gradient concentrations of vinyl chloride in groundwater are expected to be 
less than concentrations detected in onsite monitoring wells.  Also, as contaminants travel with 
groundwater, they typically move deeper in the groundwater, resulting in a lower possibility of 
vapor intrusion into basements.  In addition, if groundwater flow is in the direction of the 
adjacent stream, it is possible that vapors could have escaped through the exposed stream and 
down-gradient groundwater concentrations would be even lower (ATSDR 2005d).  Further, 
while the maximum vinyl chloride concentration in onsite groundwater was 24 ppb, vinyl 
chloride was detected in just 43 out of 127 groundwater samples collected at the landfill, and all 
other detected concentrations of vinyl chloride were 10 to 100 times lower.  Thus, while down-
gradient vinyl chloride groundwater concentrations are unknown, based on the levels of vinyl 
                                                 
1  Cancer Effects Exposure Dose  = (3.75 μg/m3) ) (365 days/yr) (30 yrs) = 1.61 μg/m3
     (70 yrs) (365 days/yr) 
Cancer Risk = 1.61 μg/m3 x 8.8 x 10-6 (μg/m3 -1)  = 1.41 x 10-5
 
2  Cancer Effects Exposure Dose  = (0.119 μg/m3) ) (365 days/yr) (30 yrs) = 0.051 μg/m3
     (70 yrs) (365 days/yr) 
Cancer Risk = 0.051 μg/m3 x 8.8 x 10-6 (μg/m3 -1)  = 4.5 x 10-7
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 chloride detected in onsite groundwater, the indoor air concentrations predicted by the Johnson-
Ettinger model using very conservative assumptions, and the distance of the down-gradient 
homes from the site, it appears unlikely that vinyl chloride detected in groundwater at the Bird 
Landfill would present an exposure concern for indoor air down-gradient of the site.   
C. Exposure to Surface Water 
Surface water samples were collected from an offsite stream and pond located immediately east 
of Area II and from wetland areas located west and south of Area I.  Incidental ingestion and 
dermal contact with contaminants detected in surface water could be possible for children or 
adults who may have accessed surface waterbodies around the landfill for wading or playing in 
the past, present, and future.  However, the majority of surface water contaminants were detected 
below or within the range of drinking water comparison values; therefore, potential exposures to 
surface water would not be expected to result in health effects (refer to Table 3).  While arsenic 
(6 ppb) was detected above the ATSDR CREG for cancer health effects (0.02 ppb) in surface 
water from a pond located east of Area II, this concentration was below the chronic EMEG (10 
ppb) for noncancer health effects in adults.  In addition, it is important to note that the 
comparison values used in this evaluation represent a daily drinking water exposure.  Individuals 
at the Bird Landfill would likely be exposed less frequently and to significantly less 
contaminated surface water through incidental ingestion and dermal contact.  For example, 
assuming a child ingests 0.05 liters (about a mouthful) of surface water contaminated with the 
maximum concentration of arsenic for 2 days a week over 26 weeks for a 10-year period, an 
increased cancer risk would not be expected.3   
D. Exposure to Soil/Sediment 
Unauthorized off-road vehicle use and trespassing have been reported at the site (GZA 2003).  
The only soil samples collected from the Bird Landfill site were sediment and wetland soil 
                                                 
3 Cancer Effects Exposure Factor = (52 days/year) (10 years) = 0.02 
 (365 days/year) (70 years)  
 
Cancer Effects Exposure Dose (Adult) = (0.006 mg/L) (0.05 L/day) (0.02) =  1.7 x 10-7 mg/kg/day 
      35 kg  
 
Cancer Risk (Adult) = 1.7 x 10-7 mg/kg/day x 1.5 (mg/kg/day)-1 = 2.6 x 10-7
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 samples collected from specific locations around Areas I and II.  While it is not possible to 
evaluate incidental ingestion and dermal contact with onsite soil for trespassers for the rest of the 
site, it is important to note that daily cover consisting of stone dust or silty sand was used at the 
landfill while it was open.  The stone dust was brought in from Bird, Inc.’s asphalt shingle 
roofing plant, and the source of the silty sand was S.M. Lorusso’s West Sand Plant, also located 
in Walpole (GZA 1998).  Both Areas I and II are now capped.   
Incidental ingestion of and dermal contact with metals identified in sediment or wetland soil 
samples could have been possible in the past, present or future for adults or children who may 
trespass on the Bird Landfill site.  However, with the exception of iron, none of the metals 
detected in sediment or wetland soils at the Bird Landfill exceeded health-based comparison 
values for residential soil exposure.  All of the metals detected in sediment and wetland soils 
were within the range of background concentrations.  In addition, a trespasser would likely be 
exposed less frequently and for a shorter duration than in a residential scenario.  While iron was 
detected above the EPA RBC for residential soil in sediment from a groundwater seep west of 
Area I and in a stream south of Area II, both concentrations were below the RBC for industrial 
soil.  Therefore, it is unlikely that individuals who might trespass in these areas would have 
sufficient exposure to result in adverse health effects (Table 4).   
VII. CANCER INCIDENCE ANALYSES 
In response to community concerns, the MDPH conducted an evaluation of the occurrence of 
cancer in the town of Walpole as a whole and its individual census tracts.  In addition, the pattern 
of cancer was evaluated at the neighborhood level to identify any unusual patterns of cancer 
diagnoses in proximity to the Bird Landfill or in any other area of Walpole.   
A. Methods for Analyzing Cancer Incidence Data 
1) Case Identification/Definition 
Cancer incidence data (i.e., reports of new cancer diagnoses) for the years 1982–2000 were 
obtained for the town of Walpole from the Massachusetts Cancer Registry (MCR), a division of 
the Center for Health Information, Statistics, Research and Evaluation within the MDPH.  Seven 
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 cancer types were evaluated, including cancers of the bladder, kidney, liver, and lung and 
bronchus, as well as Hodgkin’s disease, leukemia, and mesothelioma.  Coding for cancer types in 
this report follows the International Classification of Diseases for Oncology (ICD-O) system.  
(See Appendix A for the incidence coding definitions used in this report for these cancer types.)  
These cancer types were selected for evaluation on the basis of elevations observed at the town 
level in a preliminary review of cancer rates in Walpole, potential associations with contaminants 
of concern at the Bird Landfill, and/or residents’ concerns about suspected elevations in some 
cancer types.  Only cases reported to the MCR as a primary cancer for one of the seven cancer 
types and diagnosed among residents of Walpole were included in the analyses.  Cases were 
selected for inclusion based on the address reported to the hospital or reporting medical facility 
at the time of diagnosis. 
The MCR is a population based surveillance system that began collecting information on 
Massachusetts residents diagnosed with cancer in the state in 1982.  All newly diagnosed cancer 
cases among Massachusetts residents are required by law to be reported to the MCR within six 
months of the date of diagnosis (M.G.L. c.111s.111B).  This information is kept in a confidential 
database.  Data are collected on a daily basis and are reviewed for accuracy and completeness on 
an annual basis.  This process corrects misclassification of data (i.e., city/town misassignment).  
Once these steps are finished, the data for that year are considered “complete.”  Due to the 
volume of information received by the MCR, the large number of reporting facilities, and the 
six-month period between diagnosis and required reporting, the most current registry data that 
are complete will inherently be a minimum of two years prior to the current date.  The 19-year 
period 1982–2000 constitutes the period for which the most recent and complete cancer 
incidence data were available from the MCR at the time of this analysis.4
The term "cancer" is used to describe a variety of diseases associated with abnormal cell and 
tissue growth.  Epidemiologic studies have revealed that different types of cancer are individual 
diseases with separate causes, risk factors, characteristics, and patterns of survival (Berg 1996).  
Cancer types are classified by the location in the body where the disease originated (the primary 
                                                 
4 The data summarized in this report are drawn from data entered on MCR computer files before May 9, 2005.  The 
numbers presented in this report may change slightly in future reports, reflecting late reported cases, address 
corrections, or other changes based on subsequent details from reporting facilities. 
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 site) and the tissue or cell type of the cancer (histology).  Therefore, each of the cancer types 
reviewed in this report was evaluated separately.  Cancers that occur as the result of the 
metastasis or the spread of a primary site cancer to another location in the body are not 
considered as separate cancers and therefore were not included in these analyses. 
It should be noted that the MCR research file might contain duplicate reports of individuals 
diagnosed with cancer.  The data in this report have been controlled for duplicate cases by 
excluding them from the analyses.  Duplicate cases are additional reports of the same primary 
site cancer case.  The decision that a case was a duplicate and should be excluded from the 
analyses was made by the MCR after consulting with the reporting hospital or diagnostic facility 
and obtaining additional information regarding the histology and/or pathology of the case.  
However, reports of individuals with multiple primary site cancers were included as separate 
cases in the analyses in this report.  A multiple primary cancer case is defined by the MCR as a 
new cancer in a different primary site, or a new cancer of the same histology (cell type) as an 
earlier cancer, if diagnosed in the same primary site (original location in the body) more than two 
months after the initial diagnosis (MCR 1996).  Therefore, duplicate reports of an individual 
diagnosed with cancer were removed from the analyses whereas individuals who were diagnosed 
with more than one primary site cancer were included as separate cases.  In the town of Walpole, 
two duplicate reports were identified during the years 1982–2000 and excluded from the 
analyses. 
Calculation of Standardized Incidence Ratios (SIRs)2)  
To determine whether elevated numbers of cancer diagnoses occurred in Walpole or its 
individual census tracts, cancer incidence data were tabulated by gender according to 18 age 
groups to compare the observed number of cancer diagnoses to the number that would be 
expected based on the statewide cancer rate.  Standardized incidence ratios (SIRs) were 
calculated for the period 1982–2000 for each of the seven primary cancer types for Walpole as a 
whole and its three census tracts (CTs) as well as for three smaller time periods (e.g., 1982–1987, 
1988–1993, and 1994–2000) in order to evaluate patterns or trends in cancer incidence over time. 
To calculate standardized incidence ratios, it is necessary to obtain accurate population 
information.  The population figures used in this analysis were interpolated based on 1980, 1990, 
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 and 2000 United States census data for Walpole (U.S. DOC. 1980, 1990, 2000).  Midpoint 
population estimates were calculated for each time period evaluated (i.e., 1984, 1990, 1991, and 
1997).  To estimate the population between census years, an assumption was made that the 
change in population occurred at a constant rate throughout the 10-year interval between each 
census.5
Because accurate age group and gender specific population data are required to calculate SIRs, 
the CT is the smallest geographic area for which cancer rates can be accurately calculated.  
Specifically, a CT is a smaller statistical subdivision of a county as defined by the United States 
Census Bureau.  CTs usually contain between 2,500 and 8,000 persons and are designed to be 
homogenous with respect to population characteristics (U.S. DOC. 1990, 2000).  According to 
the 2000 United States Census, the town of Walpole is subdivided into three census tracts (CTs 
4111, 4112, and 4113) as shown in Figure 1 (U.S. DOC. 2000). 
3) Interpretation of a Standardized Incidence Ratio (SIR) 
An SIR is an estimate of the occurrence of cancer in a population relative to what might be 
expected if the population had the same cancer experience as a larger comparison population 
designated as "normal" or average.  Usually, the state as a whole is selected to be the comparison 
population.  Using the state of Massachusetts as a comparison population provides a stable 
population base for the calculation of incidence rates. 
Specifically, an SIR is the ratio of the observed number of cancer diagnoses in an area to the 
expected number of diagnoses multiplied by 100.  The population structure of each town is 
adjusted to the statewide incidence rate to calculate the number of expected cancer diagnoses.  
The SIR is a comparison of the number of cancer diagnoses in a specific area (i.e., city/town or 
census tract) compared to the statewide rate.  Comparisons of SIRs between towns or census 
tracts are not possible because each community has different population characteristics. 
                                                 
5 Using slightly different population estimates or statistical methodologies, such as grouping ages differently or 
rounding numbers at different points during calculations, may produce results slightly different from those published 
in this report. 
23 
 An SIR of 100 indicates that the number of cancer diagnoses observed in the population being 
evaluated is equal to the number of cancer diagnoses expected in the comparison or "normal" 
population.  An SIR greater than 100 indicates that more cancer diagnoses occurred than were 
expected, and an SIR less than 100 indicates that fewer cancer diagnoses occurred than were 
expected.  Accordingly, an SIR of 150 is interpreted as 50% more cancer diagnoses than the 
expected number; an SIR of 90 indicates 10% fewer cancer diagnoses than expected. 
Caution should be exercised, however, when interpreting an SIR.  The interpretation of an SIR 
depends on both the size and the stability of the SIR.  Two SIRs can have the same size but not 
the same stability.  For example, an SIR of 150 based on four expected diagnoses and six 
observed diagnoses indicates a 50% excess in cancer, but the excess is actually only two 
diagnoses.  Conversely, an SIR of 150 based on 400 expected diagnoses and 600 observed 
diagnoses represents the same 50% excess in cancer, but because the SIR is based upon a greater 
number of diagnoses, the estimate is more stable.  It is very unlikely that 200 excess diagnoses of 
cancer would occur by chance alone. As a result of the instability of incidence rates based on 
small numbers of diagnoses, SIRs were not calculated when fewer than five diagnoses were 
observed for a particular cancer type. 
4) Calculation of the 95% Confidence Interval 
To help interpret or measure the stability of an SIR, the statistical significance of each SIR was 
assessed by calculating a 95% confidence interval (95% CI) to determine if the observed number 
of diagnoses is “significantly different” from the expected number or if the difference may be 
due solely to chance (Rothman and Boice 1982).  Specifically, a 95% CI is the range of 
estimated SIR values that have a 95% probability of including the true SIR for the population.  If 
the 95% CI range does not include the value 100, then the study population is significantly 
different from the comparison or "normal" population.  "Significantly different" means there is 
less than a 5% chance that the observed difference (either increase or decrease) is the result of 
random fluctuation in the number of observed cancer diagnoses. 
For example, if a confidence interval does not include 100 and the interval is above 100 (e.g., 
105-130), there is a statistically significant excess in the number of cancer diagnoses.  Similarly, 
if the confidence interval does not include 100 and the interval is below 100 (e.g., 45-96), the 
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 number of cancer diagnoses is statistically significantly lower than expected.  If the confidence 
interval range includes 100, the true SIR may be 100.  In this case, it cannot be determined with 
certainty that the difference between the observed and expected number of diagnoses reflects a 
real cancer increase or decrease or is the result of chance.  It is important to note that statistical 
significance does not necessarily imply public health significance.  Determination of statistical 
significance is just one tool used to interpret SIRs. 
In addition to the range of the estimates contained in the confidence interval, the width of the 
confidence interval also reflects the stability of the SIR estimate.  For example, a narrow 
confidence interval (e.g., 103-115) allows a fair level of certainty that the calculated SIR is close 
to the true SIR for the population.  A wide interval (e.g., 85-450) leaves considerable doubt about 
the true SIR, which could be much lower than or much higher than the calculated SIR.  This 
would indicate an unstable statistic.  Again, due to the instability of incidence rates based on 
small numbers of diagnoses, statistical significance was not assessed when fewer than five 
diagnoses were observed. 
5) Evaluation of Risk Factor Information 
Available information reported to the MCR related to risk factors for cancer development was 
reviewed and compared to known or established incidence patterns for the cancer types 
evaluated in this report.  This information is collected for each individual at the time of cancer 
diagnosis and includes the individual’s age at diagnosis, the stage of disease, and the individual’s 
smoking history and occupation.  One or even several factors acting over time can be related to 
the development of cancer.  For example, tobacco use has been linked to lung and bronchus, 
bladder, and kidney cancers.  Other cancer risk factors may include lack of crude fiber in the 
diet, high fat consumption, alcohol abuse, and reproductive history.  Heredity, or family history, 
is an important factor for several cancers.  To a lesser extent, some occupational exposures, such 
as jobs involving contact with asbestos, have been shown to be carcinogenic (cancer causing).  
Environmental contaminants have also been associated with certain types of cancer.  The 
available risk factor information from the MCR was evaluated for residents of Walpole who 
were diagnosed with the seven cancer types evaluated in this report.  However, information 
about personal risk factors such as family history, hormonal events, diet, and other factors that 
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 may also influence the development of cancer is not collected by the MCR or any other readily 
accessible source, and therefore, it was not possible to evaluate these factors in this investigation. 
6) Determination of Geographic Distribution 
Address at the time of diagnosis for each individual diagnosed with cancer was mapped using a 
computerized geographic information system (GIS) (ESRI 2004).  This allowed for the 
assignment of census tract location for each diagnosis as well as an evaluation of the spatial 
distribution of individual diagnoses at a smaller geographic level within a census tract (i.e., 
neighborhoods).  The geographic distribution was determined using a qualitative evaluation of 
the point pattern of cancer diagnoses in Walpole.  In instances where the address information 
from the MCR was incomplete (i.e., did not include specific streets or street numbers), efforts 
were made to research those cases using Registry of Motor Vehicle records and telephone books 
issued within two years of an individual's diagnosis.  In accordance with Massachusetts laws 
aimed at protecting the confidentiality of patients (M.G.L. c.111. s 24A), maps of the locations 
of individuals with cancer cannot be provided in this report. 
B. Cancer Incidence in Walpole 
The following section presents the results of the cancer incidence analyses for Walpole and its 
individual census tracts during the 19-year time period 1982–2000.  Analysis by smaller 
geographic areas (i.e., census tracts) helps in understanding the incidence of cancer town-wide 
which may be explained by an increase or decrease in cases in a particular geographic area of the 
town.  To evaluate possible trends over time, these data were also analyzed by three smaller time 
periods (i.e., 1982–1987, 1988–1993, and 1994–2000).  Although SIRs and 95% confidence 
intervals were not calculated for some cancer types in smaller time periods due to small numbers 
of observed diagnoses (i.e., fewer than five), the expected number of diagnoses was calculated to 
determine whether excess numbers of diagnoses were occurring.  These data are summarized in 
Tables 6a–12d. 
Bladder Cancer1)  
During the 19-year time period 1982–2000, bladder cancer occurred more often than expected in 
Walpole as a whole (73 diagnoses observed vs. 65.5 expected, SIR = 112).  The observed 
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 elevation, which was not statistically significant (95% CI = 87-140), was primarily due to an 
elevation in incidence among females in the town.  Specifically, 23 diagnoses occurred among 
females compared to 16.6 expected (SIR = 138, 95% CI = 88-207).  Males were diagnosed with 
bladder cancer about as expected (50 diagnoses observed vs. 48.8 expected, SIR = 102).  There 
were no apparent trends over time in the incidence of bladder cancer in Walpole.  During the 
earliest time period evaluated, 1982–1987, this cancer type occurred approximately at or near 
expected rates among males and females.  An elevation in incidence was noted during 1988–
1993, when 26 diagnoses were observed compared to about 20 expected (SIR = 130).  The 
overall elevation was attributed to a statistically significant elevation observed among females in 
the town during this time period.  Specifically, 12 diagnoses were observed among females 
compared to five expected (SIR = 239, 95% CI = 124-418).  During more recent years (i.e., 
1994–2000), bladder cancer incidence returned closer to expected rates for males and females 
combined (29 diagnoses observed vs. 27.3 expected, SIR = 106).  Bladder cancer also occurred 
at about the rates expected among females (8 diagnoses observed vs. 7.3 expected, SIR = 110) 
during this time.   
In CT 4113, where the Bird Landfill, MacDonald Circle, and Swan Pond Village are located, 
bladder cancer occurred slightly less often than expected during 1982–2000 (19 diagnoses 
observed vs. 21.3 expected, SIR = 89).  However, different trends were observed when these data 
were analyzed for males and females separately.  Specifically, males were diagnosed with 
bladder cancer less often than expected during this time period (10 diagnoses observed vs. 15.8 
expected, SIR = 63), while females were diagnosed more often than expected (9 diagnoses 
observed vs. 5.5 expected, SIR = 164).  The observed elevation among females, which was not 
statistically significant (95% CI = 88-207), was attributed to an increase in bladder cancer 
diagnoses among females in this CT during 1988–1993 (6 diagnoses observed vs. 1.6 expected, 
SIR = 382).  This elevation was statistically significant.  Bladder cancer occurred less often than 
expected among both males and females in CT 4113 during 1982–1987 and 1994–2000. 
Residents of CTs 4111 and 4112 experienced slight elevations in bladder cancer incidence 
during the 19-year time period 1982–2000 and in some smaller time periods, but the observed 
elevations were generally based on small numbers of diagnoses over the expected numbers and 
were not statistically significant.  For example, in CT 4111, slight elevations were noted in the 
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 incidence of bladder cancer among males during 1982–1987 and 1994–2000 and among females 
during 1988–1993.  In CT 4112, males were diagnosed approximately at or near the expected 
rates in each of the smaller time periods.  Females in this census tract experienced bladder cancer 
approximately at or below expected during 1982–1987 and 1988–1993, but were diagnosed more 
often than expected during 1994–2000 (5 diagnoses observed vs. 1.8 expected, SIR = 274).  
Again, this elevation was not statistically significant (95% CI = 88-640).  See Tables 6a–6d for a 
summary of bladder cancer incidence in Walpole during 1982–2000. 
2) Hodgkin’s Disease 
The incidence of Hodgkin’s disease was elevated in Walpole during the 19-year time period 
1982–2000 (19 diagnoses observed vs. 14.2 expected, SIR = 134).  This elevation was the result 
of an increase in diagnoses among females in the town (11 diagnoses observed vs. 6.0 expected, 
SIR = 184).  Neither of these elevations was statistically significant.  During 1982–1987, one 
diagnosis was observed among females compared to almost two diagnoses expected.  However, 
during 1988–1993, females experienced a statistically significant elevation in the incidence of 
Hodgkin’s disease in the town as a whole (6 diagnoses observed vs. 2.0 expected, SIR = 301, 
95% CI = 110-656).  Incidence remained elevated among females during 1994–2000 (4 
diagnoses observed vs. 2.3 expected), but the elevation was based on 1-2 excess diagnoses than 
expected.  Males in Walpole experienced Hodgkin’s disease about as expected during the overall 
time period 1982–2000 (8 diagnoses observed vs. 8.2 expected, SIR = 98) and during each of the 
smaller time periods evaluated. 
The townwide elevations in Hodgkin’s disease incidence observed among females during the 
overall time period and some smaller time periods was the result of slight increases in each of 
Walpole’s three census tracts during some time periods.  During 1982–1987, there were no 
diagnoses of Hodgkin’s disease reported among females in CTs 4111 and 4112 compared to 0.6 
and 0.5 expected, respectively.  One female was diagnosed with this cancer type in CT 4113 
compared to 0.6 expected during this time period.  During 1988–1993, there were three 
diagnoses reported among females in CT 4111 vs. 0.7 expected, one diagnosis in CT 4112 vs. 
0.6 expected, and two diagnoses in CT 4113 vs. 0.7 expected.  During 1994–2000, there were no 
diagnoses of Hodgkin’s disease reported among females in CT 4111 vs. 0.8 expected, two 
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 diagnoses in 4112 vs. 0.6 expected, and two diagnoses in CT 4113 vs. 0.9 expected.  (SIRs and 
95% confidence intervals were not calculated because fewer than five diagnoses were observed 
in each census tract during each time period.)  Males were diagnosed with Hodgkin’s disease 
approximately as expected in each Walpole census tract during each time period evaluated.  See 
Tables 7a–7d for a summary of this information. 
3) Kidney Cancer 
The incidence of kidney cancer was greater than expected in Walpole during 1982–2000 (48 
diagnoses observed vs. 41.5 expected, SIR = 116).  The overall elevation among males and 
females combined was not statistically significant (95% CI = 85-153), but females in Walpole 
experienced a statistically significant elevation in the incidence of kidney cancer (25 diagnoses 
observed vs. 15.2 expected, SIR = 164, 95% CI = 106-242).  Males were diagnosed with kidney 
cancer less often than expected (23 diagnoses observed vs. 26.2 expected, SIR = 88).  The 
statistically significant elevation observed among females during the overall time period 
reflected non-statistically significant increases in diagnoses during each of the smaller time 
periods evaluated.  During 1982–1987, five females were diagnosed with kidney cancer 
compared to 3.4 diagnoses expected (SIR = 149).  During 1988–1993, 10 females were 
diagnosed with kidney cancer compared to 4.8 diagnoses expected (SIR = 208), a borderline 
statistically significant result (95% CI = 100-382).  Finally, during 1994–2000, ten females were 
diagnosed with kidney cancer compared to 7.4 diagnoses expected (SIR = 134). 
Analysis of incidence by census tract for the 1982–2000 time period revealed that while males in 
each of Walpole’s three census tracts experienced kidney cancer at or below the rates expected, 
females in CTs 4111 and 4113 experienced elevations in incidence, which led to the statistically 
significant elevation observed among females in the town as a whole.  In CT 4111, 11 females 
were diagnosed with kidney cancer during 1982–2000 compared to 5.7 expected (SIR = 191).  
The elevation observed among females was not statistically significant and was due to slight 
increases in incidence during each of the smaller time periods.  During 1982–1987, four females 
were diagnosed with kidney cancer in CT 4111 compared to 1.3 expected.  During 1988–1993, 
three diagnoses occurred among females in this census tract compared to 1.8 expected.  Finally, 
during 1994–2000, four diagnoses were observed among females compared to 2.5 expected.  
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 Males in CT 4111 were diagnosed with kidney cancer as expected during the 19-year time period 
1982–2000 (10 diagnoses observed vs. 10.1 expected, SIR = 99); there were no consistent trends 
over time.  During 1982–1987, two kidney cancer diagnoses were observed among males 
compared to 2.0 expected.  During 1988–1993, there were six diagnoses reported compared to 
3.3 expected.  Finally, during 1994–2000, two males were diagnosed with kidney cancer 
compared to 4.4 expected. 
In CT 4113, where the Bird Landfill is located, kidney cancer occurred about as expected among 
both males and females during 1982–1987.  During 1988–1993, males in this census tract were 
diagnosed about as expected while females experienced a statistically significant elevation in 
kidney cancer (6 diagnoses observed vs. 1.6 expected, SIR = 381, 95% CI = 139-830).  The 
incidence of kidney cancer decreased among both males and females in CT 4113 during 1994–
2000, with a total of three diagnoses observed compared to almost eight expected during this 
time period.  In CT 4112, males and females experienced kidney cancer approximately at or 
below the rates expected during 1982–1987 and 1988–1993.  However, both males and females 
in this census tract experienced elevations in incidence during more recent years.  Specifically, 
there were five diagnoses reported among males in this census tract during 1994–2000 compared 
to 3.2 expected (not statistically significant) and four diagnoses among females compared to 2.0 
expected.  These data are summarized in Tables 8a–8d. 
4) Leukemia 
Leukemia occurred more often than expected in Walpole during 1982–2000 (40 diagnoses 
observed vs. 35.3 expected, SIR = 113).  This elevation, which was not statistically significant, 
was the result of an increase in diagnoses among females in the town (20 diagnoses observed vs. 
14.7 expected, SIR = 136).  Males in the town experienced leukemia about as expected (20 
diagnoses observed vs. 20.5 expected, SIR = 97).  During 1982–1987, the incidence of this 
cancer type in Walpole was slightly lower than expected (6 diagnoses observed vs. 8.7 expected, 
SIR =69).  Incidence increased during the 1988–1993 time period, during which time 14 
diagnoses were observed compared to 9.8 expected (SIR = 143).  This elevation was not 
statistically significant and was based on approximately three additional diagnoses over the 
expected number observed among males and about one additional diagnosis observed among 
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 females.  Leukemia incidence remained slightly elevated during 1994–2000 (20 diagnoses 
observed vs. 17.7 expected, SIR = 113).  However, different trends were noted when these data 
were evaluated separately by gender.  While males experienced fewer leukemia diagnoses than 
expected (6 diagnoses observed vs. 9.9 expected, SIR = 60), females were diagnosed with 
leukemia almost twice as often as expected (14 diagnoses observed vs. 7.8 expected, SIR = 181).  
Moreover, the elevation observed among females during this time period was borderline 
statistically significant (95% CI = 99-303).  As shown in Table 9d, this townwide elevation was 
primarily the result of slight increases in leukemia diagnoses among females in each of 
Walpole’s three census tracts. 
While residents of CT 4111 were diagnosed with leukemia less often than expected during 1982–
2000, slight elevations in leukemia incidence were noted in CTs 4112 and 4113.  In CT 4111, 
leukemia occurred approximately at or below expected during each of the smaller time periods 
evaluated, although somewhat different trends were observed among males and females when 
evaluated separately by gender.  For example, an elevation in incidence was noted among 
females in this census tract during 1994–2000 (5 diagnoses observed vs. 2.6 expected).  The 
overall elevation in leukemia incidence observed in CT 4112 during 1982–2000 was primarily 
attributed to increases in diagnoses among females in this census tract during 1988–1993 and 
1994–2000.  In CT 4113, where the Bird Landfill is located, 16 individuals were diagnosed with 
leukemia compared to 12 expected (SIR = 134) during the overall time period 1982–2000.  This 
elevation was not statistically significant (95% CI = 76-217).  During 1982–1987, one resident of 
CT 4113 was diagnosed with leukemia compared to almost three diagnoses expected.  Elevations 
in incidence were noted in this CT during 1988–1993 and 1994–2000, but these were based on 
fewer than three excess diagnoses and were not statistically significant.  Specifically, five 
diagnoses occurred in CT 4113 during 1988–1993 compared to 3.2 expected (SIR = 155) and ten 
diagnoses occurred during 1994–2000 compared to 7.1 expected (SIR = 141).  See Tables 9a–9d 
for a summary of leukemia incidence results by time period and census tract in Walpole. 
Liver Cancer5)  
The incidence of liver cancer was lower than expected in Walpole during 1982–2000.  
Specifically, seven diagnoses were observed during this time period compared to about 10 
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 diagnoses expected (SIR = 69).  Six diagnoses were observed among males compared to 7.6 
expected (SIR = 79) and one diagnosis was observed among females compared to 2.5 expected.  
In addition, liver cancer occurred less often than expected in the town as a whole during each of 
the smaller time periods evaluated.  Residents in each of Walpole’s three CTs experienced liver 
cancer approximately at or below expected rates during the overall time period.  Similar trends 
were observed when these data were evaluated by smaller time periods.  In CT 4113, where the 
Bird Landfill is located, one individual was diagnosed with liver cancer during the 19-year time 
period evaluated compared to 3.4 diagnoses expected.  See Tables 10a–10d for a summary of 
these data. 
6) Lung and Bronchus Cancer 
Lung and bronchus cancer was diagnosed less often than expected among residents of Walpole 
during 1982–2000 (249 diagnoses observed vs. 258.6 expected, SIR = 96).  While females were 
diagnosed with lung and bronchus cancer as expected (102 diagnoses observed vs. 101.6 
expected, SIR =100), males were diagnosed less often than expected (147 diagnoses observed vs. 
157.0 expected, SIR = 94).  During the earliest time period, 1982–1987, lung and bronchus 
cancer occurred more often than expected in Walpole (72 diagnoses observed vs. 65.0 expected, 
SIR = 111), with similar trends among males and females when these data were evaluated 
separately by gender.  During 1988–1993, the incidence of lung and bronchus cancer was lower 
than expected (64 diagnoses observed vs. 80.1 expected, SIR = 80).  Although females were 
diagnosed with lung and bronchus cancer at about the rate expected during this time period, 
males experienced lower-than-expected incidence of lung and bronchus cancer (35 diagnoses 
observed among males vs. 49.3 expected, SIR = 71).  This SIR was statistically significant (95% 
CI = 49-99).  In more recent years (i.e., 1994–2000), the incidence of lung and bronchus cancer 
was about as expected among males and females combined and among males when evaluated 
separately by gender.  Females were diagnosed with lung and bronchus cancer less often than 
expected during 1994–2000 (46 diagnoses observed among females vs. 51.0 expected, SIR = 
90). 
Analysis by smaller geographic area revealed that the incidence of lung and bronchus cancer was 
at or below the state rate in each Walpole census tract during the 19-year time period 1982–2000.  
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 The incidence of lung and bronchus cancer appears to have decreased among males over time in 
CT 4111 with respect to the statewide experience.  No other consistent trends over time were 
noted in Walpole census tracts.  Slight elevations in the incidence of lung and bronchus cancer 
were noted in some census tracts in some time periods; however, these were based on small 
numbers of additional diagnoses over the expected numbers and were not statistically significant.  
For example, elevations were noted among males in CT 4111 during 1982–1987 (22 diagnoses 
observed vs. 16.0 expected, SIR = 137) and among females in this census tract during 1988–
1993 (15 diagnoses observed vs. 11.9 expected, SIR = 126).  Residents of CT 4112 experienced 
a statistically significant deficit in lung and bronchus cancer diagnoses during 1988–1993 (12 
diagnoses observed vs. 23.4 expected, SIR = 51, 95% CI = 27-90), with both males and females 
diagnosed about half as often as expected during this time period.  In CT 4113, where the Bird 
Landfill is located, 81 individuals were diagnosed with lung and bronchus cancer during the 
overall time period, 1982–2000, compared to 86.7 expected (SIR = 93).  During 1982–1987, the 
incidence of lung and bronchus cancer in this census tract was about as expected (21 diagnoses 
observed vs. 20.0 expected, SIR = 105).  During 1988–1993, lung and bronchus cancer occurred 
less often than expected (19 diagnoses observed vs. 26.1 expected, SIR = 73).  Finally, incidence 
remained lower than expected during 1994–2000 (41 diagnoses observed vs. 45.3 expected, SIR 
= 90).  See Tables 11a–11d for these results. 
7) Mesothelioma 
During the overall time period, 1982–2000, mesothelioma occurred near the expected rate in 
Walpole.  Specifically, four diagnoses were observed among males compared to 4.2 expected 
and two diagnoses were observed among females compared to about one expected.  There was 
one diagnosis reported during 1982–1987, three during 1988–1993, and two during 1994–2000.  
SIRs for mesothelioma were not calculated for smaller time periods or individual census tracts 
due to small numbers of observed diagnoses (i.e., fewer than five).  However, observed numbers 
were approximately at or near expected numbers when mesothelioma incidence was reviewed by 
census tract and smaller time period.  In CT 4113 where the Bird Landfill, MacDonald Circle, 
and Swan Pond Village are located, one individual was diagnosed with mesothelioma during the 
19-year time period 1982–2000.  This person was diagnosed during the middle time period 
1988–1993.  See Tables 12a–12d for a summary of this information. 
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 C. Evaluation of Cancer Risk Factors 
As previously mentioned, cancer is not just one disease but is a term used to describe a variety of 
different diseases.  As such, studies have generally shown that different cancer types have 
different causes, patterns of incidence, risk factors, latency periods (i.e., period between exposure 
and development of disease), characteristics and trends in survival.  Available information from 
the MCR related to age and gender patterns, as well as other factors related to the development 
of cancer (e.g., smoking and occupation), was reviewed for those cancer types that were 
statistically significantly elevated in Walpole or one of its census tracts during 1982–2000 or one 
of the smaller time periods evaluated.  These cancer types included bladder cancer, Hodgkin’s 
disease, and kidney cancer.  Information for each of these cancer types was compared to known 
or established incidence trends to assess whether any unexpected patterns exist among these 
cases.  For more information regarding risk factors associated with these and the other cancer 
types evaluated in this report, please refer to Appendix B.   
Age and gender are risk factors in many types of cancers, including bladder cancer, Hodgkin’s 
disease, and kidney cancer.  A review of age group specific SIRs by census tract was not 
possible because of the small numbers of diagnoses in each group.  However, where there was a 
statistically significant elevation of cancer diagnoses in Walpole or its census tracts, the 
distribution of diagnoses by age was reviewed. 
Tobacco use is a known or suggested causal risk factor in several types of cancer, including 
cancers of the bladder and kidney.  The smoking history of individuals diagnosed with these 
cancer types in Walpole was reviewed to assess the role tobacco smoking may have played in the 
development of these types of cancer among residents.   
In some studies, an association has been found with specific occupational exposure and an 
increase in the incidence of bladder cancer, Hodgkin's disease, and kidney cancer.  Therefore, 
occupational information as reported by the MCR at the time of diagnosis was reviewed for 
individuals diagnosed with these cancer types to determine the role that occupational factors may 
have played in the development of these types of cancer in Walpole.   
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 1) Bladder Cancer 
Males are four times more likely to develop bladder cancer than females (ACS, 2004a).  While 
males in Walpole experienced bladder cancer about as expected during 1982–2000, the incidence 
of this cancer type was elevated among females.  Statistically significant elevations were noted 
among females townwide and in CT 4113 during 1988–1993.  Nationally, the risk of bladder 
cancer increases with age and over 60% of people diagnosed with bladder cancer are between the 
ages of 65 and 85 years (ACS, 2004a).  Of the 73 individuals diagnosed with bladder cancer in 
the town of Walpole as a whole during 1982–2000, the average age at diagnosis was 70 and 68% 
(n = 50) were aged 65 or older.  The average age at diagnosis was also 70 for the 12 females 
diagnosed with bladder cancer during 1988–1993.  Of the six females diagnosed during this time 
period in CT 4113, the average age at diagnosis was 63. 
The most well established risk factor for bladder cancer is cigarette smoking.  Smokers are more 
than twice as likely to develop bladder cancer compared to nonsmokers (ACS, 2004a).  The risk 
of developing bladder cancer increases with the number of packs smoked per day and with 
duration of smoking.  Further, the risk of bladder cancer may be higher in women than in men 
who smoke comparable numbers of cigarettes (Castelao et al., 2001).  Approximately 25-60% of 
all bladder cancers can be attributed to tobacco use (Johansson and Cohen, 1997).  In Walpole, 
about two thirds of the individuals diagnosed with bladder cancer during 1982–2000 and for 
whom smoking history was known were current or former smokers at the time of diagnosis 
(66%, n = 41).  Smoking history was unknown for the remaining 11 individuals.  Among the 12 
females diagnosed with bladder cancer during 1988–1993, six of the 10 with a known smoking 
status were current or former smokers at the time of diagnosis and smoking history was unknown 
for two other individuals.  Among the six females diagnosed in CT 4113 during this time period, 
three were current or former smokers at the time of diagnosis, one was a nonsmoker, and 
smoking history was unknown for two individuals.  Based on this information, it is likely that 
smoking played a role in the development of bladder cancer among some individuals in Walpole. 
Studies have revealed a number of occupations that are associated with bladder cancer.  
Exposures to chemicals in the workplace account for an estimated 20-25% of all bladder cancers 
diagnosed among men in the United States (Johansson and Cohen, 1997).  Occupational 
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 exposure to aromatic amines, such as benzidine and 2-naphthylamine, increases the risk of 
bladder cancer (ACS, 2004a).  These chemicals were common in the dye industry in the past.  A 
higher risk of bladder cancer has also been observed among aromatic amine manufacturing 
workers as well as among workers in the rubber, leather, textiles, printing, and paint products 
industries (ACS, 2004a; Silverman et al., 1996).  The development of new chemicals, changed 
worker exposures, and the elimination of many known bladder carcinogens in the workplace 
have caused shifts in those occupations considered to be high risk.  For example, risks among 
dye, rubber, and leather workers have declined over time, while other occupations such as motor 
vehicle operation (e.g., drivers of trucks, buses, and taxis) and the aluminum industry have 
emerged as potential high-risk occupations (Silverman et al., 1996).  However, specific 
occupational exposures in these occupations have not been confirmed and study findings are not 
consistent.  Further, the risk of bladder cancer from occupational exposures may be increased 
among smokers (ACS, 2004a).   
Occupation as reported to the MCR was reviewed for the 12 females in Walpole diagnosed with 
bladder cancer during 1988–1993 when a statistically significant elevation was observed.  
Review of this information did not indicate any jobs that are thought to be associated with the 
development of bladder cancer.  However, occupation was reported as retired, at home, or 
unknown for almost half of the individuals (n=5), therefore, the role that occupational exposures 
may have played in the incidence of bladder cancer among females in Walpole is unclear. 
Hodgkin’s Disease2)  
Epidemiologic studies have shown that Hodgkin’s disease is more common among men than 
women.  In Walpole, during the 19-year time period 1982–2000, males were diagnosed with 
Hodgkin’s disease about as often as expected.  However, females were diagnosed with this 
cancer type more often than expected.  This elevation was primarily attributed to a statistically 
significant elevation observed among females in the town during 1988–1993.  Hodgkin’s disease 
can occur in both children and adults but is more common in two age groups: early adulthood 
(ages 15 to 40, usually 25 to 30) and late adulthood (ages 55 and up) (ACS, 2005).  The pattern 
of Hodgkin’s disease in Walpole during 1982–2000 was generally consistent with this trend: 
almost 60% (n = 11) of diagnoses occurred among individuals aged 20 to 35 and 26% (n = 5) 
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 occurred among individuals over the age of 55.  (No individuals under age 20 were diagnosed 
with this cancer type in Walpole.)  Among the six females diagnosed with Hodgkin’s disease 
during 1988–1993, five were between the ages of 20 and 32 and one was over age 55. 
Occupational exposures to workers in the chemical industry and woodworkers have also been 
suggested in several epidemiologic studies to be associated with the development of Hodgkin’s 
disease.  However, specific chemical exposures related to the development of this disease have 
not been identified and results of studies investigating occupational exposures are inconsistent 
(Mueller, 1996).  Occupational information was available for two of the seven females diagnosed 
with Hodgkin’s disease during 1988–1993.  Based on the reported occupation, workplace 
exposures related to Hodgkin’s disease would have been unlikely for both of these individuals.  
Occupation was reported as at home, unknown, or retired for five of the females diagnosed 
during this time period.  Therefore, it was not possible to determine whether occupational 
exposures contributed to the pattern of Hodgkin’s disease among females in Walpole. 
3) Kidney Cancer 
The etiology of kidney cancer is not fully understood.  However, a number of environmental, 
hormonal, cellular, and genetic factors have been studied as possible causal factors in the 
development of this cancer type.  Kidney cancer is twice as common in males as it is in females, 
and the incidence most often occurs in the fifth and sixth decades of life (50–70 year age group) 
(ACS, 2004b).  In Walpole, males were diagnosed with kidney cancer less often than expected 
during 1982–2000.  However, a statistically significant elevation in the incidence of this cancer 
type occurred among females in the town during the overall time period.  Females in CT 4113 
experienced a statistically significant elevation during 1988–1993.  The average age at diagnosis 
for the 48 males and females diagnosed with kidney cancer in Walpole during 1982–2000 was 
64 years and 88% (n = 42) of the diagnoses occurred among individuals over the age of 50.  
Among females only, the average age at diagnosis was 65 years.  In CT 4113, the average age at 
diagnosis for females diagnosed during 1988–1993 was 62 years.  These trends are consistent 
with established patterns of disease in the general population. 
Cigarette smoking is the most important known risk factor for kidney cancer.  Smoking increases 
the risk of developing kidney cancer by about 40% (ACS, 2004b).  In Walpole, 67% (n=28) of 
37 
 individuals diagnosed with kidney cancer during 1982–2000 and with a known smoking history 
were current or former smokers at the time of diagnosis.  Smoking history was unknown for the 
remaining six individuals.  Similarly, 67% of females with a known smoking history were 
current or former smokers at the time of diagnosis and smoking history was unknown for the 
remaining four individuals.  Among the six females diagnosed with kidney cancer in CT 4113 
during 1988–1993 with a known smoking history, two were current or former smokers at 
diagnosis.  Smoking history was unknown for the other two females.  
Some studies have suggested that environmental and occupational factors may be associated with 
the development of kidney cancer.  For example, an increased incidence of this cancer type has 
been observed among leather tanners, shoe workers, and workers exposed to asbestos.  Exposure 
to cadmium is also associated with an increased incidence of kidney cancer, particularly among 
men who smoke.  In addition, workplace exposure to organic solvents, such as trichloroethylene 
(TCE), may increase the risk of this cancer (AC, 2004b).  More recently, renal cell carcinoma 
(RCC), the most common type of kidney cancer, has been suggested to be associated with 
occupational exposure to petroleum, tar, and pitch products.  However, studies of oil refinery 
workers and petroleum products distribution workers have not identified a definitive relationship 
between exposure to gasoline or other petroleum products and kidney cancer (Linehan et al., 
1997; McLaughlin et al., 1996).   
Occupational data as reported to the MCR was evaluated for all females diagnosed with kidney 
cancer in Walpole during 1982–2000.  Review of this information did not reveal any jobs in 
which exposures related to the development of kidney cancer would have been likely.  One 
individual reported a job as a factory worker, however, it is unclear whether this individual 
worked in an industry associated with exposures that might cause kidney cancer.  It is important 
to note that occupation was listed as at home, retired, or unknown for 80% of these individuals (n 
= 20).  Therefore, the possible role that occupational factors may have played in the incidence of 
kidney cancer among females in Walpole could not be determined. 
D. Geographic Distribution 
Place of residence at the time of diagnosis was mapped for each cancer type to determine 
whether a geographic concentration of diagnoses exists.  In addition to calculating census-tract-
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 specific incidence ratios for seven cancer types, a qualitative evaluation was conducted to 
determine whether any one cancer type appeared to be concentrated in any area(s) within the 
town of Walpole.  For confidentiality reasons, maps of the location of individuals diagnosed with 
cancer cannot be provided in this report. 
In general, review of the geographic distribution of cancer in Walpole during 1982–2000 
revealed no apparent spatial patterns at the neighborhood level that could not be attributed to 
factors such as areas of higher population density (e.g., the presence of multiunit housing 
complexes or nursing homes).  For example, although small concentrations of some cancer types 
(e.g., bladder cancer, Hodgkin’s disease, kidney cancer, leukemia, and lung and bronchus 
cancer) were observed in certain areas of town, in general the distribution of diagnoses seemed to 
coincide closely with the pattern of population in Walpole. 
Statistically significant elevations in the incidence of some cancer types were observed in 
Walpole or one or more of its census tracts during one or more of the time periods evaluated in 
this report.  However, when the geographic distribution of these cancers was evaluated at the 
neighborhood level, the patterns of diagnoses did not appear to be unusually clustered in any one 
area.  For example, females in Walpole as a whole and in CT 4113 experienced statistically 
significant elevations in the incidence of bladder cancer during the middle time period 1988–
1993.  Also, a statistically significant elevation in the incidence of kidney cancer was noted 
among females townwide during the overall time period 1982–2000 and among females in CT 
4113 during 1988–1993.  Review of the geographic distribution of bladder and kidney cancer 
diagnoses for the town as a whole indicated that the majority of diagnoses were located in and 
around the center of town, consistent with the population density of Walpole.  Of the six bladder 
cancer diagnoses among females in CT 4113 during 1988–1993, two were located in the 
MacDonald Circle neighborhood.  None of the six females diagnosed with kidney cancer in CT 
4113 during this time period lived in the MacDonald Circle neighborhood or Swan Pond Village.  
Rather, the majority of diagnoses were located in the northern part of this census tract and not 
near the Bird Landfill.  Females in Walpole also experienced a statistically significant elevation 
in the incidence of Hodgkin’s disease during 1988–1993; however, diagnoses were widely 
distributed throughout the town and were not concentrated in any one area of Walpole.   
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 In CT 4113 where the Bird Landfill is located, there was one diagnosis of liver cancer, which has 
been associated with vinyl chloride and arsenic exposure, while about three diagnoses were 
expected, and the individual diagnosed with liver cancer was not located in close proximity to 
the landfill.  While leukemia, was slightly elevated in CT 4113, none of the individuals 
diagnosed with this cancer types were located in close proximity to the site.  Lung and bronchus 
cancer, associated with arsenic and lead exposure, occurred less than expected in CT 4113.   
When examining the MacDonald Circle neighborhood, six residents were diagnosed with one of 
two different cancer types during 1982-2000: two with bladder cancer and four with lung and 
bronchus cancer.  Review of information regarding age, gender, and smoking history for 
individuals diagnosed with cancer in this area indicates that the pattern of cancer was generally 
consistent with what would be expected given the types of cancer diagnosed.  For example, four 
of the six individuals diagnosed in this area were current or former smokers (smoking history for 
the remaining two was known).  Also, the years of diagnosis for these individuals varied 
throughout the 19 years examined, that is, no single year had more than one cancer diagnosis, 
indicating no apparent trend or pattern over time. 
Six individuals in the Swan Pond Village neighborhood were diagnosed with one of the five 
different types of cancer: bladder cancer, Hodgkin’s disease, kidney cancer, leukemia, and lung 
and bronchus cancer.  This indicates the occurrence of different diseases and does not suggest the 
presence of a common factor (environmental or nonenvironmental) related to the diagnoses.  All 
of these diagnoses occurred in 1999 and 2000.  When information regarding age, gender, and 
smoking history were reviewed for individuals diagnosed with cancer in the Swan Pond Village 
area, no unusual patterns of diagnoses were identified.  For example, the mean age at diagnosis 
for these individuals was 70 years of age, and two of the three individuals diagnosed with 
bladder, lung and bronchus, and kidney cancer were reported as current or former smokers at the 
time of diagnosis.   
The geographic distribution of each of the seven cancer types was also examined relative to the 
locations of 21e hazardous material and oil release sites mapped for Walpole.  Based on a review 
of this information, there were no unusual concentrations of cancer diagnoses that would suggest 
a possible causal role for any of the sites evaluated.   
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 VIII. DISCUSSION 
This evaluation was initiated based on community concerns about the pattern of cancer in the 
Walpole neighborhoods of MacDonald Circle and Swan Pond Village and the presence of VOCs 
detected in groundwater at the Bird Landfill.  As part of this public health assessment, MDPH 
evaluated both cancer incidence data for Walpole and reviewed available environmental 
information for the Bird Landfill to determine possible pathways of exposure for nearby 
residents.  In addition, the pattern of cancer was evaluated within Walpole census tracts to 
identify any unusual concentrations of cancer diagnoses in particular areas of town or in relation 
to areas of environmental concern. 
There are no private wells located in the path of groundwater estimated to be potentially 
impacted by the Bird Landfill site; however, future exposures to some metals and VOCs in 
groundwater are possible if private drinking water wells are installed in the path of 
contamination.  While concentrations of contaminants such as arsenic, manganese, and vinyl 
chloride detected in groundwater at the Bird Landfill are likely to be lower down-gradient from 
the site, future installation and use of private wells close to the landfill could result in health 
concerns.   
The Bird Landfill is located about 0.8 miles south of a Zone II water supply protection area 
whose aquifer deposits could be pumped for public drinking water in an extreme drought 
situation.  Because the landfill is located outside the Zone II area, it is unlikely that groundwater 
from the landfill would reach municipal wells.  However, if, under a worst case scenario 
contaminants detected in groundwater at the Bird Landfill migrate in a north/northeast direction 
and eventually reach the Zone II for the Mine Brook wells, it is likely that contaminants detected 
in groundwater at the landfill would be diluted below a level of health concern before reaching 
down-gradient municipal wells.  In addition, municipal water supplies are tested and treated on a 
routine basis according to federal and state laws.  Therefore, it is not expected that groundwater 
with contaminants originating from the Bird Landfill would be consumed as municipal drinking 
water.   
With respect to indoor air, environmental investigations conducted at Area II of the landfill 
indicate that groundwater flows away from MacDonald Circle homes and therefore exposures 
41 
 through vapor intrusion are not expected to be a potential exposure pathway for residents of this 
neighborhood (GZA 1998).  To address possible vapor intrusion in Swan Pond Village homes 
located approximately 1500 feet down-gradient of the landfill, the Johnson-Ettinger model was 
employed using very conservative assumptions.  The model predicted that it is unlikely that 
VOCs detected in groundwater at the Bird Landfill would present an exposure concern for indoor 
air in homes down-gradient of the site.   
There is evidence of trespassing at the Bird Landfill, and thus, past, present, and future exposures 
to contaminants in surface water, soil, and sediment through dermal contact or incidental 
ingestion could be possible at the site.  However, the majority of contaminants detected in 
surface water, sediment, and wetland soils, were below or within the range of background 
concentrations and comparison values and it is unlikely that a trespasser would be exposed for 
sufficient frequency and duration to result in adverse health effects or increased cancer risk.   
The cancer types evaluated in this report were selected based on their potential association with 
contaminants of concern identified at the Bird Landfill site, resident concern over suspected 
elevations in some cancer types, and/or statistically significant elevations observed town-wide in 
published MCR reports.  In the town of Walpole as a whole, cancer incidence rates for the seven 
cancer types evaluated during the 19-year time period, 1982–2000, and the three smaller time 
periods were generally near expected rates based on cancer incidence in the state of 
Massachusetts.  In Walpole as a whole, bladder cancer (1988–1993) and kidney cancer (1982–
2000 and 1988–1993) were statistically significantly elevated in females.  This was due to 
statistically significant elevations in bladder cancer and kidney cancer among females during the 
middle time period 1988 to 1993 in CT 4113, where the Bird Landfill site is located.  However, 
the risk factor analysis suggested that tobacco use likely played an important role in diagnoses of 
kidney and bladder cancer for some individuals and there were no trends in cancer diagnoses 
over time.  There was also a statistically significant elevation in Hodgkin’s disease among 
females in Walpole as a whole during the middle time period 1988 to 1993, with elevations in 
each CT contributing to the town-wide elevation.  The geographic pattern of bladder cancer, 
Hodgkin’s disease, and kidney cancer in females did not indicate a concentration or an atypical 
distribution of females within any CT, including CT 4113.  Males in Walpole as a whole and in 
CT 4113 were diagnosed with these three cancer types approximately at or below the expected 
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 rates.  At the time this cancer incidence investigation was conducted, complete data records 
included cancer diagnoses that occurred from 1982–2000.  The MCR recently released two 
additional years of cancer incidence data and therefore it was possible to also evaluate more 
recent data for bladder cancer, kidney cancer, and Hodgkin’s disease.  All three cancer types 
occurred less often than expected among Walpole males and females during 2001 and 2002.  In 
CT 4113, three males were diagnosed with bladder cancer, kidney cancer, and Hodgkin’s 
disease, and there were no females diagnosed with any of the three cancer types during these 
years.   
In addition to an evaluation of cancer incidence rates, available risk factor information was 
reviewed for those cancer types that displayed statistically significant elevations in incidence in 
Walpole or one of its census tracts during 1982–2000 or one of the smaller time periods 
evaluated.  In general, cancer trends observed in Walpole were similar to those seen in the 
general population and in Massachusetts.  Data reviewed suggest that smoking likely played 
some role in the diagnosis of certain cancers (bladder and kidney cancer) among some 
individuals in Walpole.  The role that occupational exposures may have played in the incidence 
of bladder cancer, Hodgkin’s disease, and kidney cancer in Walpole is unclear due to incomplete 
information available from the MCR.   
Finally, analysis of the geographic distribution of place of residence for individuals diagnosed 
with cancer did not reveal any atypical spatial patterns that would suggest a common factor 
related to the incidence of cancer in Walpole as a whole or in the three census tracts that 
comprise the town.  That is, no unusual concentrations of individuals diagnosed with the seven 
cancer types evaluated were observed in the vicinity of the Bird Landfill site, including the 
MacDonald Circle neighborhood, Swan Pond Village, or any other area in Walpole.  Based on 
the information reviewed in this evaluation, it does not appear that a common factor 
(environmental or nonenvironmental) played a major role in the incidence of cancer in the census 
tract where the Bird Landfill is located, in the census tracts that divide the town, or in the town of 
Walpole as a whole during the 19-year time period, 1982–2000.   
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 IX. CHILD HEALTH CONSIDERATIONS 
ATSDR and MDPH recognize that the unique vulnerabilities of infants and children demand 
special emphasis in communities faced with contamination of their environment.  Children are at 
greater risk than adults form certain kinds of exposure to hazardous substances emitted from 
waste sites.  They are more likely exposed because they play outdoors and because they often 
bring food into contaminated areas.  Because of their smaller stature, they may breathe dust, soil, 
and heavy vapors close to the ground.  Children are also smaller, resulting in higher doses of 
chemical exposure per body weight.  The developing body systems of children can sustain 
permanent damage if certain toxic exposures occur during critical growth stages.  Most 
importantly, children depend completely on adults for risk identification and management 
decisions, housing decisions, and access to medical care.   
The incidence and pattern of cancer among children in Walpole is discussed in Section VI 
(“Cancer Incidence Analysis”) of this report.  As discussed before, future exposure to metals and 
VOCs could be possible for children if private drinking water wells are installed in the path of 
contamination.  The MDPH recommends that the Town of Walpole carefully review future 
private well installation requests if proposed wells are to be installed in the path of the estimated 
extent of contaminated groundwater.  Past, present, and future exposures to arsenic in surface 
water and iron in sediment could be possible for children who access the site.  However, based 
on conservative exposure estimates it is unlikely that anyone would have contact with surface 
water and sediment at the Bird Landfill site for a sufficient frequency and duration of time to 
result in adverse health effects.  No other exposures were identified that would indicate that 
children are more likely than adults to be impacted by the Bird Landfill site.    
X. LIMITATIONS 
This public health assessment is an investigation that considers descriptive health outcome data 
for cancer to determine whether the pattern or occurrence of selected cancers is unusual.  The 
purpose of this investigation is to evaluate the patterns of cancer in a geographical context in 
relation to available information about factors, including environmental factors, related to cancer 
to see whether further investigation seems warranted.  Information from descriptive analyses, 
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 which may suggest that a common etiology (or cause) is possible, can serve to identify areas 
where further public health actions may be warranted.  Inherent limitations in this type of 
analysis and the available data make it impossible to determine the precise causal relationships or 
synergistic roles that may have played a part in the development of individual cancers in this 
community.  Also, this type of analysis cannot determine what may have caused any one 
individual’s cancer.  Cancers in general have a variety of risk factors known or suggested to be 
related to the etiology (cause) of the disease that could not be evaluated in this report.  It is 
believed that many cancers are related largely to behavioral factors such as cigarette smoking, 
diet, and alcohol consumption.  Other factors associated with cancer are socioeconomic status, 
heredity/genetics, race, and geography.  It is beyond the scope of this report to determine the 
causal relationship of these factors and the development of cancer or other health outcomes in 
Walpole.  
XI. CONCLUSIONS 
• Future exposures to VOCs and metals detected in groundwater at the Bird Landfill 
are possible if private wells are installed for drinking water purposes down-gradient 
of the site.  Ingestion of contaminants detected in groundwater drawn into potential 
future private wells could result in health concerns.   
• Except under extreme drought conditions, it is unlikely that groundwater 
contaminants detected at the Bird Landfill would reach the Zone II protection area for 
the Mine Brook wells located 0.8 miles north of the site, and therefore exposures 
through municipal drinking water would not be expected.   
• Based on the levels of VOCs such as vinyl chloride detected in onsite groundwater, 
conservative indoor air concentrations predicted by the Johnson-Ettinger model, and 
the distance of homes north-northeast of the site, it is unlikely that contaminants 
detected in groundwater at the Bird Landfill would present an exposure concern for 
indoor air in down-gradient homes.   
• Intermittent exposures to onsite surface water, sediment, and wetland soils are 
possible for trespassers at the Bird Landfill in the past, present, and future.  However, 
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 based on the contaminant levels detected and the frequency and duration of contact 
expected, it is unlikely that potential exposures would result in adverse health effects.   
• The majority of cancer types evaluated during the 19–year time period 1982–2000 
occurred near expected rates in the Town of Walpole and in the three census tracts 
that comprise the town.  In Walpole as a whole, bladder cancer (1988–1993) and 
kidney cancer (1982–2000 and 1988–1993) were statistically significantly elevated in 
females.  The elevation was due to statistically significant elevations in bladder 
cancer and kidney cancer among females from 1988 to 1993 in CT 4113, where the 
Bird Landfill, MacDonald Circle, and Swan Pond Village are located.  A statistically 
significant elevation in Hodgkin’s disease was also observed among females from 
1988 to 1993 in Walpole as a whole.  An evaluation of available risk factor 
information suggested that tobacco use likely played an important role in diagnoses of 
kidney and bladder cancer for some individuals, and none of the seven cancer types 
were elevated in a consistent pattern over time or in any one area of Walpole.   
• Review of the geographic distribution of the seven cancer types in Walpole revealed 
no apparent spatial patterns at the neighborhood level, including in the vicinity of the 
Bird Landfill site, MacDonald Circle, or the Swan Pond Village neighborhood.  
• Based on the information reviewed in this evaluation, including available 
environmental data for the Bird Landfill site and risk factor information for 
individuals diagnosed with cancer, it does not appear that a common factor 
(environmental or nonenvironmental) played a major role in the incidence of cancer 
in the census tract containing the Bird Landfill site, MacDonald Circle, and the Swan 
Pond Village area, or in the town of Walpole as a whole during the 19-year time 
period, 1982–2000.  
ATSDR requires that one of five conclusion categories be used to summarize findings of 
a public health assessment.  These categories are as follows: (1) Urgent Public Health 
Hazard; (2) Public Health Hazard; (3) Indeterminate Public Health Hazard; (4) No 
Apparent Public Health Hazard; (5) No Public Health Hazard.  A category is selected 
from site-specific conditions such as the degree of public health hazard based on the 
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 presence and duration of human exposure, contaminant concentration, the nature of toxic 
effects associated with site-related contaminants, presence of physical hazards, and 
community health concerns.  Therefore, based on MDPH’s evaluation of the available 
environmental data, the exposure pathway analysis, and risk factor information related to 
the cancer types evaluated in this analysis, ATSDR would classify the Bird Landfill site 
as posing no apparent public health hazard in the past and present.  Since private wells 
could be installed in the path of contaminated groundwater north-northeast of the site 
making drinking water exposures possible, the Bird Landfill would pose a public health 
hazard in the future should wells be installed in contaminated groundwater areas.   
XII. RECOMMENDATIONS 
• The MDPH recommends that the town of Walpole review the testing and approval 
process currently in place for new private well construction to ensure contaminated 
groundwater at the Bird Landfill will not be consumed as drinking water by residents 
in the vicinity of the site.   
• The MDPH recommends no further investigation of cancer incidence in relation to 
the Bird Landfill at this time, but will continue to monitor cancer incidence in the 
town of Walpole through the Massachusetts Cancer Registry.  
XIII. PUBLIC HEALTH ACTION PLAN 
The Public Health Action Plan for the Bird Landfill contains a description of actions to be taken 
by the ATSDR and/or the MDPH at and in the vicinity of the site subsequent to completion of 
this public health assessment.  The purpose of the Public Health Action Plan is to ensure that this 
public health assessment not only identifies public health hazards, but also provides a plan of 
action designed to mitigate and prevent adverse human health effects resulting from exposure to 
hazardous substances in the environment.  Included is a commitment on the part of the 
ATSDR/MDPH to follow up on this plan to ensure that it is implemented.  The public health 
actions to be implemented by ATSDR/MDPH are as follows: 
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 • The MDPH is available to assist the Walpole Board of Health in defining a testing 
and approval process for new private well construction in the vicinity of the Bird 
Landfill.   
• The MDPH will continue to monitor the incidence of all cancer types in the town 
of Walpole through city/town cancer incidence reports published by the 
Massachusetts Cancer Registry. 
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Floor, Boston, MA 02108. 
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The Public Health Assessment, Evaluation of Cancer Incidence, 1982-2000, and Environmental 
Concerns Related to the Bird Landfill in Walpole, Norfolk County, Massachusetts, was prepared 
by the Massachusetts Department of Public Health under a cooperative agreement with the 
Agency for Toxic Substances and Disease Registry (ATSDR).  It is in accordance with approved 
methodology and procedures existing at the time the Public Health Assessment was initiated.  
Editorial review was conducted by MDPH.   
 
 
_______________________________________________ 
Technical Project Officer, CAT, SPAB, DHAC, ATSDR 
 
The Division of Health Assessment and Consultation, ATSDR, has reviewed this Public Health 
Assessment and concurs with its findings. 
 
 
__________________________________ 
Team Lead, CAT, SPAB, DHAC  
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MAPPED/   
NOT MAPPED SPILL ID/RTN LOCATION AID ADDRESS  DATE MATERIALS SOURCE STATUS
MAPPED N84-0434 UNKNOWN NEPONSET ST. S.WALPOLE 7/12/1984 UNKNOWN UNKNOWN UNKNOWN
MAPPED N87-1791 UNKNOWN ENDEON ESTATE  MYLOD RD 12/22/1987 #2 FUEL OIL UST UNKNOWN
MAPPED N89-1718 UNKNOWN ALBANY RD 10/13/1989 HYDRAULIC FLUID MACHINERY UNKNOWN
MAPPED N89-2106 UNKNOWN 985 PROVIDENCE HIGHWAY 12/11/1989 GASOLINE PIPE/HOSE/LINE UNKNOWN
MAPPED N91-0515 L H JOHNSON CO COBBLE KNOLL DR 4/18/1991 HYDRAULIC FLUID PIPE/HOSE/LINE UNKNOWN
MAPPED N92-1120 FOUR SEASONS ICE RINK 600 PROVIDENCE HWY 9/2/1992 WASTE OIL DRUM UNKNOWN
MAPPED N92-1527 SKATING RINK 600 PROVIDENCE HWY 11/18/1992 AMMONIA PIPE/HOSE/LINE UNKNOWN
MAPPED N93-0024 POLE HOLE SLEEPY HOLLOW RD 1/6/1993 UNKNOWN UNKNOWN UNKNOWN
MAPPED N83-0083 UNKNOWN 95 WEST ST. 5/16/1983 #6 FUEL OIL UNKNOWN UNKNOWN
MAPPED N83-0128 UNKNOWN 740 MAIN ST. 6/2/1983 TRANSFORMER OIL UNKNOWN UNKNOWN
MAPPED N84-0182 UNKNOWN RT.1 & RT.27 3/17/1984 GASOLINE UNKNOWN UNKNOWN
MAPPED N85-0898 UNKNOWN KENDALL TO 95 WEST ST. 11/25/1985 HYDRAULIC OIL UNKNOWN UNKNOWN
MAPPED N85-0994 UNKNOWN 18 INDUSTRIAL RD. 12/30/1985 METHYLENE CHLORIDE UNKNOWN UNKNOWN
MAPPED N86-0752 UNKNOWN
MILL POND/112 WASHINGTON 
ST. 8/18/1986 MISCELLANEOUS OIL UNKNOWN UNKNOWN
MAPPED N86-1176 BECO 740 MAIN ST UNKNOWN MISCELLANEOUS OIL UNKNOWN UNKNOWN
MAPPED N86-1227 UNKNOWN 112 WASHINGTON STREET 12/2/1986 NON PCB TRANS. OIL UNKNOWN UNKNOWN
MAPPED N86-1254 UNKNOWN 100 NEPONSET STREET 12/9/1986 NO. 6 FUEL OIL UST UNKNOWN
MAPPED N86-5003 UNKNOWN 333 CONEY ST. 4/10/1986 #2 FUEL OIL UNKNOWN UNKNOWN
MAPPED N87-0149 UNKNOWN 21 SUMMER STREET 2/10/1987 UNKNOWN UNKNOWN UNKNOWN
MAPPED N87-0355 UNKNOWN 95 WEST ST 7/18/1989 #2 FUEL OIL UNKNOWN UNKNOWN
MAPPED N87-0696 UNKNOWN 2415 SOUTH MAIN ST 5/27/1987 #6 FUEL OIL UNKNOWN UNKNOWN
MAPPED N87-0890 WALPOLE MA CORNER RT.1 & RT 27 6/25/1987 UNKNOWN DRUM UNKNOWN
MAPPED N87-1031 SOUTH WALPOLE 100 NEPONSET ST. 7/29/1987 MISCELLANEOUS OIL UNKNOWN UNKNOWN
MAPPED N87-1091 SHAMROCK ROOFING 1724 WASHINGTON ST UNKNOWN ASPHALT UNKNOWN UNKNOWN
MAPPED N87-1767 UNKNOWN
CORNER OF WINTER & MAIN 
STS 12/16/1987 DIESEL FUEL
VEH. FUEL 
TANK UNKNOWN
MAPPED N88-0498 UNKNOWN WALPOLE STATE PRISON UNKNOWN TRANSFORMER OIL TRANSFORMER UNKNOWN
MAPPED N88-0542 MOBIL STATION 751 MAIN STREET UNKNOWN GASOLINE UST UNKNOWN
MAPPED N88-0856 UNKNOWN HEMLOCK & CHERRY STREET 6/14/1988 HERBICIDES PIPE/HOSE/LINE UNKNOWN
MAPPED N88-0946 UNKNOWN MCI UNKNOWN TRANSFORMER OIL TRANSFORMER UNKNOWN
MAPPED N88-1174 MCI DIV OF CAPITAL PLAN AND OP CEDAR JUNCTION 8/5/1988 WASTE OIL UNKNOWN UNKNOWN
MAPPED N88-1188 UNKNOWN RTES 1 & 27 8/8/1988 SOLVENTS UNKNOWN UNKNOWN
MAPPED N88-1316 UNKNOWN 6 DUNBAR CT UNKNOWN #2 FUEL OIL
VEH. FUEL 
TANK UNKNOWN
MAPPED N88-1514 UNKNOWN 3 DONNER DRIVE 9/28/1988 UNKNOWN UNKNOWN UNKNOWN
MAPPED N88-1823 KW ZION (JUNKYARD) 1700 MAIN STREET UNKNOWN GASOLINE UNKNOWN UNKNOWN
MAPPED N89-**** UNKNOWN 923 MAIN ST 7/6/1989 PERCHLORETHYLENE UNKNOWN UNKNOWN
MAPPED N89-0353 UNKNOWN 42 CEDAR ST 3/14/1989 MISCELLANEOUS OIL ODOR UNKNOWN
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MAPPED N89-0608 UNKNOWN 1171R MAIN ST. UNKNOWN WASTE OIL DRUM UNKNOWN
MAPPED N89-0619 UNKNOWN ALBANY ROAD/PILOTS WAY UNKNOWN PAINT UNKNOWN UNKNOWN
MAPPED N89-0861 UNKNOWN 481 MAIN ST 5/25/1989 GASOLINE AST UNKNOWN
MAPPED N89-0883 UNKNOWN 153 WASHINGTON ST 5/30/1989 DIESEL FUEL
VEH. FUEL 
TANK UNKNOWN
MAPPED N89-0982 UNKNOWN 953 MAIN ST. UNKNOWN PHOPLEX AC-261 DRUM UNKNOWN
MAPPED N89-1118 UNKNOWN 923 MAIN ST. 7/5/1989 PERCHLOROETHYLENE PIPE/HOSE/LINE UNKNOWN
MAPPED N89-1484 UNKNOWN 16 COUNTY ST 9/3/1989 #2 FUEL OIL AST UNKNOWN
MAPPED N89-1647 UNKNOWN 180 MAIN ST. 9/29/1989 DIESEL FUEL DRUM UNKNOWN
MAPPED N89-1856 UNKNOWN 100 NEPONSET ST. 10/30/1989 MISC UST UNKNOWN
MAPPED N89-2044 BIRD MACHINE 100 NEPONSET ST 12/6/1989 HYDRAULIC FLUID DRUM UNKNOWN
MAPPED N90-0025 UNKNOWN 187 GOULD ST. 1/4/1990 #2 FUEL OIL AST UNKNOWN
MAPPED N90-1000 UNKNOWN 1171 MAIN ST. 6/21/1990 HYDRAULIC FLUID
HYDRAULIC 
LINE UNKNOWN
MAPPED N90-1090 UNKNOWN 740 MAIN ST. 7/9/1990 GASOLINE PIPE/HOSE/LINE UNKNOWN
MAPPED N90-1593 MCI CEDAR JUNCTION RTE 1A/MAIN ST 9/25/1990 MISC DETERGENTD DRUM UNKNOWN
MAPPED N90-2035 UNKNOWN 740 MAIN ST. 12/17/1990 DIESEL FUEL UNKNOWN UNKNOWN
MAPPED N91-0050 TRUCK TANK SPILL 460 MAIN ST 1/15/1991 DIESEL FUEL TANK UNKNOWN
MAPPED N91-0378 ZION AUTOMOTIVE 1700 MAIN ST UNKNOWN MISCELLANEOUS OIL UNKNOWN UNKNOWN
MAPPED N91-0412 CIBA CORNING 333 CONY ST 3/26/1991 MERCURY UNKNOWN UNKNOWN
MAPPED N92-0552 MCI CEDAR JUNCTION DEDHAM ST 5/1/1992 PAINT DRUMS UNKNOWN
MAPPED N92-0827 RESIDENTIAL 15 CHAPMAN ST 6/30/1992 #2 FUEL OIL AST UNKNOWN
MAPPED N92-1041 U-HAUL 1 PRODUCTION RD 8/17/1992 PAINTS,SOLVENTS,WASTE OIL DRUM UNKNOWN
MAPPED N92-1156 REFUELING SPILL 25 INDUSTRIAL RD 9/10/1992 DIESEL FUEL
VEH. FUEL 
TANK UNKNOWN
MAPPED N92-1375 CIBA CONING DIAGNOSTICS 333 CONEY ST 11/19/1992 HYDROQUINONE UNKNOWN UNKNOWN
MAPPED N93-0067 HEARTLAND PLAZA 514 MAIN ST 1/15/1993 DIESEL FUEL
VEH. FUEL 
TANK UNKNOWN
MAPPED N93-0853 STOP & SHOP 80 SOUTH ST 6/24/1993 HYDRAULIC FLUID COMPACTOR UNKNOWN
MAPPED N93-1026 BIRD MACHINE CO 100 NEPONSET ST 8/1/1993 MACHINE COOLING OIL STORAGE TANK UNKNOWN
NOT MAPPED N83-0114 UNKNOWN WASHINGTON ST. 5/24/1983 UNKNOWN UNKNOWN UNKNOWN
NOT MAPPED N83-0325 UNKNOWN SOUTH ST. 10/11/1983 #6 FUEL OIL UNKNOWN UNKNOWN
NOT MAPPED N84-0003 UNKNOWN RT.1 S.WALPOLE 1/6/1984 GASOLINE UNKNOWN UNKNOWN
NOT MAPPED N84-0179 UNKNOWN WASHINGTON ST. E.WALPOLE 3/26/1984 GASOLINE UST UNKNOWN
NOT MAPPED N84-0625 UNKNOWN RT.1A 9/21/1984 GASOLINE UST UNKNOWN
NOT MAPPED N85-0125 UNKNOWN
GAS STATION @ 
INTERSECTION RT. 2/22/1985 GASOLINE UNKNOWN UNKNOWN
NOT MAPPED N85-0689 UNKNOWN RT.1A 9/11/1985 #6 FUEL OIL UNKNOWN UNKNOWN
NOT MAPPED N86-0101 UNKNOWN TULMER ST. 2/15/1986 #2 FUEL OIL UNKNOWN UNKNOWN
NOT MAPPED N86-0376 UNKNOWN HEARTLAND PLAZA RTE.1A 5/16/1986 DIESEL FUEL UNKNOWN UNKNOWN
NOT MAPPED N86-0506 UNKNOWN
RTE. 95N/BEFORE CONEY 
ST.EXIT 6/17/1986 DIESEL FUEL UNKNOWN UNKNOWN
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NOT MAPPED N86-1095 UNKNOWN RTE.1 & UNION STREET 7/16/1986 WHITE MILKY SUBSTANCE UNKNOWN UNKNOWN
NOT MAPPED N87-0526 UNKNOWN RTE 1/STADIUM MOBIL 4/21/1987 GASOLINE UNKNOWN UNKNOWN
NOT MAPPED N87-0575 UNKNOWN
SOUTH ST/FORMER KENDALL 
CO 4/29/1987 #6 FUEL OIL UST UNKNOWN
NOT MAPPED N87-0676 UNKNOWN OLD POST RD AT RT.1 5/19/1987 DIESEL FUEL UNKNOWN UNKNOWN
NOT MAPPED N87-1137 UNKNOWN RT 95N UNKNOWN #2 FUEL OIL UNKNOWN UNKNOWN
NOT MAPPED N87-1639 WALPOLE/SHARON LINE ROUTE 1 SOUTHBOUND 11/18/1987 GASOLINE
VEH. FUEL 
TANK UNKNOWN
NOT MAPPED N88-0412 UNKNOWN RT 1 & UNION ST UNKNOWN GASOLINE
VEH. FUEL 
TANK UNKNOWN
NOT MAPPED N88-0887 POLE # 43/126-1 NORTH STREET 6/19/1900 TRANSFORMER OIL TRANSFORMER UNKNOWN
NOT MAPPED N88-1111 ROUTE 1A MAIN ST 7/29/1988 GASOLINE PIPE/HOSE/LINE UNKNOWN
NOT MAPPED N88-1629 ROUTE 95 OFFRAMP ROUTE 1 SOUTH BY UNKNOWN UNKNOWN DRUM UNKNOWN
NOT MAPPED N88-2013 POLE #33-171 WASHINGTON STREET 12/21/1988 TRANSFORMER OIL TRANSFORMER UNKNOWN
NOT MAPPED N89-0102 BICKFORDS RTES 1 & 95 1/23/1989 DIESEL FUEL
VEH. FUEL 
TANK UNKNOWN
NOT MAPPED N89-1125 UNKNOWN RTE # 1 7/7/1989 GARBAGE
INCINERATION 
AS UNKNOWN
NOT MAPPED N89-1212 KUHN TRANSPORTATION WALPOLE H2O SUPPLY 8/1/1989 DIESEL FUEL TANK UNKNOWN
NOT MAPPED N90-1235 RTE #1 7/27/1990 DIESEL FUEL
VEH. FUEL 
TANK UNKNOWN
NOT MAPPED N92-0180 PURITY SUPREME RTE 1A - MAIN ST 2/14/1992 #2 FUEL OIL PIPE/HOSE/LINE UNKNOWN
NOT MAPPED N92-0985 CONTAINER WASHINGTON & SLAVE 8/4/1992 SULFURIC ACID CONTAINER UNKNOWN
NOT MAPPED N92-1124 US POST OFFICE COMMON ST @ CENTER 9/3/1992 #2 FUEL OIL AST UNKNOWN
NOT MAPPED N92-1137 UNKNOWN UNKNOWN UNKNOWN UNKNOWN UNKNOWN
NOT MAPPED N92-1306 POND SCUM WILLWT POND 10/9/1992 GREEN MATERIAL DRUM UNKNOWN
MAPPED 3-0000024
FISH CHEMICAL & EQUIPMENT 
(INDUSTRIAL) 18 INDUSTRIAL RD 1/15/1987
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE PIPE WCSPRM
MAPPED 3-0000446
OLD COLONY GAS0LINE (FORMER, 
GAS STATION) 21 PROVIDENCE HWY 7/23/1986
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE UST DEPNDS
MAPPED 3-0000603
BLACKBURN & UNION PRIVILEGES 
(FORMER, MANUFACTURING) SOUTH ST 4/15/1987 ASBESTOS
LAGOON, 
UNCONTAIN, 
UST TIER1A
MAPPED 3-0001034 MCI WALPOLE (MUNICIPAL) MAIN ST 1/15/1987
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE TRANSFORM TIERII
MAPPED 3-0001382
WIMBLETON TENNIS COURTS 
(COMMERCIAL) 20 COUNTY ST RTE 109 11/24/1987
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE UST PENNFA
MAPPED 3-0001603
WOODWORKERS INC 
(COMMERCIAL) 767-777 EAST ST 1/15/1990
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE UNKNOWN RAO
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MAPPED 3-0001721 HOLLINGSWORTH & VOSE CO 112 WASHINGTON ST 1/15/1987
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE UNKNOWN DEPNFA
MAPPED 3-0001722 SEWER EXCAVATION MAIN ST SPEAR AVE 1/15/1988
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE UNKNOWN TIER1D
MAPPED 3-0001723 BIRD AND SONS FMR WASHINGTON ST 1/15/1987
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE UNKNOWN RAO
MAPPED 3-0001779 MAJORS SERVICE STATION FMR 745 MAIN ST 1/15/1987
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE UNKNOWN DEPNDS
MAPPED 3-0001801 HM GOULD & MOBIL OIL CO 295 UNION ST 1/15/1989
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE UNKNOWN TIERII
MAPPED 3-0001875 MOBIL STATION (GAS STATION) 751 MAIN ST 11/15/1988
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE UST RAO
MAPPED 3-0001944
SPECIALTY CONVERTORS 
(INDUSTRIAL, WETLANDS) 2000 MAIN ST 1/15/1989
PETROLEUM BASED OIL, UNKNOWN 
CHEMICAL OF TYPE - OIL
DRUMS, 
LEACHFIELD, 
PIPE, SEPTIc TIER1D
MAPPED 3-0002053
KENDALL MILL FMR (FORMER, 
INDUSTRIAL) STATION ST W ST 10/15/1989
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE UST RAO
MAPPED 3-0002469
BIRD MACHINE CO CART PATH 
(FORMER, INDUSTRIAL, OPEN 
SPACE) 100 NEPONSET ST 1/15/1990
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE LANDFILL WCSPRM
MAPPED 3-0002494
J CONNOLLY & SONS 
(COMMERCIAL) 609 MAIN ST 1/15/1990 DIESEL FUEL UNKNOWN RAO
MAPPED 3-0002628
BIRD JOHNSON COMPANY 
(INDUSTRIAL, MANUFACTURING) 110 NORFOLK ST 3/28/1989 PETROLEUM BASED OIL UST RAO
MAPPED 3-0002742 PROPERTY (FARM, RESIDENTIAL) 1018 NORTH ST 10/23/1989
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE UST RAO
MAPPED 3-0002751 CYR OIL CO (GAS STATION) MAIN ST N ST 1/15/1990
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE UST RAO
MAPPED 3-0003029 EXXON STATION (GAS STATION) 985 PROVIDENCE HWY 4/15/1990
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE UST RAO
MAPPED 3-0003067 COMMERCIAL PROPERTY 28 INDUSTRIAL WAY 12/18/1989
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE UNKNOWN DEPNDS
MAPPED 3-0003190 SHELL STATION (GAS STATION) 920 MAIN ST 7/15/1990 UNKNOWN CHEMICAL OF TYPE - OIL UNKNOWN REMOPS
MAPPED 3-0003244
AMERICAN AUTO AUCTIONS FMR 
(AUTO DEALER, FORMER) 600 PROVIDENCE HWY 7/15/1993
UNKNOWN CHEMICAL OF TYPE - OIL, 
WASTE OIL
DRYWELL, 
LEACHFIELD PENNFA
MAPPED 3-0003310
BIRD MACHINE OIL SPILL 
(MANUFACTURING) 100 NEPONSET ST 10/15/1990
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE UST WCSPRM
MAPPED 3-0003356
BOSTON EDISON SUBSTATION 
(UTILITY) MAIN ST 10/15/1990
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE TRANSFORM RAO
MAPPED 3-0003544 MOBIL STATION 01 137 PROVIDENCE HWY HIGH PLN 4/15/1991
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE PENNFA
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MAPPED 3-0003574
RODMAN FORD TRUCK CENTER 
(REPAIR YARD) PROVIDENCE HWY 4/15/1991 WASTE OIL
LEACHFIELD, 
UST RAO
MAPPED 3-0003642 GETTY PETROLEUM (GAS STATION) 571 MAIN ST 7/15/1991 PETROLEUM BASED OIL UST RAO
MAPPED 3-0003645 BEACH PROPERTY (FORMER) ELM ST 7/15/1991 PETROLEUM BASED OIL UNKNOWN WCSPRM
MAPPED 3-0004055
UNDEVELOPED PROPERTY (OPEN 
SPACE) TURCO DR 10/15/1992
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE UNKNOWN TIER1D
MAPPED 3-0004452
SUNOCO SERVICE STATION (GAS 
STATION) 1041 MAIN ST 9/29/1992 PETROLEUM BASED OIL UST TIERII
MAPPED 3-0004812
CUMBERLAND FARMS 
(COMMERCIAL, GAS STATION) 1185 WASHINGTON ST 10/1/1993 GASOLINE PIPE, UST REMOPS
MAPPED 3-0010765 WALPOLE FIRE DEPT (MUNICIPAL) 20 STONE ST 3/29/1994
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE (15 GAL) PIPE RAO
MAPPED 3-0010789 NO LOCATION AID 920 MAIN ST 3/18/1994 WASTE OIL (980 PPM) UNKNOWN RAO
MAPPED 3-0010863 FMR GAS STATION (COMMERCIAL) 739 MAIN ST 4/14/1994
GASOLINE (140 PPMV), PETROLEUM 
BASED OIL, TOTAL PETROLEUM 
HYDROCARBONS (TPH) (50 PPM) UST RAONR
MAPPED 3-0011220
OFF ROUTE ONE (PARKING LOT, 
ROADWAY) 25 WALPOLE SOUTH PARK RD 6/30/1994
DIESEL FUEL (100 GAL), DIESEL FUEL 
(125 GAL) FUELTANK RAO
MAPPED 3-0011271 NO LOCATION AID (COMMERCIAL) 215 MAIN ST 7/12/1994
BENZENE (1783 PPMV), GASOLINE (1800 
PPMV) UST RAO
MAPPED 3-0011445 NO LOCATION AID (ROADWAY) OLD FISHER LN 8/10/1994
DIESEL FUEL (10 GAL), DIESEL FUEL (15 
GAL)
FUELTANK, 
VEHICLE RAO
MAPPED 3-0011467
FRONT OF 595WASHINGTON 
ST/POLE #78/24 (RESIDENTIAL, 
ROADWAY) WASHINGTON ST 8/14/1994
MINERAL OIL, UNKNOWN CHEMICAL OF 
TYPE - OIL (20 GAL) TRANSFORM RAO
MAPPED 3-0011674 NO LOCATION AID (COMMERCIAL) 985 PROVIDENCE HWY 9/30/1994 GASOLINE (15 GAL), GASOLINE (31.2 GAL) VEHICLE RAO
MAPPED 3-0011865 NO LOCATION AID (RESIDENTIAL) 377 NORTH ST 11/17/1994
FUEL OIL #2 (100 GAL), FUEL OIL #2 (75 
GAL) PIPE RAO
MAPPED 3-0011931 NO LOCATION AID 1 PRODUCTION RD 12/6/1994 GASOLINE, GASOLINE (300 PPMV) UST RAO
MAPPED 3-0011958 NO LOCATION AID (RESIDENTIAL) 173 MYLOD ST 12/13/1994
TOTAL PETROLEUM HYDROCARBONS 
(TPH) (2400 PPM), TOTAL PETROLEUM 
HYDROCARBONS (TPH) (5570 MG/KG) UST RAO
MAPPED 3-0011999
POLE #91/2 @16 HARDING ST 
(RESIDENTIAL) HARDING ST 12/24/1994
UNKNOWN CHEMICAL OF TYPE - OIL (20 
GAL), UNKNOWN CHEMICAL OF TYPE - 
OIL (25 GAL) TRANSFORM RAO
MAPPED 3-0012079
REAR OF FACILITY AT LOADING 
DOCK (INDUSTRIAL) 333 CONEY ST 1/20/1995
DIESEL FUEL (10 GAL), DIESEL FUEL (50 
GAL) VEHICLE RAO
MAPPED 3-0012120
MCCARTHY WAREHOUSE  ROUTE 1 
(COMMERCIAL) 295 UNION ST 1/31/1995
FUEL OIL #2 (100 GAL), FUEL OIL #2 (70 
GAL) TANKER RAO
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MAPPED 3-0012636 WALPOLE HIGH SCHOOL 257 COMMON ST 6/29/1995
FUEL OIL #2 (1500 PPMV), FUEL OIL #4 
(1500 PPMV) UST RAO
MAPPED 3-0012692 NO LOCATION AID 110 NORFOLK ST 7/14/1995 ETHANE, 1,1-DICHLORO- (1900 UG/L) UNKNOWN RAO
MAPPED 3-0013087
PEGGY LAWTON KITCHENS INC 
(COMMERCIAL) 255 WASHINGTON ST 10/26/1995
FUEL OIL #2 (10 GAL), FUEL OIL #2 (330 
PPMV) UST RAO
MAPPED 3-0013186
TEXACO STATION RTE1/RTE 27 
(COMMERCIAL) 985 PROVIDENCE HWY RTE 1 11/28/1995
OIL, UNKNOWN CHEMICAL OF TYPE - OIL 
(25 GAL) TANKER STMRET
MAPPED 3-0013236 NO LOCATION AID 935 EAST ST 12/7/1995
TOTAL PETROLEUM HYDROCARBONS 
(TPH) (2.7 MG/L) UNKNOWN DPS
MAPPED 3-0013242
NEAR NORFOLK TOWNLINE 
(ROADWAY) WINTER ST 12/10/1995 PETROLEUM BASED OIL (23 GAL) VEHICLE RAO
MAPPED 3-0013321
SCHOOL MEADOW AT BROOK 
WELLFIELD 1303 WASHINGTON ST 1/11/1996
FUEL OIL #2 (17 MG/L), FUEL OIL #2 (9200 
MG/KG) UNKNOWN RAO
MAPPED 3-0013338
PAD MOUNTED TRANSFORMER 
PMH9655 (COMMERCIAL, 
INDUSTRIAL, ROADWAY) 412 HIGH PLAINS ST 1/17/1996 MINERAL OIL (165 GAL) TRANSFORM RAO
MAPPED 3-0013681 NO LOCATION AID (COMMERCIAL) 80 SOUTH ST 4/19/1996 DIESEL FUEL (30 GAL) VEHICLE RAO
MAPPED 3-0014101 BLESSED CHURCH 10 DIAMOND ST 8/8/1996
FUEL OIL #2 (101 PPMV), FUEL OIL #2 (101 
PPMV) UST RAO
MAPPED 3-0014118 RTE 1 (COMMERCIAL) 985 BOSTON PROV HWY 8/13/1996
BENZENE, DIMETHYL (24000 UG/L), 
BENZENE, ETHYL- (990 UG/L), BENZENE, 
METHYL- (6000 UG/L), GASOLINE UST RAONR
MAPPED 3-0014220
NEXT TO 908 & 920 MAIN ST 
(COMMERCIAL) 935 EAST ST 9/12/1996
LUBRICATING OIL (36 INCH), UNKNOWN 
CHEMICAL OF UNKNOWN TYPE (45.6 
INCH) UNKNOWN DPS
MAPPED 3-0014259 NO LOCATION AID 514 HIGH PLAIN ST 9/18/1996 BENZENE (290 PPB) UNKNOWN DPS
MAPPED 3-0014291 NO LOCATION AID (COMMERCIAL) 112 WASHINGTON ST 10/2/1996
UNKNOWN CHEMICAL OF TYPE - OIL (100 
GAL) MACHINERY RAO
MAPPED 3-0014490
PIONEER FARMS GREENHOUSE 
(COMMERCIAL) 505 FISHER ST 11/11/1996
FUEL OIL #2 (175 GAL), FUEL OIL #2 (200 
GAL) PIPE RAO
MAPPED 3-0014684 REAR ALLEY 943 MAIN ST 1/2/1997 FUEL OIL #2, FUEL OIL #2 (150 GAL) AST RAO
MAPPED 3-0014695 NO LOCATION AID (COMMERCIAL) 1340 MAIN ST 1/6/1997
GASOLINE (115 PPM), GASOLINE (115 
PPMV), GASOLINE (464 PPM) UST REMOPS
MAPPED 3-0014755 NO LOCATION AID 506 HIGH PLAIN ST 1/23/1997 BENZENE UNKNOWN DPS
MAPPED 3-0014756 NO LOCATION AID
642 BOSTON PROVIDENCE 
HWY 1/23/1997 BENZENE UNKNOWN DPS
MAPPED 3-0014831
POLE 74/59 (RESIDENTIAL, RIGHT 
OF WAY) FOREST AND WEST ST 2/17/1997
UNKNOWN CHEMICAL OF TYPE - OIL (10 
GAL), UNKNOWN CHEMICAL OF TYPE - 
OIL (25 GAL) TRANSFORM RAO
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MAPPED 3-0014992 NO LOCATION AID (COMMERCIAL) 1439 MAIN ST 4/11/1997
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE, UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (3 INCH) FORMER, UST RAO
MAPPED 3-0015034 RAMP (ROADWAY) RTE 95 SOUTH @ CONEY ST 4/20/1997 GASOLINE (15 GAL) VEHICLE RAO
MAPPED 3-0015135
DAY CARE CENTER/SUNOCO 
SERVICE STATION (SCHOOL) 62 FRONT ST 5/23/1997
UNKNOWN CHEMICAL OF TYPE - OIL (7.7 
MG/L), UNKNOWN CHEMICAL OF TYPE - 
OIL (7.73 PPM) UST RAONR
MAPPED 3-0015417
BECO/POLE #446/1 (INDUSTRIAL, 
POLE #1) SADDLE WAY 8/14/1997
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE (25 GAL) PIPE RAO
MAPPED 3-0015444 POLE #451/3 (ROADWAY) DOVER RD 8/19/1997
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE (15 GAL), UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (30 GAL) PIPE RAO
MAPPED 3-0015688 NO LOCATION AID 24 INDUSTRIAL RD 11/4/1997
ETHANE, 1,1,2,2-TETRACHLORO- (2 UG/L), 
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL (5 UG/L) UNKNOWN RAO
MAPPED 3-0015734 MCI (STATE) MAIN ST (RTE 1A) 11/20/1997
DIESEL FUEL, UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (1 GAL/HR) UST RAO
MAPPED 3-0016685 MCI (MUNICIPAL) CEDAR JCT 4/9/1998 GASOLINE (1980 PPMV) UST RAO
MAPPED 3-0016820
WEBSTER TRUCKING 
(COMMERCIAL) 25 INDUSTRIAL RD 5/20/1998
DIESEL FUEL (241 PPMV), DIESEL FUEL 
(247 PPM) UST RAO
MAPPED 3-0016915 NO LOCATION AID (INDUSTRIAL) 24 INDUSTRIAL RD 6/15/1998 BENZENE, METHYL- (60 GAL) AST RAO
MAPPED 3-0016990 SUMMER ST (RESIDENTIAL) 10 COBBLE KNOLL DR 6/29/1998
PETROLEUM BASED OIL, PETROLEUM 
BASED OIL (10.3 MG/L) UNKNOWN RAO
NOT MAPPED 3-0016994
LOTS 4 AND 5  POLE 25 WEST SIDE 
RTE 1 BOSTON PROVIDENCE HWY 6/30/1998 BENZENE, DIMETHYL (7.4 PPM) UNKNOWN DPS
MAPPED 3-0017188 STADIUM MOBIL (COMMERCIAL) 2285 PROVIDENCE HWY 8/20/1998
BENZENE, DIMETHYL (7400 PPB), 
BENZENE, METHYL- (9500 UG/L), 
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE (4700 PPB) UNKNOWN TIERII
MAPPED 3-0017224 PETES DREAM (COMMERCIAL) 1065 MAIN ST 8/27/1998
FUEL OIL #2 (297 PPMV), FUEL OIL #2 (297 
PPMV) UST TIERII
MAPPED 3-0017485 AT WILLOW ST (INDUSTRIAL) 100 NEPONSET ST 10/27/1998 CUTTING OIL (100 PPMV), OIL (100 PPMV) UST RAO
MAPPED 3-0017705
CORNER OF NORTON AVE AND 
SCHOOL ST 50 SCHOOL ST 12/7/1998
1,1 BIPHENYL, CHLORO DERIVS. (47 
MG/KG), 1,2-BENZENEDICARBOXYLIC 
ACID, BIS(2-ETHYLHEXYL) ESTER (24 
UG/L), ACENAPHTHYLENE, 1,2-DIHYDRO 
(250 MG/KG), BENZ[A]ANTHRACENE (500 
MG/KG), BENZ[E]ACEPHENANTHRYLENE 
(610 MG/KG), BENZO(K)FLUORANTHENE 
(240 MG/KG), BEN UNKNOWN RAO
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MAPPED 3-0017709
BECO TRANSMISSION LINE RIGHT 
OF WAY NEAR 2 TAFT ST OFF RTE 1A 12/9/1998
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL, UNKNOWN 
CHEMICAL OF UNKNOWN TYPE, WASTE 
OIL DRUMS RAO
MAPPED 3-0017751 NO LOCATION AID (RESIDENTIAL) 291 PLIMPTON ST 12/17/1998 FUEL OIL #2, FUEL OIL #2 (8.8 GAL)
AST, PIPE, 
TANKER RAO
MAPPED 3-0017796 NORTH STREET (COMMERCIAL) 745 MAIN ST 12/29/1998 GASOLINE (175 PPMV) UST REMOPS
MAPPED 3-0018762
BETWEEN 11 AND 15 APPLE TREE 
LANE (ROADWAY) APPLE TREE LN 9/18/1999
UNKNOWN CHEMICAL OF TYPE - OIL (20 
GAL), UNKNOWN CHEMICAL OF TYPE - 
OIL (20 GAL) TRANSFORM RAO
MAPPED 3-0018831 NO LOCATION AID (ROADWAY) 331 WEST ST 10/7/1999 UNKNOWN UNKNOWN TIER1D
MAPPED 3-0018926 RESIDENCE 1611 WASHINGTON ST 11/3/1999 FUEL OIL #2 (100 GAL), OIL (100 GAL) UNKNOWN TIER1C
MAPPED 3-0019121 NO LOCATION AID 1075 MAIN ST 12/27/1999
2-METHYLNAPHTHALENE (34 UG/L), 
BENZENE (75 UG/L), NAPHTHALENE (185 
UG/L) UNKNOWN TIERII
MAPPED 3-0019146
BOSTON EDISON (COMMERCIAL, 
ROADWAY) 740 MAIN ST AKA RTE 1A 1/8/2000
UNKNOWN CHEMICAL OF TYPE - OIL (70 
GAL), UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (75 GAL)
REGULATOR, 
VOLTAGE RAO
MAPPED 3-0019565 NO LOCATION AID (COMMERCIAL) 1075 MAIN ST 5/23/2000
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE, UNKNOWN CHEMICAL OF 
UNKNOWN TYPE (.5 INCH) UST RAONR
MAPPED 3-0019617 RTE 1A (COMMERCIAL) 1333 MAIN ST 6/12/2000 FUEL OIL #2, FUEL OIL #2 (3600 INCH) UST RAO
MAPPED 3-0019692 NO LOCATION AID (COMMERCIAL) 333 CONEY ST 7/6/2000
DIESEL FUEL (45 GAL), UNKNOWN 
CHEMICAL OF UNKNOWN TYPE (20 GAL) VEHICLE RAO
MAPPED 3-0019859 RTE 1 AND PINE ST WALPOLE PARK S 8/9/2000
METHANE, BROMODICHLORO- (6 UG/L), 
METHANE, TRICHLORO- (9 UG/L) UNKNOWN RAO
MAPPED 3-0019925 NO LOCATION AID 541 THRU 571 MAIN ST 9/1/2000
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL (6.1 UG/L) UNKNOWN RAO
NOT MAPPED 3-0020110 EXIT 10 (ROADWAY) RTE 95 N 11/13/2000
UNKNOWN CHEMICAL OF TYPE - OIL, 
UNKNOWN CHEMICAL OF TYPE - OIL, 
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE (1 GAL) VEHICLE RAO
MAPPED 3-0020444 NO LOCATION AID (ROADWAY) 900 WASHINGTON ST 3/5/2001
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE (50 GAL) VEHICLE RAO
NOT MAPPED 3-0020549 NEAR PINE ST (COMMERCIAL)
VACANT PARCEL 54-21 OFF 
RTE 1 3/30/2001
BENZ[A]ANTHRACENE (1.09 MG/KG), 
BENZ[E]ACEPHENANTHRYLENE (1.43 
MG/KG), BENZO[A]PYRENE (.99 MG/KG), 
DIBENZ[A,H]ANTHRACENE (.888 MG/KG), 
INDENO(1,2,3-CD)PYRENE (.888 MG/KG), 
LEAD (730 MG/KG), LEAD (730 PPM) UNKNOWN RAO
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 Table 1 (Continued)
MAPPED/   
NOT MAPPED SPILL ID/RTN LOCATION AID ADDRESS  DATE MATERIALS SOURCE STATUS
MAPPED 3-0020605 NO LOCATION AID (COMMERCIAL) 2285 PROVIDENCE HWY 4/19/2001
GASOLINE (.6 INCH), UNKNOWN 
CHEMICAL OF UNKNOWN TYPE (.1 INCH) UNKNOWN RAONR
MAPPED 3-0020712 NO LOCATION AID (COMMERCIAL) 1340 MAIN ST 5/16/2001 GASOLINE (30 GAL), GASOLINE (40 GAL) PIPE RAONR
MAPPED 3-0020901 MCI CEDAR JUNCTION (STATE) MAIN ST 7/12/2001 OIL, OIL (30 PPM) UNKNOWN RAO
MAPPED 3-0021359 NO LOCATION AID (COMMERCIAL) 920 MAIN ST 12/28/2001
BENZENE (63.6 UG/L), BENZENE, 
DIMETHYL (12330 UG/L), BENZENE, 
ETHYL- (700 UG/L), BENZENE, METHYL- 
(3620 UG/L), BTEX (5 MG/L), 
NAPHTHALENE (515 UG/L), UNKNOWN 
CHEMICAL OF TYPE - HAZARDOUS 
MATERIAL (149 UG/L) UNKNOWN RAONR
NOT MAPPED 3-0021454
NEAR NO 1303 (COMMERCIAL, 
RESIDENTIAL, ROADWAY) WASHINGTON ST 2/1/2002
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE (10 GAL), WASTE OIL (.25 GAL)
HYDRAULIC, 
PIPE, VEHICLE RAO
MAPPED 3-0021458 BEHIND BUILDINGS 961 MAIN ST 2/4/2002 NAPHTHALENE (7.3 MG/KG) UNKNOWN RAO
MAPPED 3-0021561 SHELL STATION 137870 920 MAIN ST 10/10/2001
2-METHYLNAPHTHALENE (5.35 MG/KG), 
BENZ[A]ANTHRACENE (3.53 MG/KG), 
CHRYSENE (16.2 MG/KG) UNKNOWN RAONR
MAPPED 3-0021915 ROUTE 1 AND PINE ST 15 WALPOLE PARK S 7/2/2002 LEAD (.046 MG/L) UNKNOWN TIER1B
NOT MAPPED 3-0022095
UTILITY POLE 4/9DA STATION 447 
(RIGHT OF WAY, UTILITY) MAIN ST NEAR 1491 9/12/2002 MINERAL OIL, MINERAL OIL (30 GAL) TRANSFORM RAO
MAPPED 3-0022209 NO LOCATION AID (COMMERCIAL) 743 MAIN ST 10/15/2002
FUEL OIL #2 (175 GAL), FUEL OIL #2 (200 
GAL), FUEL OIL #2 (275 GAL) AST RAONR
MAPPED 3-0022307
NO LOCATION AID (COMMERCIAL, 
INDUSTRIAL) 18 RENMER AVE 11/14/2002 GASOLINE (20 GAL) VEHICLE RAO
MAPPED 3-0022399
WALPOLE MALL PARKING LOT 
(COMMERCIAL) 70-90 PROVIDENCE HWY 12/16/2002
DIESEL FUEL (20 GAL), DIESEL FUEL (5 
GAL)
FUEL TANK, 
VEHICLE RAO
MAPPED 3-0022577 VACANT LAND 1425 MAIN ST 2/19/2003 ETHENE, TETRACHLORO- (12.9 UG/L) UNKNOWN DPS
MAPPED 3-0022935 BIRD MACHINE CO (INDUSTRIAL) 100 NEPONSET ST 6/17/2003
PETROLEUM BASED OIL, UNKNOWN 
CHEMICAL OF TYPE - OIL UNKNOWN RAO
MAPPED 3-0023506
NSTAR SERVICE CENTER 
(COMMERCIAL) 760 MAIN ST 1/14/2004
GASOLINE (.05 GAL/HR), GASOLINE (5 
GAL) PIPE, UST RAO
MAPPED 3-0023513 BIRD MACHINE 100 NEPONSET ST 1/14/2004 LEAD (4500 MG/KG) UNKNOWN TIERII
MAPPED 3-0023575 BIRD MACHINE CO (COMMERCIAL) 100 NEPONSET ST 1/23/2004 OIL UNKNOWN TIERII
MAPPED 3-0023589
HOLLINGSWORTH AND VOSE 
COMPANY 112 WASHINGTON ST 1/20/2004
CHROMIUM (2110 MG/KG), COPPER (2540 
MG/KG), LEAD (372 MG/KG) UNKNOWN RAO
MAPPED 3-0023619 BOYDEN SCHOOL 1852 WASHINGTON ST 2/20/2004 GAL) TANKER RAO
NOT MAPPED 3-0023787
BEACH PROPERTY  KENDALL 
COMPANY ELM ST 4/21/2004
BENZ[A]ANTHRACENE (31.9 MG/KG), 
BENZ[E]ACEPHENANTHRYLENE (24.3 
MG/KG) UNKNOWN TIER1D
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MAPPED/   
NOT MAPPED SPILL ID/RTN LOCATION AID ADDRESS  DATE MATERIALS SOURCE STATUS
MAPPED 3-0024105
BIRD MACHINE COMPANY-
DEMOLITION DEBRIS 100 NEPONSET ST 7/30/2004
LEAD (.0331 MG/L), NICKEL (1.426 MG/L), 
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE (.00000021 MG/KG), ZINC (1.218 
MG/L) UNKNOWN UNCLSS
MAPPED 3-0020901 MCI CEDAR JUNCTION (STATE) MAIN ST 7/12/2001 OIL, OIL (30 PPM) UNKNOWN RAO
MAPPED 3-0024107 SHELL SERVICE STATION #137870 920 MAIN ST 8/2/2004
UNKNOWN CHEMICAL OF TYPE - 
HAZARDOUS MATERIAL (.911 UG/G) UNKNOWN RAONR
MAPPED 3-0024222
BAKER HUGHES INC  FMLY BIRD 
MACHINE CO 100 NEPONSET ST 9/8/2004 NICKEL (.14 MG/L) UNKNOWN UNCLSS
MAPPED 3-0024400 ROUTE 1 (COMMERCIAL)
985 BOSTON PROVIDENCE 
HWY 11/10/2004
GASOLINE (100 PPMV), UNKNOWN 
CHEMICAL OF UNKNOWN TYPE (100 
PPMV) UST TIERII
MAPPED 3-0024474
CALLAHAN COMPANY  42-07-15N 71-
15-57W (INDUSTRIAL) 18 INDUSTRIAL RD 12/8/2004
2-PROPANONE (1300 GAL), 2-
PROPANONE (1300 LBS) PIPE, TANKER UNCLSS
MAPPED 3-0024498 BIRD PARK (WATERBODY) RHOADES AVE 12/17/2004 PETROLEUM BASED OIL UNKNOWN UNCLSS
MAPPED 3-0024542 SUNOCO SERVICE STATION 1041 MAIN ST 1/4/2005 UNKNOWN UNKNOWN UNCLSS
MAPPED 3-0024565 CALLAHAN CO (INDUSTRIAL) 18 INDUSTRIAL RD 1/14/2005 2-PROPANONE (200 GAL) UNKNOWN RAO
MAPPED 3-0024608
CORNER OF JUNE STREET 
(RESIDENTIAL) 259-261 WASHINGTON ST 2/1/2005 FUEL OIL #2 PIPE UNCLSS
MAPPED 3-0024703 NO LOCATION AID (RESIDENTIAL) 141 LINCOLN RD 3/16/2005 GAL) AST, PIPE UNCLSS
MAPPED 3-0024778 CALLAHAN COMPANY 18 INDUSTRIAL RD 4/6/2005
2-BUTANONE (17900 UG/L), ETHENE , 1,2-
DICHLORO- (1370 UG/L), ETHENE, 
CHLORO- (184 UG/L) UNKNOWN UNCLSS
MAPPED 3-0024804
MOBIL STATION 01-137 
(COMMERCIAL) 980 PROVIDENCE HWY 4/26/2005
UNKNOWN CHEMICAL OF UNKNOWN 
TYPE (400 GAL) PIPE UNCLSS
Source:  Massachusetts Deparment of Environmental Protection (MDEP) Bureau of Waste Site Cleanup. 2004.  Downloadable Site Lists.  http://www.state.ma.us/dep/bwsc/sites/sdown.htm
Notes:
Spill ID - Spill Identification Number (applicable for releases reported prior to October 1993).  Definition: NA Not Applicable
RTN - Release Tracking Number.  Unique ID number assigned to releases not remediated by October 1993 and to those occuring October 1993-present. 
Location Aid - Place name of release
Address - Street location of release
Date - Date of release (releases prior to October 1993), or date release was reported to MDEP (for releases occurring October 1993-present)
Materials - Chemical(s) in release
Sources - Origin(s) of release contamination.  Definitions: AST Aboveground Storage Tank; UST Underground Storage Tank. 
Status - Remediation status of release.  Definitions: ADQREG Adequately Regulated; DEFT1B Default Tier 1B; DEPMOU DEP Memorandum of Understanding; DEPNDS Not a Disposal Site (DEP); DEPNFA No 
Further Action (DEP Determined); DPS Downgradient Property Status; DPSTRM Downgradient Property Status Terminated; INVSUB Submittal Invalidated by DEP; LSPNFA LSP No Further Action; PENNDS 
Pending Not a Disposal Site; PENNFA Pending No Further Action; RAO Release Action Outcome; RAONR Response Action Outcome Not Required; REMOPS Remedy Operation Status; SPECPR Special Project; 
STMRET Response Action Outcome Statement Retracted; TCLASS Tier Classification; TIER1A Tier 1A; TIER1B Tier 1B; TIER1C Tier 1C; TIERII Tier II; UNCLSS Unclassified; WCSPRM Waiver Completion 
Statement Permanent.
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 CREG = 0.02
Chronic EMEG (child); RMEG (child) = 3
Chronic EMEG (Adult), RMEG (adult) = 10
U.S. EPA MCL = 10
RMEG (child) = 700
RMEG (adult) = 2000
MDEP MMCL = 2000
CREG = 0.6
MDEP MMCL = 5
Chronic EMEG (child) = 2
Chronic EMEG (adult) = 7
MDEP MMCL = 5
Chloroethane May-87 LF-3A 250 EPA RBC = 3.6
Hexavalent Chromium: RMEG (child) = 30
Hexavalent Chromium: RMEG (adult) = 300
MDEP MMCL = 100
Hexavalent Chromium: RMEG (child) = 30
Hexavalent Chromium: RMEG (adult) = 300
MDEP MMCL = 100
Intermediate EMEG (child) = 100
Intermediate EMEG (adult) = 400
MDEP MMCL (Action Level) = 1300
Intermediate EMEG (child) = 3,000
Intermediate EMEG (adult) = 10,000
EPA RBC = 61
MDEP MMCL = 70
Iron Nov-94 LF-3D 898,000 EPA RBC = 11,000
MCLG = 0
MDEP MMCL = 15
Cadmium Jun-02 CSA-2D
Copper Nov-04 CSA-6S
Chromium (total) Nov-94 LF-UP
Lead Nov-94
Arsenic Nov-94 LF-UP
Benzene Nov-04
Barium Nov-94 LF-UP
CSA-3
Contaminant Date of sample Descriptive location of sample Maximum concentration (ppb) Drinking water comparison value (ppb)
16.4
189
986
21
230LF-UP
506
1,2-Dichloroethylene, cis- Nov-94 LF-3S
Chromium (VI)
110
May-99 580CSA-7S
818
Table 2
Maximum concentrations of contaminants detected in on-site groundwater samples at the Bird Landfill
that exceeded comparison values  (samples taken from 1984 - 2005) 
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 Table # 2 (Continued)
RMEG (child) = 500
RMEG (adult) = 2000
EPA RBC = 730
RMEG (child) = 50
RMEG (adult) = 200
EPA RBC = 180
RMEG (child) = 100
RMEG (adult) = 400
EPA RBC (residential) = 1.2
MDEP MMCL = 5
EPA RBC (residential) = 1.6
MCLG = 0
MDEP MMCL = 5
CREG = 0.03
Chronic EMEG (child) = 0.2
Chronic EMEG (adult) = 0.7
MCLG = 0
MDEP MMCL = 2
Data sources:   
GZA GeoEnvironmental, Inc.  1998.  Addendum to the Comprehensive Site Assessment (CSA), Bird, Inc. Landfill.
GZA GeoEnvironmental, Inc.  2000.  2000 Semi-Annual Groundwater Monitoring Report, Bird, Inc. Landfill.
GZA GeoEnvironmental, Inc.  2001.  2001 Semi-Annual Groundwater Monitoring Report.  Bird, Inc. Landfill.  
GZA GeoEnvironmental, Inc.  2002.  2002 Semi-Annual Groundwater Monitoring Report, Bird, Inc. Landfill.  
GZA GeoEnvironmental, Inc.  2005.  Semi-Annual Groundwater Monitoring Report (Spring 2005), Bird Inc. Landfill.
Intermediate EMEG (adult) = Environmental Media Evaluation Guide for adults (I.e., for exposures between 14 days and 1 year) (ATSDR, ATSDR 2005b)
Drinking water comparison value (ppb)
LF-1 26,000
Descriptive location of sample Maximum concentration (ppb)
Manganese
Nov-95
May-92
Silver May-97
LF-3S 24
LF-1 250
Chronic EMEG (adult/child) = Environmental Media Evaluation Guide (i.e., for adult or childhood exposures greater than 1 year) (ATSDR 2005b)
Comparison values (source organization, reference):
Intermediate EMEG (child) = Environmental Media Evaluation Guide for children (I.e., for exposures between 14 days and 1 year and considers vulnerabilities of children when it comes to environmental exposures). 
(ATSDR, ATSDR 2005b)
CREG = Cancer Risk Evaluation Guide for 1 x 10-6 excess cancer risk (ATSDR, ATSDR 2005b)
Tetrachlorethylene Nov-99 LF-6D
Contaminant Date of sample
GZA GeoEnvironmental, Inc.  1997.  Bird Landfill: Draft Comprehensive Site Assessment.
41
Trichloroethylene Nov-99 34LF-6D
Vinyl Chloride
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 Table # 2 (Continued)
EPA RBC = EPA Region 3 Risk Based Concentration for tap water (U.S. EPA, U.S. EPA 2004)
MCLG = Maximum Contaminant Level Goal for drinking water (U.S. EPA, ATSDR 2005b)
MDEP MMCL = Massachusetts Maxiumum Contaminant Level for drinking water (MDEP, MDEP 2004 )
RMEG (adult/child) = Reference Dose Media Evaluation Guides (an estimate of a daily exposure to the general public, including sensitive subgroups, that is likely to be without appreciable risk of 
deleterious effects during a specified duration of exposure). (ATSDR 2005b)
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 CREG = 0.02
Chronic EMEG (child); RMEG (child) = 3
Chronic EMEG (Adult), RMEG (adult) = 10
U. S. EPA MCL = 10
RMEG (child) = 700
RMEG (adult) = 2000
MDEP MMCL = 2000
CREG = 0.6
MDEP MMCL = 5
Chronic EMEG (child) = 2
Chronic EMEG (adult) = 7
MDEP MMCL = 5
Iron May-96 SW-1 52,000 EPA RBC = 11,000
MCLG = 0
MDEP MMCL = 15
RMEG (child) = 500
RMEG (adult) = 2000
RMEG (child) = 50
RMEG (adult) = 200
Data sources:   
GZA GeoEnvironmental, Inc.  2001.  2001 Semi-Annual Groundwater Monitoring Report.  Bird, Inc. Landfill.  
GZA GeoEnvironmental, Inc.  2005.  Semi-Annual Groundwater Monitoring Report (Spring 2005), Bird Inc. Landfill.
Barium May-96 SW-1
SW-1
Benzene May-96 SW-1
Manganese
0.97
Lead May-96
May-96
SW-4 85
Chronic EMEG (adult/child) = Environmental Media Evaluation Guide (i.e., for adult or childhood exposures greater than 1 year) (ATSDR 2005b)
Comparison values (source organization, reference):
CREG = Cancer Risk Evaluation Guide for 1 x 10-6 excess cancer risk (ATSDR, ATSDR 2005b)
Drinking water comparison value (ppb)
6
1080
Contaminant Date of sample Descriptive location of sample Maximum concentration (ppb)
Arsenic May-96 SW-5
1,530
Cadmium May-99 SW-4 8.6
Silver May-96 SW-4 85
GZA GeoEnvironmental, Inc.  2002.  2002 Semi-Annual Groundwater Monitoring Report, Bird, Inc. Landfill.  
GZA GeoEnvironmental, Inc.  2000.  2000 Semi-Annual Groundwater Monitoring Report, Bird, Inc. Landfill.
GZA GeoEnvironmental, Inc.  1998.  Addendum to the Comprehensive Site Assessment (CSA), Bird, Inc. Landfill.
GZA GeoEnvironmental, Inc.  1997.  Bird Landfill: Draft Comprehensive Site Assessment.
Table 3
Maximum concentrations of contaminants detected in on-site surface water samples at the Bird Landfill
that exceeded comparison values  (samples taken from May 1996 - November 2005) 
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Table #3 (Continued)
Intermediate EMEG (adult) = Environmental Media Evaluation Guide for adults (I.e., for exposures between 14 days and 1 year) (ATSDR, ATSDR 2005b)
EPA RBC = EPA Region 3 Risk Based Concentration for tap water (U.S. EPA, U.S. EPA 2004)
MCLG = Maximum Contaminant Level Goal for drinking water (U.S. EPA, ATSDR 2005b)
MDEP MMCL = Massachusetts Maxiumum Contaminant Level for drinking water (MDEP, MDEP 2004 )
Intermediate EMEG (child) = Environmental Media Evaluation Guide for children (I.e., for exposures between 14 days and 1 year and considers 
vulnerabilities of children when it comes to environmental exposures). (ATSDR, ATSDR 2005b)
RMEG (adult/child) = Reference Dose Media Evaluation Guides (an estimate of a daily exposure to the general public, including sensitive subgroups, 
that is likely to be without appreciable risk of deleterious effects during a specified duration of exposure). (ATSDR 2005b)
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Environmental 
Medium 
Exposure 
Pathway 
Contaminant(s) Point of 
Exposure 
Route of 
Exposure 
Receptor 
Population 
Time 
Frame 
Type of 
Pathway 
Notes 
Groundwater 
contamination 
Metals, VOCs, 
PAHs 
Off-site 
municipal/ 
private wells  
Ingestion, 
Inhalation Residents 
Past, 
Present Eliminated 
Municipal water tested and 
treated.  One private well not 
used, other private well has a 
filter and is located outside 
estimated extent of 
contaminated groundwater.  
Groundwater 
contamination 
Metals, VOCs, 
PAHs 
Off-site 
municipal/ 
private wells   
Ingestion, 
Inhalation Residents Future Potential 
Exposures are possible if 
new private wells are 
installed down gradient of 
the landfill.  Potential 
impacts to municipal wells 
are unlikely.   
Groundwater 
Volatilization 
of shallow 
groundwater  
to indoor air 
VOCs  
(e.g. Vinyl 
Chloride) 
Off-site 
residences 
with 
basements 
Inhalation Residents 
Past, 
Present, 
Future 
Potential 
Off-site concentrations of 
VOCs in groundwater are 
expected to be below a level 
of health concern for 
possible indoor air exposure 
in down-gradient homes. 
Surface Water Surface water VOCs, Metals Stream, pond, wetland Ingestion Trespassers 
Past, 
Present, 
Future 
Potential 
Concentrations detected in 
surface water are unlikely to 
result in adverse health 
effects for recreational 
exposure scenario. 
Concentrations detected in 
wetland soils and sediment 
are below comparison 
values.  
Potential Soil/Sediment Soil/sediment Metals Stream, pond, wetland Ingestion Trespassers 
Past, 
Present, 
Future 
Table 4 
Summary of Possible Exposure Pathways for the Bird Landfill 
Walpole, Massachusetts 
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 31 26.2 119 81 -- 168 24 19.8 121 77 -- 180 7 6.3 111 44 -- 228
4112 22 18.2 121 76 -- 183 15 13.3 113 63 -- 186 7 4.9 143 57 -- 296
4113 19 21.3 89 54 -- 139 10 15.8 63 30 -- 116 9 5.5 164 75 -- 311
Town Total† 73 65.5 112 87 -- 140 50 48.8 102 76 -- 135 23 16.6 138 88 -- 207
† One case for which census tract designation was not possible was included in the town total.
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 6a
Bladder Cancer Incidence
Walpole, Massachusetts
1982–2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 10 7.2 139 67 -- 256 8 5.4 148 64 -- 292 2 1.8 NC NC -- NC
4112 5 6.0 84 27 -- 196 5 4.4 114 37 -- 265 0 1.6 NC NC -- NC
4113 2 5.6 NC NC -- NC 1 4.1 NC NC -- NC 1 1.4 NC NC -- NC
Town Total† 18 18.7 96 57 -- 152 15 13.9 108 60 -- 178 3 4.8 NC NC -- NC
† One case for which census tract designation was not possible was included in the town total.
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 6b
Bladder Cancer Incidence
Walpole, Massachusetts
1982–1987
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 10 8.1 123 59 -- 227 6 6.2 97 36 -- 212 4 2.0 NC NC -- NC
4112 6 5.7 105 38 -- 229 4 4.2 NC NC -- NC 2 1.5 NC NC -- NC
4113 10 6.2 161 77 -- 296 4 4.6 NC NC -- NC 6 1.6 382 * 139 -- 831
Town Total 26 19.9 130 85 -- 191 14 14.9 94 51 -- 158 12 5.0 239 * 124 -- 418
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 6c
Bladder Cancer Incidence
Walpole, Massachusetts
1988-1993
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 11 9.7 114 57 -- 203 10 7.2 138 66 -- 254 1 2.4 NC NC -- NC
4112 11 6.8 163 81 -- 291 6 4.9 121 44 -- 264 5 1.8 274 88 -- 640
4113 7 10.9 64 26 -- 132 5 7.9 64 20 -- 148 2 3.0 NC NC -- NC
Town Total 29 27.3 106 71 -- 153 21 20.0 105 65 -- 160 8 7.3 110 47 -- 216
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 6d
Bladder Cancer Incidence
Walpole, Massachusetts
1994–2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 5 5.4 92 30 -- 214 2 3.4 NC NC -- NC 3 2.0 NC NC -- NC
4112 6 4.0 150 55 -- 327 3 2.2 NC NC -- NC 3 1.8 NC NC -- NC
4113 8 5.0 161 69 -- 317 3 2.8 NC NC -- NC 5 2.1 233 75 -- 543
Town Total 19 14.2 134 81 -- 209 8 8.2 98 42 -- 192 11 6.0 184 92 -- 330
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 7a
Hodgkin's Disease Incidence
Walpole, Massachusetts
1982–2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 0 1.5 NC NC -- NC 0 0.9 NC NC -- NC 0 0.6 NC NC -- NC
4112 1 1.2 NC NC -- NC 1 0.7 NC NC -- NC 0 0.5 NC NC -- NC
4113 2 1.5 NC NC -- NC 1 0.9 NC NC -- NC 1 0.6 NC NC -- NC
Town Total 3 4.2 NC NC -- NC 2 2.5 NC NC -- NC 1 1.7 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 7b
Hodgkin's Disease Incidence
Walpole, Massachusetts
1982–1987
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 4 1.8 NC NC -- NC 1 1.1 NC NC -- NC 3 0.7 NC NC -- NC
4112 2 1.3 NC NC -- NC 1 0.7 NC NC -- NC 1 0.6 NC NC -- NC
4113 3 1.6 NC NC -- NC 1 0.9 NC NC -- NC 2 0.7 NC NC -- NC
Town Total 9 4.6 194 89 -- 368 3 2.6 NC NC -- NC 6 2.0 301 * 110 -- 656
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 7c
Hodgkin's Disease Incidence
Walpole, Massachusetts
1988-1993
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 1 1.8 NC NC -- NC 1 1.1 NC NC -- NC 0 0.8 NC NC -- NC
4112 3 1.4 NC NC -- NC 1 0.8 NC NC -- NC 2 0.6 NC NC -- NC
4113 3 2.1 NC NC -- NC 1 1.3 NC NC -- NC 2 0.9 NC NC -- NC
Town Total 7 5.3 131 53 -- 270 3 3.1 NC NC -- NC 4 2.3 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 7d
Hodgkin's Disease Incidence
Walpole, Massachusetts
1994–2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 21 15.8 133 82 -- 203 10 10.1 99 47 -- 182 11 5.7 191 95 -- 343
4112 12 11.6 103 53 -- 180 7 7.2 98 39 -- 202 5 4.5 111 36 -- 260
4113 15 14.1 106 59 -- 175 6 8.9 67 24 -- 146 9 5.2 173 79 -- 329
Town Total 48 41.5 116 85 -- 153 23 26.2 88 56 -- 132 25 15.2 164 * 106 -- 242
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 8a
Kidney Cancer Incidence
Walpole, Massachusetts
1982–2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 6 3.3 182 66 -- 396 2 2.0 NC NC -- NC 4 1.3 NC NC -- NC
4112 2 2.7 NC NC -- NC 2 1.6 NC NC -- NC 0 1.1 NC NC -- NC
4113 3 2.7 NC NC -- NC 2 1.7 NC NC -- NC 1 1.0 NC NC -- NC
Town Total 11 8.7 126 63 -- 225 6 5.4 111 41 -- 243 5 3.4 149 48 -- 347
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 8b
Kidney Cancer Incidence
Walpole, Massachusetts
1982–1987
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 9 5.2 173 79 -- 329 6 3.3 179 65 -- 390 3 1.8 NC NC -- NC
4112 1 3.8 NC NC -- NC 0 2.4 NC NC -- NC 1 1.5 NC NC -- NC
4113 9 4.4 204 93 -- 387 3 2.8 NC NC -- NC 6 1.6 381 * 139 -- 830
Town Total 19 13.4 142 85 -- 222 9 8.6 105 48 -- 199 10 4.8 208 100 -- 382
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 8c
Kidney Cancer Incidence
Walpole, Massachusetts
1988-1993
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 6 6.9 87 32 -- 189 2 4.4 NC NC -- NC 4 2.5 NC NC -- NC
4112 9 5.1 176 80 -- 334 5 3.2 158 51 -- 369 4 2.0 NC NC -- NC
4113 3 7.9 NC NC -- NC 1 4.9 NC NC -- NC 2 3.0 NC NC -- NC
Town Total 18 19.9 90 54 -- 143 8 12.5 64 28 -- 127 10 7.4 134 64 -- 247
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 8d
Kidney Cancer Incidence
Walpole, Massachusetts
1994–2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 12 13.6 88 45 -- 154 6 8.2 73 27 -- 159 6 5.4 111 40 -- 241
4112 12 9.9 122 63 -- 212 4 5.6 NC NC -- NC 8 4.3 186 80 -- 367
4113 16 12.0 134 76 -- 217 10 6.9 145 69 -- 267 6 5.1 118 43 -- 257
Town Total 40 35.3 113 81 -- 154 20 20.5 97 59 -- 150 20 14.7 136 83 -- 209
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 9a
Leukemia Incidence
Walpole, Massachusetts
1982–2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 2 3.3 NC NC -- NC 1 2.0 NC NC -- NC 1 1.3 NC NC -- NC
4112 3 2.7 NC NC -- NC 3 1.5 NC NC -- NC 0 1.2 NC NC -- NC
4113 1 2.7 NC NC -- NC 1 1.6 NC NC -- NC 0 1.1 NC NC -- NC
Town Total 6 8.7 69 25 -- 150 5 5.1 98 32 -- 230 1 3.6 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 9b
Leukemia Incidence
Walpole, Massachusetts
1982–1987
 
 90 
Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 4 3.8 NC NC -- NC 4 2.3 NC NC -- NC 0 1.5 NC NC -- NC
4112 5 2.8 180 58 -- 420 1 1.6 NC NC -- NC 4 1.2 NC NC -- NC
4113 5 3.2 155 50 -- 362 4 1.9 NC NC -- NC 1 1.3 NC NC -- NC
Town Total 14 9.8 143 78 -- 241 9 5.8 155 71 -- 293 5 3.9 127 41 -- 296
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 9c
Leukemia Incidence
Walpole, Massachusetts
1988-1993
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 6 6.1 98 36 -- 214 1 3.5 NC NC -- NC 5 2.6 195 63 -- 454
4112 4 4.5 NC NC -- NC 0 2.5 NC NC -- NC 4 2.0 NC NC -- NC
4113 10 7.1 141 67 -- 259 5 3.9 128 41 -- 298 5 3.2 156 50 -- 365
Town Total 20 17.7 113 69 -- 175 6 9.9 60 22 -- 132 14 7.8 181 99 -- 303
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 9d
Leukemia Incidence
Walpole, Massachusetts
1994–2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 3 3.9 NC NC -- NC 2 2.9 NC NC -- NC 1 1.0 NC NC -- NC
4112 3 2.8 NC NC -- NC 3 2.1 NC NC -- NC 0 0.7 NC NC -- NC
4113 1 3.4 NC NC -- NC 1 2.6 NC NC -- NC 0 0.9 NC NC -- NC
Town Total 7 10.1 69 28 -- 143 6 7.6 79 29 -- 173 1 2.5 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 10a
Liver Cancer Incidence
Walpole, Massachusetts
1982–2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 0 0.7 NC NC -- NC 0 0.5 NC NC -- NC 0 0.2 NC NC -- NC
4112 1 0.6 NC NC -- NC 1 0.4 NC NC -- NC 0 0.2 NC NC -- NC
4113 0 0.6 NC NC -- NC 0 0.4 NC NC -- NC 0 0.2 NC NC -- NC
Town Total 1 1.9 NC NC -- NC 1 1.3 NC NC -- NC 0 0.5 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 10b
Liver Cancer Incidence
Walpole, Massachusetts
1982–1987
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 1 1.1 NC NC -- NC 0 0.8 NC NC -- NC 1 0.3 NC NC -- NC
4112 0 0.8 NC NC -- NC 0 0.6 NC NC -- NC 0 0.2 NC NC -- NC
4113 1 0.9 NC NC -- NC 1 0.7 NC NC -- NC 0 0.2 NC NC -- NC
Town Total 2 2.8 NC NC -- NC 1 2.1 NC NC -- NC 1 0.7 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 10c
Liver Cancer Incidence
Walpole, Massachusetts
1988-1993
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 2 2.0 NC NC -- NC 2 1.5 NC NC -- NC 0 0.5 NC NC -- NC
4112 2 1.5 NC NC -- NC 2 1.1 NC NC -- NC 0 0.4 NC NC -- NC
4113 0 2.3 NC NC -- NC 0 1.7 NC NC -- NC 0 0.6 NC NC -- NC
Town Total 4 5.7 NC NC -- NC 4 4.3 NC NC -- NC 0 1.4 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 10d
Liver Cancer Incidence
Walpole, Massachusetts
1994–2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 99 99.0 100 81 -- 122 58 60.4 96 73 -- 124 41 38.7 106 76 -- 144
4112 69 73.8 94 73 -- 118 41 43.6 94 67 -- 128 28 30.2 93 62 -- 134
4113 81 86.7 93 74 -- 116 48 52.5 91 67 -- 121 33 34.2 97 66 -- 136
Town Total 249 258.6 96 85 -- 109 147 157.0 94 79 -- 110 102 101.6 100 82 -- 122
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 11a
Lung & Bronchus Cancer Incidence
Walpole, Massachusetts
1982–2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 30 24.4 123 83 -- 175 22 16.0 137 86 -- 208 8 8.4 95 41 -- 188
4112 21 20.4 103 64 -- 157 11 13.2 83 42 -- 149 10 7.2 138 66 -- 254
4113 21 20.0 105 65 -- 161 12 12.8 94 48 -- 163 9 7.1 126 58 -- 239
Town Total 72 65.0 111 87 -- 140 45 42.3 106 78 -- 142 27 22.6 119 79 -- 174
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 11b
Lung & Bronchus Cancer Incidence
Walpole, Massachusetts
1982–1987
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 33 30.9 107 73 -- 150 18 19.0 95 56 -- 150 15 11.9 126 70 -- 207
4112 12 23.4 51 * 27 -- 90 7 14.0 50 20 -- 103 5 9.3 54 17 -- 125
4113 19 26.1 73 44 -- 114 10 16.0 62 30 -- 115 9 10.0 90 41 -- 170
Town Total 64 80.1 80 62 -- 102 35 49.3 71 * 49 -- 99 29 30.8 94 63 -- 135
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 11c
Lung & Bronchus Cancer Incidence
Walpole, Massachusetts
1988-1993
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 36 40.9 88 62 -- 122 18 23.2 78 46 -- 123 18 17.8 101 60 -- 160
4112 36 30.0 120 84 -- 166 23 16.5 139 88 -- 209 13 13.5 97 51 -- 165
4113 41 45.3 90 65 -- 123 26 25.3 103 67 -- 150 15 20.0 75 42 -- 124
Town Total 113 116.1 97 80 -- 117 67 65.1 103 80 -- 131 46 51.0 90 66 -- 120
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 11d
Lung & Bronchus Cancer Incidence
Walpole, Massachusetts
1994–2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 2 2.0 NC NC -- NC 2 1.7 NC NC -- NC 0 0.3 NC NC -- NC
4112 3 1.4 NC NC -- NC 1 1.1 NC NC -- NC 2 0.3 NC NC -- NC
4113 1 1.6 NC NC -- NC 1 1.3 NC NC -- NC 0 0.3 NC NC -- NC
Town Total 6 5.1 119 43 -- 259 4 4.2 NC NC -- NC 2 0.9 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 12a
Mesothelioma Incidence
Walpole, Massachusetts
1982–2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 0 0.4 NC NC -- NC 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC
4112 1 0.4 NC NC -- NC 0 0.3 NC NC -- NC 1 0.1 NC NC -- NC
4113 0 0.3 NC NC -- NC 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC
Town Total 1 1.1 NC NC -- NC 0 0.9 NC NC -- NC 1 0.2 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 12b
Mesothelioma Incidence
Walpole, Massachusetts
1982–1987
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 1 0.6 NC NC -- NC 1 0.5 NC NC -- NC 0 0.1 NC NC -- NC
4112 1 0.5 NC NC -- NC 0 0.4 NC NC -- NC 1 0.1 NC NC -- NC
4113 1 0.5 NC NC -- NC 1 0.4 NC NC -- NC 0 0.1 NC NC -- NC
Town Total 3 1.6 NC NC -- NC 2 1.3 NC NC -- NC 1 0.3 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 12c
Mesothelioma Incidence
Walpole, Massachusetts
1988-1993
 
Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
4111 1 0.9 NC NC -- NC 1 0.8 NC NC -- NC 0 0.1 NC NC -- NC
4112 1 0.6 NC NC -- NC 1 0.5 NC NC -- NC 0 0.1 NC NC -- NC
4113 0 1.0 NC NC -- NC 0 0.8 NC NC -- NC 0 0.2 NC NC -- NC
Town Total 2 2.5 NC NC -- NC 2 2.1 NC NC -- NC 0 0.4 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 12d
Mesothelioma Incidence
Walpole, Massachusetts
1994–2000
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APPENDIX A 
Cancer Incidence Coding Definitions
 
  ICD-O-1 and Other  
Pre-ICD-O-2 Codes 
ICD-O-2 Codes ICD-O-3 Codes 
Cancer Site / Type Site code Histology code Site code Histology code Site code Histology code 
Bladder 188.0-188.9 except 9590-9980 C67.0-C67.9 except 9590-9989 C67.0-C67.9 except 9590-9989 
Hodgkin’s Disease 140.0-199.9 includes O9650-
O9667, P9653-
P9683, B9653-
B9658 
C00.00-C80.9 includes 9650-
9667 
C00.00-C80.9 includes 9650-
9667 
Kidney &  
Renal Pelvis 
189.0, 189.1 except 9590-9980 C64.9, C65.9 
 
except 9590-9989 C64.9, C65.9 
 
except 9590-9989 
Leukemia 
 
 
 
 
140.0-199.9 
 
includes O9800-
O9943, O9951, 
P9803-P9943, 
B9803-B9943 
1. C00.0-C80.9 
 
 
AND 
2. C42.0, C42.1, 
C42.4 
1. includes 9800-
9822, 9824-9826, 
9828-9941 
 
2. includes 9823, 
9827 
1. C00.0-C80.9 
 
 
 
AND 
2. C42.0, C42.1, 
C42.4 
1. includes 9733, 
9742, 9800-9820, 
9826, 9831-9948, 
9963-9964 
 
2. includes 9823, 
9827 
Liver 
 
155.0 except 9590-9980 C22.0 
 
except 9590-9989 C22.0 
 
except 9590-9989 
Lung & Bronchus 
 
162.2-162.9 
 
except 9050-9053, 
9590-9980 
C34.0-C34.9 
 
except 9590-9989 C34.0-C34.9 
 
except 9590-9989 
Mesothelioma 140.0-199.9 includes O9050-
O9053, P9051, 
P9053 
C00.0-C80.9 includes 9050-
9053 
C00.0-C80.9 includes 9050-
9055 
*Note:  Includes invasive tumors only, selected by excluding in situ stages J0, S0, TTISNXM0, TTANXMX, TTANXM0, TTAN0MX, TTISN0M0, TTISNXMX, 
TTISN0MX, TTISN0M0, TTIN0M0, TTIN0MX, TTINXM0, and TTINXMX (1982-1994 data) or by specifying behavior code (1995-present data). 
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RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES 
______________________________________________________________________________ 
 
Bladder Cancer 
 
The American Cancer Society estimates that bladder cancer will affect 63,210 people in the U.S. 
in 2005, accounting for 7% of all cancers diagnosed in the United States among men and 2% 
among women.  In Massachusetts, bladder cancer accounts for approximately 6% of all cancers 
diagnosed among males and females combined (ACS, 2005).  Males are three times more likely 
to develop bladder cancer than females and whites are two times more likely to develop this 
disease than blacks.  The risk of bladder cancer increases with age and the mean age at diagnosis 
is 68-69 years (ACS, 2000). 
The greatest risk factor for bladder cancer is cigarette smoking.  Smokers are more than twice as 
likely to develop bladder cancer compared to nonsmokers (ACS, 2000).  The risk of developing 
bladder cancer increases with the number of packs smoked per day and with duration of 
smoking.  Further, the risk of bladder cancer may be higher in women than in men who smoke 
comparable numbers of cigarettes (Castelao et al., 2001).  Approximately 25-60% of all bladder 
cancers can be attributed to tobacco use (Johansson and Cohen, 1997).  Smoking cessation has 
been found to reduce the risk of developing bladder cancer by 30% to 60% (Silverman et al., 
1996). 
Studies have also revealed a number of occupations that are associated with bladder cancer.  In 
fact, exposures to chemicals in the workplace account for an estimated 20-25% of all bladder 
cancers diagnosed among men in the U.S. (Johansson and Cohen, 1997).  Occupational exposure 
to aromatic amines, such as benzidine and 2-naphthylamine, increases the risk of bladder cancer 
(ACS, 2000).  These chemicals were common in the dye industry in the past.  A higher risk of 
bladder cancer has also been observed among aromatic amine manufacturing workers as well as 
among workers in the rubber, leather, textiles, printing, and paint products industries (ACS, 
2000; Silverman et al., 1996).  The development of new chemicals, changed worker exposures, 
and the elimination of many known bladder carcinogens in the workplace have caused shifts in 
those occupations considered to be high risk.  For example, risks among dye, rubber, and leather 
workers have declined over time, while other occupations such as motor vehicle operation (e.g., 
drivers of trucks, buses, and taxis) and the aluminum industry have emerged as potential high-
risk occupations (Silverman et al., 1996).  However, specific occupational exposures in these 
occupations have not been confirmed and study findings are not consistent.  Further, the risk of 
bladder cancer from occupational exposures may be increased among smokers (ACS, 2000). 
Dietary factors such as consumption of fried foods as well as foods high in fat and cholesterol 
have been found to be associated with increased bladder cancer risk (Silverman et al., 1996).  
Use of the Chinese herb, Aristocholia fangchi, found in some dietary supplements, has also been 
linked with bladder cancer (ACS, 2000).  Use of some anti-cancer drugs (e.g., cyclophosphamide 
and chlornaphazine), use of phenacetin, and infection with Shistosoma haematobium (a parasite 
found in Africa) are thought to be associated with the development of bladder cancer, however, 
not all epidemiological studies have produced convincing findings (Silverman et al., 1996). 
_______________________________________________________________________________________________________ 
Source:  Community Assessment Program, Center for Environmental Health, Massachusetts Department of Public Health.  
March 2005.   
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Other risk factors for bladder cancer include a personal history of bladder cancer, certain rare 
birth defects involving the bladder, and exposure to ionizing radiation (ACS, 2000; Silverman et 
al., 1996).  Exposure to chlorinated by-products in drinking water has also been suggested to 
increase bladder cancer risk, however, a recent population-based study found that an association 
was present only among smokers (Cantor et al., 1998). 
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Hodgkin’s Disease 
 
Hodgkin’s disease (or Hodgkin’s lymphoma) is a form of cancer that involves the lymphatic 
system and can be distinguished from non-Hodgkin’s lymphomas by cancer cell type.  The 
American Cancer Society estimates that there will be approximately 7,350 new cases of this 
disease in the U.S. in 2005, accounting for less than 1% of all cancer types, and approximately 
1,410 deaths (ACS, 2005).  Because of substantial improvement in effective therapy for this 
disease, mortality rates have decreased approximately 60% since the early 1970s (ACS, 1999). 
Epidemiologic studies have shown that Hodgkin’s disease is more common among men than 
women and more common among whites than blacks.  People of Jewish descent appear to be at 
higher risk of Hodgkin’s disease compared to people of non-Jewish descent (Mueller, 1996).  
Although the disease is relatively rare among children, two peaks in the age distribution have 
been observed for this cancer type.  The first peak occurs in young adults usually between the 
ages of 15 to 40 (typically ages 25-30) and the second peak occurs in adults aged 55 years and 
above.   
No major risk factors for Hodgkin’s disease have been found (ACS, 1999).  However, the 
clinical and cellular features of Hodgkin’s disease suggest a chronic infectious process (Mueller, 
1996).  The bimodal age distribution of this disease suggests that two distinct etiologies (or 
causes) for Hodgkin’s disease may be involved for each group.  Researchers have proposed that 
among young adults, Hodgkin’s disease is caused by a biological agent of low infectivity.  
Among individuals of older ages, the cause is probably similar to those of other lymphomas 
(Mueller, 1996).  The virus that has been linked most specifically to this disease is the Epstein-
Barr virus (EBV).  EBV, a herpesvirus, is common in the general population and causes 
mononucleosis or “mono.”  Approximately 40% to 50% of Hodgkin’s disease cases are 
associated with EBV (Weiss, 2000).  In addition, several studies have also shown that young 
adults who have developed infectious mononucleosis have a significantly higher risk of 
developing Hodgkin’s disease (ACS, 1999).  However, the absence of EBV infection in about 
half the cases and the high prevalence of EBV in the general population suggest that EBV may 
be only one of several factors in the development of this cancer.  Although cytomegalovirus 
(CMV) and the more recently identified human herpesvirus type 6 have been considered as 
possible factors in the development of Hodgkin’s disease, results of antibody studies are 
inconsistent and these viruses do not appear to be related to risk of Hodgkin’s disease (Mueller, 
1996). 
Slightly higher rates of Hodgkin’s disease occur among people with reduced immunity, such as 
those with AIDS, people with congenital immune deficiencies, and individuals on 
immunosuppressant medication following organ transplants.  However, Hodgkin’s disease 
occurs at a much lower rate than non-Hodgkin’s lymphomas among this group of individuals 
(ACS, 1999). 
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Hodgkin’s disease trends in the young adult population reveal that the disease has become 
increasingly associated with populations both of middle to higher socioeconomic status and 
small family size.  These factors are consistent with susceptibility to late infections with common 
childhood viruses, supporting the theory that Hodgkin’s disease is associated with an infectious 
agent (Mueller, 1996).  Occupational exposures to workers in the chemical industry and 
woodworkers have also been suggested in several epidemiologic studies to be associated with the 
development of Hodgkin’s disease.  However, specific chemical exposures related to the 
development of this disease have not been identified and results of studies investigating 
occupational exposures are inconsistent (Mueller, 1996).  Based on an examination of medical 
and scientific literature, the American Cancer Society concludes that although the exact cause 
remains unknown, Hodgkin’s disease does not seem to be caused by genetic, lifestyle (e.g., 
dietary), or environmental factors (ACS, 1999). 
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Kidney Cancer 
 
Kidney cancer involves a number of tumor types located in various areas of the kidney and renal 
system.  Renal cell cancer (which affects the main area of the kidney) accounts for over 90% of 
all malignant kidney tumors (ACS, 2001).  The American Cancer Society estimates that there 
will be approximately 36,160 cases of kidney and upper urinary tract cancer, resulting in more 
than 12,660 deaths in 2005 (ACS, 2004).  The incidence and mortality from kidney cancer is 
higher in urban areas, which may be due to increased access to diagnostic services and other 
factors such as smoking.  Kidney cancer is twice as common in males as it is in females and the 
incidence most often occurs in the fifth and sixth decades of life (50-70 year age group) (ACS, 
2001).  The gender distribution of this disease may be attributed to the fact that men are more 
likely to smoke and are more likely to be exposed to potentially carcinogenic chemicals at work. 
Since 1970, U.S. incidence rates for renal cell cancer have risen between 2 and 4% annually 
among the four major race and gender groups (i.e., white males, white females, black males, and 
black females) (Chow et al., 1999; McLaughlin et al., 1996).  Rapid increases in incidence 
among blacks as compared to among whites have resulted in an excess of the disease among 
blacks; age-adjusted incidence rates between 1975 and 1995 for white men, white women, black 
men, and black women were 9.6, 4.4, 11.1, and 4.9 per 100,000 person-years, respectively 
(Chow et al., 1999).  Rising incidence rates may be partially due to the increased availability of 
screening for kidney cancer. 
The etiology of kidney cancer is not fully understood.  However, a number of environmental, 
hormonal, cellular, and genetic factors have been studied as possible causal factors in the 
development of renal cell carcinoma.  Cigarette smoking is the most important known risk factor 
for renal cell cancer.  Smoking increases the risk of developing renal cell cancer by 30% to 100% 
(ACS, 2001).  In both males and females, a statistically significant dose-response relationship 
between smoking and this cancer has been observed.  Approximately one-third of renal cell 
cancers in men and one-quarter of those in women may be caused by cigarette smoking (ACS, 
2001).  
Virtually every study that has examined body weight and renal cell cancer has observed a 
positive association.  Some studies suggest that obesity is a factor in 20% of people who develop 
kidney cancer (ACS, 2001).  This is especially true among women and researchers suspect that 
this may be related to changes in certain hormones, such as estrogen in women (ACS, 2001; 
McLaughlin et al., 1996).   A diet high in protein (meat, animal fats, milk products, margarine 
and oils) has been implicated in epidemiological studies as a risk factor for renal cell carcinoma 
(ACS, 2001; McLaughlin et al., 1996).  Consumption of adequate amounts of fruits and 
vegetables lowers the risk of renal cell cancer.  In addition, use of diuretics and antihypertensive 
medications are associated with increased risk of renal cell carcinoma.  However, hypertension 
has also been linked to kidney cancer and it is not clear whether the disease or the medications 
used to treat them is the cause (ACS, 2001).  Long-term use of pain relievers such as phenacetin 
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(and possibly acetaminophen and aspirin) increases the risk for cancer of the renal pelvis and 
renal cell carcinoma (ACS, 2001). 
Certain medical conditions that affect the kidneys have also been shown to increase kidney 
cancer risk.  There is an increased incidence of renal carcinoma in patients with end-stage renal 
disease who develop acquired cystic disease of the kidney.  This phenomenon is seen among 
patients on long-term dialysis for renal failure (Linehan et al., 1997).  In addition, an association 
has been established between the incidence of von Hippel-Lindau disease and certain other 
inherited conditions in families and renal cell carcinoma, suggesting that genetic and hereditary 
risk factors may be important in the development of kidney cancer (ACS, 2001; McLaughlin et 
al., 1996). 
Environmental and occupational factors have also been associated with the development of 
kidney cancer.  Some studies have shown an increased incidence of this cancer type among 
leather tanners, shoe workers, and workers exposed to asbestos.  Exposure to cadmium is 
associated with an increased incidence of kidney cancer, particularly in men who smoke (ACS, 
2001; Linehan et al,. 1997).   In addition, workplace exposure to organic solvents, particularly 
trichloroethylene, may increase the risk of this cancer (ACS, 2001).  Although occupational 
exposure to petroleum, tar, and pitch products has been implicated in the development of kidney 
cancer, most studies of oil refinery workers and petroleum products distribution workers have 
not identified a definitive relationship between gasoline exposure and renal cancer (Linehan et 
al., 1997; McLaughlin et al., 1996). 
Wilms’ tumor is the most common type of kidney cancer affecting children and accounts for 
approximately 5% to 6% of all kidney cancers and about 6% of all childhood cancers.  This 
cancer is more common among African Americans than other races and among females than 
males.  Wilms’ tumor most often occurs in children under the age of 5 years.  The causes of 
Wilms’ tumor are not known, but certain birth defect syndromes and other genetic risk factors 
(such as family history or genetic mutations) are connected with this cancer.  However, most 
children who develop Wilms’ tumor do not have any known birth defects or inherited gene 
changes.  No environmental risk factors, either before or after a child’s birth, have been shown to 
be associated with the development of Wilms’ tumor (ACS, 1999). 
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Leukemia 
Leukemia is the general term that includes a group of different cancers that occur in the blood 
forming organs and result in the formation of abnormal amounts and types of white blood cells in 
the blood and bone marrow.  Individuals with leukemia generally maintain abnormally high 
amounts of leukocytes or white blood cells in their blood.  This condition results in an 
individual’s inability to maintain certain body functions, particularly a person’s ability to combat 
infection. 
In 2005, leukemia is expected to affect approximately 34,810 individuals (19,640 males and 
15,420 females) in the United States, resulting in 22,570 deaths.  In Massachusetts, 
approximately 770 individuals will be diagnosed with the disease in 2005, representing more 
than 2% of all cancer diagnoses.  There are four major types of leukemia: acute lymphoid 
leukemia (ALL), acute myeloid leukemia (AML), chronic lymphoid leukemia (CLL), and 
chronic myeloid leukemia (CML).  There are also a few rare types, such as hairy cell leukemia.  
In adults, the most common types are AML and CLL.  Leukemia is the most common type of 
childhood cancer, accounting for about 30% of all cancers diagnosed in children.  The majority 
of these cases are of the ALL type (ACS, 2005). 
While ALL occurs predominantly among children (peaking between ages 2 and 3 years), an 
elevation in incidence is also seen among older individuals.  The increase in incidence among 
older individuals begins at approximately 40-50 years of age, peaking at about age 85 (Linet and 
Cartwright, 1996).  ALL is more common among whites than African Americans and among 
males than females (Weinstein and Tarbell, 1997).  Exposure to high-dose radiation (e.g., by 
survivors of atomic bomb blasts or nuclear reactor accidents) is a known environmental risk 
factor associated with the development of ALL (Scheinberg et al., 1997).  Significant radiation 
exposure (e.g., diagnostic x-rays) before birth may carry up to a 5-fold increased risk of 
developing ALL (ACS 2000b).  However, few studies report an increased risk of leukemia 
associated with residing in proximity to nuclear plants or occupational exposure to low-dose 
radiation (Linet and Cartwright, 1996; Scheinberg et al., 1997).  It is unclear whether exposure to 
electromagnetic fields (EMF) plays a role in the development of ALL, however, most studies to 
date have found little or no risk (ACS 2000b). 
Few other risk factors for ALL have been identified.  There is evidence that genetics may play an 
important role in the development of this leukemia type.  Studies indicate that siblings of twins 
who develop leukemia are at an increased risk of developing the disease.  Children with Down’s 
syndrome are 10 to 20 times more likely to develop acute leukemia (Weinstein and Tarbell, 
1997).  In addition, other genetic diseases, such as Li-Fraumeni syndrome and Klinefelter’s 
syndrome, are associated with an increased risk of developing leukemia.  Patients receiving 
medication that suppresses the immune system (e.g., organ transplant patients) may be more 
likely to develop ALL (ACS 2000b).  ALL has not been definitively linked to chemical 
exposure, however, childhood ALL may be associated with maternal occupational exposure to 
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pesticides during pregnancy (Infante-Rivard et al., 1999).  Certain rare types of adult ALL are 
caused by human T-cell leukemia/lymphoma virus-I (HTLV-I) (ACS, 2000a).  Some reports 
have linked other viruses with various types of leukemia, including Epstein-Barr virus and 
hepatitis B virus.  Still others propose that leukemia may develop as a response to viral infection.  
However, no specific virus has been identified as related to ALL (Linet and Cartwright, 1996).  
Recent reports also suggest an infectious etiology for some childhood ALL cases, although a 
specific viral agent has not been identified and findings from studies exploring contact among 
children in day-care do not support this hypothesis (Greaves MF, 1997; Kinlen and Balkwill, 
2001; Rosenbaum et al., 2000). 
Although AML can occur in children (usually during the first two years of life), AML is the most 
common leukemia among adults, with an average age at diagnosis of 65 years (ACS, 2000a and 
2000b).  This type of leukemia is more common among males than among females but affects 
African Americans and whites at similar rates (Scheinberg et al., 1997).  High-dose radiation 
exposure (e.g., by survivors of atomic bomb blasts or nuclear reactor accidents), long-term 
occupational exposure to benzene, and exposure to certain chemotherapy drugs, especially 
alkylating agents (e.g., mechlorethamine, cyclophosphamide), have been associated with an 
increased risk of developing AML among both children and adults (ACS, 2000a and 2000b; 
Linet and Cartwright, 1996).  The development of childhood AML is suspected to be related to 
parental exposure to pesticides and other chemicals, although findings are inconsistent (Linet and 
Cartwright, 1996).  Recent studies have suggested a link between electromagnetic field (EMF) 
exposure (e.g., from power lines) and leukemia (Minder and Pfluger, 2001; Schuz et al., 2001).  
However, there is conflicting evidence regarding EMF exposure and leukemia and it is clear that 
most cases are not related to EMF (ACS, 2000a; Kleinerman et al., 2000). 
Other possible risk factors related to the development of AML include cigarette smoking and 
genetic disorders.  It is estimated that approximately one-fifth of cases of AML are caused by 
smoking (Scheinberg et al., 1997).  Also, a small number of AML cases can be attributed to rare 
inherited disorders.  These include Down’s syndrome in children, Fanconi’s anemia, Wiskott-
Aldrich syndrome, Bloom’s syndrome, Li-Fraumeni syndrome, and ataxia telangiectasia (ACS, 
2000a and 2000b).  Recently, scientists have suggested that a mutation in a gene responsible for 
the deactivation of certain toxic metabolites may have the ability to increase the risk of acute 
myeloid leukemia in adults.  However, further research is necessary in order to confirm the 
findings of this study (Smith et al., 2001).  
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Twice as many men as women are affected by this type of leukemia (Deisseroth et al., 1997).  
While genetics and diseases of the immune system have been suggested as playing a role in the 
development of CLL, high-dose radiation and benzene exposure have not (ACS, 1999; Weinstein 
and Tarbell, 1997).  It is thought that individuals with a family history of CLL are two to four 
times as likely to develop the disease.  Some studies have identified an increased risk of 
developing CLL (as well as ALL, AML, and CML) among farmers due to long-term exposure to 
herbicides and/or pesticides (Linet and Cartwright, 1996).  In addition, many researchers believe 
that cigarette smoking plays a role in some chronic leukemias.  The role of EMF in the 
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development of chronic leukemia remains controversial (ACS, 1999).  Although viruses have 
been implicated in the etiology of other leukemias, there is no evidence that viruses cause CLL 
(Deisseroth et al., 1997). 
Of all the leukemias, CML is among the least understood.  While this disease can occur at any 
age, CML is extremely rare in children (about 2% of leukemias in children) and the average age 
of diagnosis is 40 to 50 years (ACS 1999).  Incidence rates are higher in males than in females, 
but unlike the other leukemia types, rates are higher in blacks than in whites in the U.S. (Linet 
and Cartwright, 1996).  High-dose radiation exposure may increase the risk of developing CML 
(ACS, 1999).  Finally, CML has been associated with chromosome abnormalities such as the 
Philadelphia chromosome (Weinstein and Tarbell, 1997). 
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Liver Cancer 
An estimated 17,550 people in the U.S. (12,130 men and 5,420 women) will be diagnosed with 
liver cancer in 2005, accounting for approximately 1% of all new cancers (ACS, 2005).  
Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver, accounting for 
about 75% of all cases.  Rarer forms of malignant liver cancer include cholangiocarcinomas, 
angiosarcomas, and hepatoblastomas in children.  Although HCC is approximately ten times 
more common in developing countries in East and Southeast Asia and Africa, incidence is 
rapidly increasing in the United States (ACS, 2001).  Rates of HCC in the U.S. have increased by 
70% over the past two decades (Yu et al., 2000).  Similar trends have been observed in Canada 
and Western Europe.  The primary reason for the higher rates observed in recent years is the 
increase in hepatitis C virus infection, an important factor related to liver cancer (El-Serag, 2001; 
El-Serag and Mason, 2000).  Men are at least two to three times more likely to develop liver 
cancer than women (Yu et al., 2000).  Incidence rates are also higher among African Americans 
than whites.  Although the risk of developing HCC increases with increasing age, the disease can 
occur in persons of any age (London and McGlynn, 1996). 
Several important risk factors for liver cancer have been identified.  Chronic infection with 
hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most significant risk factors for 
developing liver cancer (ACS, 2001).  It is estimated that 80% of HCC cases worldwide can be 
attributed to HBV infection (Yu et al., 2000).  However, HBV accounts for only about a quarter 
of the cases in the U.S. and infection with HCV plays a much larger role in the incidence of this 
cancer.  HBV and HCV can be spread through intravenous drug use (e.g., the sharing of 
contaminated needles), unprotected sexual intercourse, and transfusion of and contact with 
unscreened blood and blood products.  In addition, mothers who are infected with these viruses 
can pass them on to their children at birth or in early infancy (ACS, 2001). 
Cirrhosis is also a major risk factor for the development of liver cancer.  Cirrhosis is a 
progressive disease that causes inflammation and scar tissue to form on the liver, which can often 
lead to cancer.  Researchers estimate that 60% to 80% of HCC cases are associated with 
cirrhosis.  However, it is unclear if cirrhosis itself causes liver cancer or if the underlying causes 
of cirrhosis contribute to the development of this disease (Garr et al., 1997).  Most liver cirrhosis 
in the U.S. occurs as a result of chronic alcohol abuse, but HBV and HCV are also major causes 
of cirrhosis (ACS, 2001).  In addition, certain inherited metabolic diseases, such as 
hemochromatosis, which causes excess iron accumulation in the body, can lead to cirrhosis 
(ACS, 2001).  Some studies have shown that people with hemochromatosis are at an increased 
risk of developing liver cancer (Fracanzani et al., 2001). 
Epidemiological and environmental evidence indicates that exposure to certain chemicals and 
toxins can also contribute significantly to the development of liver cancer.  For example, chronic 
consumption of alcoholic beverages has been associated with liver cancer (Wogan, 2000).  As 
noted above, it is unclear if alcohol itself causes HCC or if underlying cirrhosis is the cause 
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(London and McGlynn, 1996).  However, it is clear that alcohol abuse can accelerate liver 
disease and may act as a co-carcinogen in the development of liver cancer (Ince and Wands, 
1999).  Long-term exposure to aflatoxin can also cause liver cancer.  Aflatoxins are carcinogenic 
agents produced by a fungus found in tropical and subtropical regions.  Individuals may be 
exposed to aflatoxins if they consume contaminated peanuts and other foods that have been 
stored under hot, humid conditions (Wogan, 2000).  Vinyl chloride, a known human carcinogen 
used in the manufacturing of some plastics, and thorium dioxide, used in the past for certain x-
ray tests, are risk factors for a rare type of liver cancer called angiosarcoma (ACS, 2001; London 
and McGlynn, 1996).  These chemicals may also increase the risk of HCC, but to a lesser degree.  
The impact of both thorium dioxide and vinyl chloride on the incidence of liver cancer was much 
greater in the past, since thorium dioxide has not been used for decades and exposure of workers 
to vinyl chloride is now strictly regulated in the U.S. (ACS, 2001).  Drinking water contaminated 
with arsenic may increase the risk of liver cancer in some parts of the world (ACS, 2001; 
ATSDR, 2001). 
The use of oral contraceptives by women may also be a risk factor in the development of liver 
cancer.  However, most of the studies linking oral contraceptives and HCC involved types of oral 
contraceptives that are no longer used.  There is some indication that the increased risk may be 
confined to oral contraceptives containing mestranol.  It is not known if the newer oral 
contraceptives, which contain different types and doses of estrogen and different combinations of 
estrogen with other hormones, significantly increase the risk of HCC (ACS, 2001; London and 
McGlynn, 1996).  Long-term anabolic steroid use may slightly increase the risk of HCC; 
however, a definitive relationship has not been established (ACS, 2001; London and McGlynn, 
1996).  Although many researchers believe that cigarette smoking plays a role in the 
development of liver cancer, the evidence for this is still inconclusive (Mizoue et al., 2000; 
London and McGlynn, 1996). 
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Lung Cancer 
Lung cancer generally arises in the epithelial tissue of the lung.  Several different histologic or 
cell types of lung cancer have been observed.  The various types of lung cancer occur in different 
regions of the lung and each type is associated with slightly different risk factors (Blot and 
Fraumeni 1996).  The most common type of lung cancer in the United States today is 
adenocarcinoma which accounts for about 40% of all lung cancers (ACS, 2000).  The greatest 
established risk factor for all types of lung cancer is cigarette smoking, followed by occupational 
and environmental exposures. 
 
The incidence of lung cancer increases sharply with age peaking at about age 60 or 70.  Lung 
cancer is very rare in people under the age of 40.  The incidence is greater among men than 
women (probably because men are more likely to be smokers than women) and among blacks 
than whites (Blot and Fraumeni, 1996).  The American Cancer Society estimates that lung cancer 
will be diagnosed in 172,570 people in the U.S. in 2005, accounting for about 13% of all cancers 
(ACS, 2005).  Lung cancer is the leading cause of cancer death among both men and women; 
more people die of lung cancer than of colon, breast, and prostate cancers combined (ACS, 
2000).  In Massachusetts, incidence rates in 1997 were 76.7 per 100,000 and 49.2 per 100,000 
for males and females, respectively (MCR, 2000).  Nationwide, the incidence rate declined 
significantly in men during the 1990s, most likely as a result of decreased smoking rates over the 
past 30 years.  Rates for women have continued to increase, but at a much slower pace and have 
begun to level off.  This is because decreasing smoking patterns among women have lagged 
behind those of men (ACS, 2005).  Trends in lung cancer incidence suggest that the disease has 
become increasingly associated with populations of lower socioeconomic status, since these 
individuals have higher rates of smoking than individuals of other groups (Blot and Fraumeni 
1996). 
 
More than 80% of all lung cancers are caused directly by smoking cigarettes and many of the 
rest are due to exposure to second hand smoke, or environmental tobacco smoke.  The longer a 
person has been smoking and the higher the number of cigarettes smoked per day, the greater the 
risk of lung cancer.  Smoking cessation decreases the elevated risk by about 50%, however, 
former smokers still carry a greater risk than those who have never smoked (ACS, 2000). 
 
Workplace exposures have also been identified as playing important roles in the development of 
lung cancer.  Occupational exposure to asbestos is an established risk factor for this disease; 
asbestos workers are about seven times more likely to die from lung cancer than the general 
population (ACS, 2000).  Underground miners exposed to radon and uranium are at an increased 
risk for developing lung cancer (ACS, 2000; Samet and Eradze, 2000).  Chemical workers, talc 
miners and millers, paper and pulp workers, carpenters, metal workers, butchers and meat 
packers, vineyard workers, carpenters and painters, and shipyard and railroad manufacture 
workers are some of the occupations associated with an increased risk of lung cancer (Blot and 
_______________________________________________________________________________________________________ 
Source:  Community Assessment Program, Center for Environmental Health, Massachusetts Department of Public Health.  
March 2005.   
122 
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES 
______________________________________________________________________________ 
Fraumeni, 1996; Pohlablen et al., 2000).  In addition to asbestos and radon, chemical compounds 
such as arsenic, chloromethyl ethers, chromium, vinyl chloride, nickel chromates, coal products, 
mustard gas, ionizing radiation, and fuels such as gasoline are also occupational risk factors for 
lung cancer (ACS, 2000; Blot and Fraumeni, 1996).  Industrial sand workers exposed to 
crystalline silica are also at an increased risk for lung cancer (Rice et al., 2001; Steenland and 
Sanderson, 2001).  Occupational exposure to the compounds noted above in conjunction with 
cigarette smoking dramatically increases the risk of developing lung cancer (Blot and Fraumeni, 
1996). 
 
As noted above, exposure to radon (a naturally occurring radioactive gas produced by the 
breakdown of radium and uranium) has been associated with increased risk of developing lung 
cancer among miners.  Recently, a number of studies have demonstrated that exposure to 
elevated levels of residential radon may also increase lung cancer risk (Lubin and Boice, 1997; 
Kreienbrock et al., 2001; Tomasek et al., 2001).  Epidemiological evidence suggests that radon 
may be the second leading cause of lung cancer after smoking (Samet and Eradze, 2000).  
However, actual lung cancer risk is determined by cumulative lifetime exposure to indoor radon.  
Therefore, normal patterns of residential mobility suggest that most people living in high-radon 
homes experience lifetime exposures equivalent to residing in homes with lower radon levels 
(Warner et al., 1996). 
 
Tuberculosis and some types of pneumonia may increase the risk of lung cancer due to scarred 
lung tissue (ACS, 2000).  In addition, people who have had lung cancer have a higher risk of 
developing another tumor.  A family history of lung cancer may also slightly increase the risk, 
however, it is unclear whether this is due to inherited factors or environmental tobacco smoke 
(ACS, 2000). 
 
Air pollution may increase the risk of developing lung cancer, however, this risk is much lower 
than that due to cigarette smoking (ACS, 2000). 
 
Diet has also been implicated in the etiology of lung cancer, however, the exact relationship is 
unclear.  Diets high in fruits and vegetables decrease lung cancer risk, but the reasons for this are 
unknown (Brownson et al., 1998).  A recent study showed a positive association between total 
fat, monounsaturated fat, and saturated fat and lung cancer among males, however, this effect 
was not observed among women (Bandera et al., 1997). 
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Mesothelioma 
Mesothelioma is a malignant (cancerous) tumor arising in the mesothelial cells of the pleura, 
peritoneum or pericardium which are tissues lining the chest cavity, abdominal cavity, and cavity 
around the heart, respectively.  Seventy-five percent of mesotheliomas start in the pleura 
(membranes surrounding the lungs), while 10%-20% start in the peritoneum (membranes of the 
abdomen).  Very rarely, mesothelioma occurs in the pericardium (membranes surrounding the 
heart) (ACS, 2004).  In the United States, an estimated 2,000 to 3,000 new cases of 
mesothelioma are diagnosed every year.  While the incidence of mesothelioma increased steeply 
in the United States during the 1970’s to the mid-1990’s, more recent data indicate that incidence 
rates appear to have stabilized and may now be decreasing (ACS, 2004; Price and Ware, 2004).  
Men are five times more likely to develop mesothelioma than women and the disease is more 
common in whites than blacks (ACS, 2004).  The latency period (i.e., the interval between first 
exposure to a disease-causing agent and the appearance of symptoms of the disease [Last 1995]) 
ranges from 20 to 50 years and most individuals diagnosed with mesothelioma are over 65 years 
of age (ACS, 2004). 
 
Asbestos exposure (via inhalation or ingestion) is the most well-established risk factor associated 
with mesothelioma and occupational exposure to asbestos accounts for most cases of this disease 
(ACS, 2006).  In case-control studies, up to 75% of individuals with mesothelioma had been 
exposed to asbestos (Antman et al., 1997).  Asbestos is a naturally occurring fibrous mineral that 
has been used historically as an insulating material (ACS, 2006).  The carcinogenic effect of 
these fibers is believed to be related to the physical properties of the fibers rather than the 
chemical make-up.  Therefore, this type of cancer may be caused by the physical irritation of the 
cells by asbestos fibers (ACS, 2004).  Also, the risk of mesothelioma is dose-dependent: it 
increases with duration and level of exposure (ACS, 2004). 
 
Occupations such as insulation workers, asbestos factory workers, shipyard workers, asbestos 
miners and millers, and construction workers have been identified as being at high risk of 
developing mesothelioma due to asbestos exposure (ACS, 2004; Antman et al., 1997).  Family 
members of workers exposed to asbestos are suspected to be at an increased risk of developing 
mesothelioma because they may breathe in asbestos fibers from the clothing of exposed workers 
(ACS, 2004, 2006).  Exposure to asbestos-containing building material is also a concern, 
particularly in older buildings when these materials begin to decompose.  Asbestos may be 
detected in a water supply as well through the corrosion of asbestos-cement pipes (ACS, 2006).  
It is estimated that one-third of mesothelioma cases in the U.S. are caused by non-occupational 
exposure to asbestos such as among family members of workers and residents living near 
asbestos factories and mines (ACS, 2006). 
 
Other risk factors for mesothelioma include exposure to thorium dioxide, used in the past for 
certain x-ray tests, and exposure to chemicals related to asbestos (e.g., zeolite) (ACS, 2004, 
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Antman et al., 1997).  More recently, the simian virus SV40 has been implicated in the etiology 
of some mesotheliomas but the role of this virus remains unclear (ACS, 2004, Rizzo et al., 
2001). 
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 ATSDR Glossary of Terms 
 
The Agency for Toxic Substances and Disease Registry (ATSDR) is a federal public health 
agency with headquarters in Atlanta, Georgia, and 10 regional offices in the United States. 
ATSDR's mission is to serve the public by using the best science, taking responsive public health 
actions, and providing trusted health information to prevent harmful exposures and diseases 
related to toxic substances. ATSDR is not a regulatory agency, unlike the U.S. Environmental 
Protection Agency (EPA), which is the federal agency that develops and enforces environmental 
laws to protect the environment and human health. This glossary defines words used by ATSDR 
in communications with the public. It is not a complete dictionary of environmental health terms. 
If you have questions or comments, call ATSDR's toll-free telephone number, 1-888-42-ATSDR 
(1-888-422-8737). 
 
General Terms 
 
Absorption  
The process of taking in. For a person or an animal, absorption is the process of a substance 
getting into the body through the eyes, skin, stomach, intestines, or lungs.  
 
Acute  
Occurring over a short time [compare with chronic].  
 
Acute exposure  
Contact with a substance that occurs once or for only a short time (up to 14 days) [compare with 
intermediate duration exposure and chronic exposure].  
 
Additive effect  
A biologic response to exposure to multiple substances that equals the sum of responses of all the 
individual substances added together [compare with antagonistic effect and synergistic effect].  
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 Adverse health effect  
A change in body function or cell structure that might lead to disease or health problems  
 
Aerobic  
Requiring oxygen [compare with anaerobic].  
 
Ambient  
Surrounding (for example, ambient air).  
 
Anaerobic  
Requiring the absence of oxygen [compare with aerobic].  
 
Analyte  
A substance measured in the laboratory. A chemical for which a sample (such as water, air, or 
blood) is tested in a laboratory. For example, if the analyte is mercury, the laboratory test will 
determine the amount of mercury in the sample.  
 
Analytic epidemiologic study  
A study that evaluates the association between exposure to hazardous substances and disease by 
testing scientific hypotheses.  
 
Antagonistic effect  
A biologic response to exposure to multiple substances that is less than would be expected if the 
known effects of the individual substances were added together [compare with additive effect 
and synergistic effect].  
 
Background level  
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 An average or expected amount of a substance or radioactive material in a specific environment, 
or typical amounts of substances that occur naturally in an environment.  
 
Biodegradation  
Decomposition or breakdown of a substance through the action of microorganisms (such as 
bacteria or fungi) or other natural physical processes (such as sunlight).  
 
Biologic indicators of exposure study  
A study that uses (a) biomedical testing or (b) the measurement of a substance [an analyte], its 
metabolite, or another marker of exposure in human body fluids or tissues to confirm human 
exposure to a hazardous substance [also see exposure investigation].  
 
Biologic monitoring  
Measuring hazardous substances in biologic materials (such as blood, hair, urine, or breath) to 
determine whether exposure has occurred. A blood test for lead is an example of biologic 
monitoring.  
 
Biologic uptake  
The transfer of substances from the environment to plants, animals, and humans.  
 
Biomedical testing  
Testing of persons to find out whether a change in a body function might have occurred because 
of exposure to a hazardous substance.  
 
Biota  
Plants and animals in an environment. Some of these plants and animals might be sources of 
food, clothing, or medicines for people.  
 
Body burden  
130 
 The total amount of a substance in the body. Some substances build up in the body because they 
are stored in fat or bone or because they leave the body very slowly.  
 
CAP [see Community Assistance Panel.]  
 
Cancer  
Any one of a group of diseases that occur when cells in the body become abnormal and grow or 
multiply out of control.  
 
Cancer risk  
A theoretical risk for getting cancer if exposed to a substance every day for 70 years (a lifetime 
exposure). The true risk might be lower.  
 
Carcinogen  
A substance that causes cancer.  
 
Case study  
A medical or epidemiologic evaluation of one person or a small group of people to gather 
information about specific health conditions and past exposures.  
 
Case-control study  
A study that compares exposures of people who have a disease or condition (cases) with people 
who do not have the disease or condition (controls). Exposures that are more common among the 
cases may be considered as possible risk factors for the disease.  
 
CAS registry number  
A unique number assigned to a substance or mixture by the American Chemical Society 
Abstracts Service. 
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Central nervous system  
The part of the nervous system that consists of the brain and the spinal cord.  
 
CERCLA [see Comprehensive Environmental Response, Compensation, and Liability Act of 
1980]  
 
Chronic  
Occurring over a long time [compare with acute].  
 
Chronic exposure  
Contact with a substance that occurs over a long time (more than 1 year) [compare with acute 
exposure and intermediate duration exposure]  
 
Cluster investigation 
A review of an unusual number, real or perceived, of health events (for example, reports of 
cancer) grouped together in time and location. Cluster investigations are designed to confirm 
case reports; determine whether they represent an unusual disease occurrence; and, if possible, 
explore possible causes and contributing environmental factors.  
 
Community Assistance Panel (CAP)  
A group of people from a community and from health and environmental agencies who work 
with ATSDR to resolve issues and problems related to hazardous substances in the community. 
CAP members work with ATSDR to gather and review community health concerns, provide 
information on how people might have been or might now be exposed to hazardous substances, 
and inform ATSDR on ways to involve the community in its activities.  
 
Comparison value (CV)  
Calculated concentration of a substance in air, water, food, or soil that is unlikely to cause 
harmful (adverse) health effects in exposed people. The CV is used as a screening level during 
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 the public health assessment process. Substances found in amounts greater than their CVs might 
be selected for further evaluation in the public health assessment process.  
 
Completed exposure pathway [see exposure pathway].  
 
Comprehensive Environmental Response, Compensation, and Liability Act of 1980 
(CERCLA)  
CERCLA, also known as Superfund, is the federal law that concerns the removal or cleanup of 
hazardous substances in the environment and at hazardous waste sites. ATSDR, which was 
created by CERCLA, is responsible for assessing health issues and supporting public health 
activities related to hazardous waste sites or other environmental releases of hazardous 
substances. This law was later amended by the Superfund Amendments and Reauthorization Act 
(SARA). 
 
 
Concentration  
The amount of a substance present in a certain amount of soil, water, air, food, blood, hair, urine, 
breath, or any other media.  
 
Contaminant  
A substance that is either present in an environment where it does not belong or is present at 
levels that might cause harmful (adverse) health effects.  
 
Delayed health effect  
A disease or an injury that happens as a result of exposures that might have occurred in the past.  
 
Dermal  
Referring to the skin. For example, dermal absorption means passing through the skin.  
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 Dermal contact  
Contact with (touching) the skin [see route of exposure].  
 
Descriptive epidemiology  
The study of the amount and distribution of a disease in a specified population by person, place, 
and time.  
 
Detection limit  
The lowest concentration of a chemical that can reliably be distinguished from a zero 
concentration.  
 
Disease prevention  
Measures used to prevent a disease or reduce its severity.  
 
Disease registry  
A system of ongoing registration of all cases of a particular disease or health condition in a 
defined population.  
 
DOD  
United States Department of Defense.  
 
DOE  
United States Department of Energy.  
 
Dose (for chemicals that are not radioactive)  
The amount of a substance to which a person is exposed over some time period. Dose is a 
measurement of exposure. Dose is often expressed as milligram (amount) per kilogram (a 
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 measure of body weight) per day (a measure of time) when people eat or drink contaminated 
water, food, or soil. In general, the greater the dose, the greater the likelihood of an effect. An 
"exposure dose" is how much of a substance is encountered in the environment. An "absorbed 
dose" is the amount of a substance that actually got into the body through the eyes, skin, 
stomach, intestines, or lungs.  
 
Dose (for radioactive chemicals)  
The radiation dose is the amount of energy from radiation that is actually absorbed by the body. 
This is not the same as measurements of the amount of radiation in the environment.  
 
Dose-response relationship  
The relationship between the amount of exposure [dose] to a substance and the resulting changes 
in body function or health (response).  
 
Environmental media  
Soil, water, air, biota (plants and animals), or any other parts of the environment that can contain 
contaminants.  
 
Environmental media and transport mechanism  
Environmental media include water, air, soil, and biota (plants and animals). Transport 
mechanisms move contaminants from the source to points where human exposure can occur. The 
environmental media and transport mechanism is the second part of an exposure pathway.  
 
EPA  
United States Environmental Protection Agency.  
 
Epidemiologic surveillance [see Public health surveillance]. 
 
Epidemiology  
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 The study of the distribution and determinants of disease or health status in a population; the 
study of the occurrence and causes of health effects in humans.  
 
Exposure  
Contact with a substance by swallowing, breathing, or touching the skin or eyes. Exposure may 
be short-term [acute exposure], of intermediate duration, or long-term [chronic exposure].  
 
Exposure assessment  
The process of finding out how people come into contact with a hazardous substance, how often 
and for how long they are in contact with the substance, and how much of the substance they are 
in contact with.  
 
Exposure-dose reconstruction  
A method of estimating the amount of people's past exposure to hazardous substances. Computer 
and approximation methods are used when past information is limited, not available, or missing.  
 
Exposure investigation  
The collection and analysis of site-specific information and biologic tests (when appropriate) to 
determine whether people have been exposed to hazardous substances.  
 
Exposure pathway  
The route a substance takes from its source (where it began) to its end point (where it ends), and 
how people can come into contact with (or get exposed to) it. An exposure pathway has five 
parts: a source of contamination (such as an abandoned business); an environmental media and 
transport mechanism (such as movement through groundwater); a point of exposure (such as a 
private well); a route of exposure (eating, drinking, breathing, or touching), and a receptor 
population (people potentially or actually exposed). When all five parts are present, the exposure 
pathway is termed a completed exposure pathway.  
 
Exposure registry  
A system of ongoing followup of people who have had documented environmental exposures.  
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Feasibility study  
A study by EPA to determine the best way to clean up environmental contamination. A number 
of factors are considered, including health risk, costs, and what methods will work well.  
 
Geographic information system (GIS)  
A mapping system that uses computers to collect, store, manipulate, analyze, and display data. 
For example, GIS can show the concentration of a contaminant within a community in relation to 
points of reference such as streets and homes.  
 
Grand rounds  
Training sessions for physicians and other health care providers about health topics.  
 
Groundwater  
Water beneath the earth's surface in the spaces between soil particles and between rock surfaces 
[compare with surface water].  
 
Half-life (t½)  
The time it takes for half the original amount of a substance to disappear. In the environment, the 
half-life is the time it takes for half the original amount of a substance to disappear when it is 
changed to another chemical by bacteria, fungi, sunlight, or other chemical processes. In the 
human body, the half-life is the time it takes for half the original amount of the substance to 
disappear, either by being changed to another substance or by leaving the body. In the case of 
radioactive material, the half life is the amount of time necessary for one half the initial number 
of radioactive atoms to change or transform into another atom (that is normally not radioactive). 
After two half lives, 25% of the original number of radioactive atoms remain.  
 
Hazard  
A source of potential harm from past, current, or future exposures.  
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 Hazardous Substance Release and Health Effects Database (HazDat)  
The scientific and administrative database system developed by ATSDR to manage data 
collection, retrieval, and analysis of site-specific information on hazardous substances, 
community health concerns, and public health activities.  
 
Hazardous waste  
Potentially harmful substances that have been released or discarded into the environment.  
 
Health consultation  
A review of available information or collection of new data to respond to a specific health 
question or request for information about a potential environmental hazard. Health consultations 
are focused on a specific exposure issue. Health consultations are therefore more limited than a 
public health assessment, which reviews the exposure potential of each pathway and chemical 
[compare with public health assessment].  
 
Health education  
Programs designed with a community to help it know about health risks and how to reduce these 
risks.  
 
Health investigation  
The collection and evaluation of information about the health of community residents. This 
information is used to describe or count the occurrence of a disease, symptom, or clinical 
measure and to evaluate the possible association between the occurrence and exposure to 
hazardous substances.  
 
Health promotion  
The process of enabling people to increase control over, and to improve, their health.  
 
Health statistics review  
138 
 The analysis of existing health information (i.e., from death certificates, birth defects registries, 
and cancer registries) to determine if there is excess disease in a specific population, geographic 
area, and time period. A health statistics review is a descriptive epidemiologic study.  
 
Indeterminate public health hazard  
The category used in ATSDR's public health assessment documents when a professional 
judgment about the level of health hazard cannot be made because information critical to such a 
decision is lacking.  
 
Incidence  
The number of new cases of disease in a defined population over a specific time period [contrast 
with prevalence].  
 
Ingestion  
The act of swallowing something through eating, drinking, or mouthing objects. A hazardous 
substance can enter the body this way [see route of exposure].  
 
Inhalation  
The act of breathing. A hazardous substance can enter the body this way [see route of exposure].  
 
Intermediate duration exposure  
Contact with a substance that occurs for more than 14 days and less than a year [compare with 
acute exposure and chronic exposure].  
 
In vitro  
In an artificial environment outside a living organism or body. For example, some toxicity 
testing is done on cell cultures or slices of tissue grown in the laboratory, rather than on a living 
animal [compare with in vivo].  
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 In vivo  
Within a living organism or body. For example, some toxicity testing is done on whole animals, 
such as rats or mice [compare with in vitro].  
 
Lowest-observed-adverse-effect level (LOAEL)  
The lowest tested dose of a substance that has been reported to cause harmful (adverse) health 
effects in people or animals.  
 
Medical monitoring  
A set of medical tests and physical exams specifically designed to evaluate whether an 
individual's exposure could negatively affect that person's health.  
 
Metabolism  
The conversion or breakdown of a substance from one form to another by a living organism.  
 
Metabolite  
Any product of metabolism.  
 
mg/kg  
Milligram per kilogram.  
 
mg/cm2  
Milligram per square centimeter (of a surface).  
 
mg/m3  
Milligram per cubic meter; a measure of the concentration of a chemical in a known volume (a 
cubic meter) of air, soil, or water.  
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Migration  
Moving from one location to another.  
 
Minimal risk level (MRL)  
An ATSDR estimate of daily human exposure to a hazardous substance at or below which that 
substance is unlikely to pose a measurable risk of harmful (adverse), noncancerous effects. 
MRLs are calculated for a route of exposure (inhalation or oral) over a specified time period 
(acute, intermediate, or chronic). MRLs should not be used as predictors of harmful (adverse) 
health effects [see reference dose].  
 
Morbidity  
State of being ill or diseased. Morbidity is the occurrence of a disease or condition that alters 
health and quality of life.  
 
Mortality  
Death. Usually the cause (a specific disease, a condition, or an injury) is stated.  
 
Mutagen  
A substance that causes mutations (genetic damage).  
 
Mutation  
A change (damage) to the DNA, genes, or chromosomes of living organisms.  
 
National Priorities List for Uncontrolled Hazardous Waste Sites (National Priorities List or 
NPL)  
EPA's list of the most serious uncontrolled or abandoned hazardous waste sites in the United 
States. The NPL is updated on a regular basis. 
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National Toxicology Program (NTP) 
Part of the Department of Health and Human Services. NTP develops and carries out tests to 
predict whether a chemical will cause harm to humans.  
 
No apparent public health hazard  
A category used in ATSDR's public health assessments for sites where human exposure to 
contaminated media might be occurring, might have occurred in the past, or might occur in the 
future, but where the exposure is not expected to cause any harmful health effects.  
 
No-observed-adverse-effect level (NOAEL)  
The highest tested dose of a substance that has been reported to have no harmful (adverse) health 
effects on people or animals.  
 
No public health hazard  
A category used in ATSDR's public health assessment documents for sites where people have 
never and will never come into contact with harmful amounts of site-related substances.  
 
NPL [see National Priorities List for Uncontrolled Hazardous Waste Sites] 
 
Physiologically based pharmacokinetic model (PBPK model)  
A computer model that describes what happens to a chemical in the body. This model describes 
how the chemical gets into the body, where it goes in the body, how it is changed by the body, 
and how it leaves the body.  
 
Pica  
A craving to eat nonfood items, such as dirt, paint chips, and clay. Some children exhibit pica-
related behavior.  
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 Plume  
A volume of a substance that moves from its source to places farther away from the source. 
Plumes can be described by the volume of air or water they occupy and the direction they move. 
For example, a plume can be a column of smoke from a chimney or a substance moving with 
groundwater.  
 
Point of exposure  
The place where someone can come into contact with a substance present in the environment 
[see exposure pathway].  
 
Population  
A group or number of people living within a specified area or sharing similar characteristics 
(such as occupation or age).  
 
Potentially responsible party (PRP)  
A company, government, or person legally responsible for cleaning up the pollution at a 
hazardous waste site under Superfund. There may be more than one PRP for a particular site.  
 
ppb  
Parts per billion.  
 
ppm  
Parts per million.  
 
Prevalence  
The number of existing disease cases in a defined population during a specific time period 
[contrast with incidence].  
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 Prevalence survey  
The measure of the current level of disease(s) or symptoms and exposures through a 
questionnaire that collects self-reported information from a defined population.  
 
Prevention  
Actions that reduce exposure or other risks, keep people from getting sick, or keep disease from 
getting worse.  
 
Public availability session  
An informal, drop-by meeting at which community members can meet one-on-one with ATSDR 
staff members to discuss health and site-related concerns. 
 
Public comment period  
An opportunity for the public to comment on agency findings or proposed activities contained in 
draft reports or documents. The public comment period is a limited time period during which 
comments will be accepted.  
 
Public health action  
A list of steps to protect public health.  
 
Public health advisory  
A statement made by ATSDR to EPA or a state regulatory agency that a release of hazardous 
substances poses an immediate threat to human health. The advisory includes recommended 
measures to reduce exposure and reduce the threat to human health.  
 
Public health assessment (PHA)  
An ATSDR document that examines hazardous substances, health outcomes, and community 
concerns at a hazardous waste site to determine whether people could be harmed from coming 
into contact with those substances. The PHA also lists actions that need to be taken to protect 
public health [compare with health consultation].  
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Public health hazard  
A category used in ATSDR's public health assessments for sites that pose a public health hazard 
because of long-term exposures (greater than 1 year) to sufficiently high levels of hazardous 
substances or radionuclides that could result in harmful health effects.  
 
Public health hazard categories  
Public health hazard categories are statements about whether people could be harmed by 
conditions present at the site in the past, present, or future. One or more hazard categories might 
be appropriate for each site. The five public health hazard categories are no public health hazard, 
no apparent public health hazard, indeterminate public health hazard, public health hazard, and 
urgent public health hazard.  
 
Public health statement 
The first chapter of an ATSDR toxicological profile. The public health statement is a summary 
written in words that are easy to understand. The public health statement explains how people 
might be exposed to a specific substance and describes the known health effects of that 
substance.  
 
Public health surveillance 
The ongoing, systematic collection, analysis, and interpretation of health data. This activity also 
involves timely dissemination of the data and use for public health programs. 
 
Public meeting  
A public forum with community members for communication about a site.  
 
Radioisotope  
An unstable or radioactive isotope (form) of an element that can change into another element by 
giving off radiation.  
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 Radionuclide  
Any radioactive isotope (form) of any element.  
 
RCRA [see Resource Conservation and Recovery Act (1976, 1984)]  
 
Receptor population  
People who could come into contact with hazardous substances [see exposure pathway].  
 
Reference dose (RfD)  
An EPA estimate, with uncertainty or safety factors built in, of the daily lifetime dose of a 
substance that is unlikely to cause harm in humans.  
 
Registry  
A systematic collection of information on persons exposed to a specific substance or having 
specific diseases [see exposure registry and disease registry].  
 
Remedial investigation  
The CERCLA process of determining the type and extent of hazardous material contamination at 
a site.  
 
Resource Conservation and Recovery Act (1976, 1984) (RCRA) 
This Act regulates management and disposal of hazardous wastes currently generated, treated, 
stored, disposed of, or distributed.  
 
RFA  
RCRA Facility Assessment. An assessment required by RCRA to identify potential and actual 
releases of hazardous chemicals.  
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RfD [see reference dose] 
 
Risk  
The probability that something will cause injury or harm.  
 
Risk reduction  
Actions that can decrease the likelihood that individuals, groups, or communities will experience 
disease or other health conditions.  
 
Risk communication  
The exchange of information to increase understanding of health risks.  
 
Route of exposure  
The way people come into contact with a hazardous substance. Three routes of exposure are 
breathing [inhalation], eating or drinking [ingestion], or contact with the skin [dermal contact].  
 
Safety factor [see uncertainty factor]  
 
SARA [see Superfund Amendments and Reauthorization Act]  
 
Sample  
A portion or piece of a whole. A selected subset of a population or subset of whatever is being 
studied. For example, in a study of people the sample is a number of people chosen from a larger 
population [see population]. An environmental sample (for example, a small amount of soil or 
water) might be collected to measure contamination in the environment at a specific location.  
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 Sample size  
The number of units chosen from a population or an environment.  
 
Solvent  
A liquid capable of dissolving or dispersing another substance (for example, acetone or mineral 
spirits).  
 
Source of contamination  
The place where a hazardous substance comes from, such as a landfill, waste pond, incinerator, 
storage tank, or drum. A source of contamination is the first part of an exposure pathway.  
 
Special populations  
People who might be more sensitive or susceptible to exposure to hazardous substances because 
of factors such as age, occupation, sex, or behaviors (for example, cigarette smoking). Children, 
pregnant women, and older people are often considered special populations.  
 
Stakeholder  
A person, group, or community who has an interest in activities at a hazardous waste site.  
 
Statistics  
A branch of mathematics that deals with collecting, reviewing, summarizing, and interpreting 
data or information. Statistics are used to determine whether differences between study groups 
are meaningful.  
 
Substance  
A chemical.  
 
Substance-specific applied research  
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 A program of research designed to fill important data needs for specific hazardous substances 
identified in ATSDR's toxicological profiles. Filling these data needs would allow more accurate 
assessment of human risks from specific substances contaminating the environment. This 
research might include human studies or laboratory experiments to determine health effects 
resulting from exposure to a given hazardous substance.  
 
Superfund [see Comprehensive Environmental Response, Compensation, and Liability Act of 
1980 (CERCLA) and Superfund Amendments and Reauthorization Act (SARA)  
 
Superfund Amendments and Reauthorization Act (SARA)  
In 1986, SARA amended the Comprehensive Environmental Response, Compensation, and 
Liability Act of 1980 (CERCLA) and expanded the health-related responsibilities of ATSDR. 
CERCLA and SARA direct ATSDR to look into the health effects from substance exposures at 
hazardous waste sites and to perform activities including health education, health studies, 
surveillance, health consultations, and toxicological profiles.  
 
Surface water  
Water on the surface of the earth, such as in lakes, rivers, streams, ponds, and springs [compare 
with groundwater].  
 
Surveillance [see public health surveillance]  
 
Survey  
A systematic collection of information or data. A survey can be conducted to collect information 
from a group of people or from the environment. Surveys of a group of people can be conducted 
by telephone, by mail, or in person. Some surveys are done by interviewing a group of people 
[see prevalence survey].  
 
Synergistic effect  
A biologic response to multiple substances where one substance worsens the effect of another 
substance. The combined effect of the substances acting together is greater than the sum of the 
effects of the substances acting by themselves [see additive effect and antagonistic effect].  
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Teratogen  
A substance that causes defects in development between conception and birth. A teratogen is a 
substance that causes a structural or functional birth defect.  
 
Toxic agent  
Chemical or physical (for example, radiation, heat, cold, microwaves) agents that, under certain 
circumstances of exposure, can cause harmful effects to living organisms.  
 
Toxicological profile  
An ATSDR document that examines, summarizes, and interprets information about a hazardous 
substance to determine harmful levels of exposure and associated health effects. A toxicological 
profile also identifies significant gaps in knowledge on the substance and describes areas where 
further research is needed.  
 
Toxicology  
The study of the harmful effects of substances on humans or animals.  
 
Tumor  
An abnormal mass of tissue that results from excessive cell division that is uncontrolled and 
progressive. Tumors perform no useful body function. Tumors can be either benign (not cancer) 
or malignant (cancer).  
 
Uncertainty factor  
Mathematical adjustments for reasons of safety when knowledge is incomplete. For example, 
factors used in the calculation of doses that are not harmful (adverse) to people. These factors are 
applied to the lowest-observed-adverse-effect-level (LOAEL) or the no-observed-adverse-effect-
level (NOAEL) to derive a minimal risk level (MRL). Uncertainty factors are used to account for 
variations in people's sensitivity, for differences between animals and humans, and for 
differences between a LOAEL and a NOAEL. Scientists use uncertainty factors when they have 
some, but not all, the information from animal or human studies to decide whether an exposure 
will cause harm to people [also sometimes called a safety factor].  
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Urgent public health hazard  
A category used in ATSDR's public health assessments for sites where short-term exposures 
(less than 1 year) to hazardous substances or conditions could result in harmful health effects that 
require rapid intervention.  
 
Volatile organic compounds (VOCs)  
Organic compounds that evaporate readily into the air. VOCs include substances such as 
benzene, toluene, methylene chloride, and methyl chloroform.  
 
Other glossaries and dictionaries: 
Environmental Protection Agency (http://www.epa.gov/OCEPAterms/) 
 
National Center for Environmental Health (CDC) 
(http://www.cdc.gov/nceh/dls/report/glossary.htm) 
 
National Library of Medicine (NIH) 
(http://www.nlm.nih.gov/medlineplus/mplusdictionary.html) 
 
For more information on the work of ATSDR, please contact: 
 
Office of Policy and External Affairs 
Agency for Toxic Substances and Disease Registry 
1600 Clifton Road, N.E. (MS E-60) 
Atlanta, GA 30333 
Telephone: (404) 498-0080  
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